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In troduction
To relieve hip pain, restore the range of motion, and improve independency, almost 
21.000 total hip arthroplasties (THA) are implanted each year in the Netherlands.1 The 
incidence of osteoarthrosis of the hip is 27.000 cases per year and the Dutch government 
expects this number to increase by 52% over the period 2007 till 2040,2 the expected 
consequence is that the number of THA will also increase. Fortunately, the THA is one of 
the most successful medical intervention in the world and is even called 'The operation of 
the century'.3 Over more than half a century THA are implanted in older patients. In the 
last 3 decades THA are increasingly implanted in young patients because of these good 
results with older patients.4,5 However, in young patients the results are more variable 
with higher failure rates reported.6-12
This thesis is about the technique and results of the total hip arthroplasty in young 
patients. The chapters will focus on the results of cemented THA in patients much 
younger than the average, older population with end stage hip diseases. Not only 
primary THA will be discussed, but also the outcome of revision THA in this demanding 
population will be studied. The content of the chapters will explain why THA in young 
patients are still an orthopaedic challenge.
H istory
The current concept of the THA has been popularized by Sir John Charnley in 1959 
(Figure 1A-B).13 Before this period it was custom to treat end-stage hip diseases with 
osteotom ies of the pelvis or proximal femur, or by removal of the femoral head (a 
Girdlestone hip). In 1915 Murphy describes a new technique with the interposition of the 
fascia lata in the hip jo in t to relieve hip pain.14 In 1923 Smith-Petersen performed a first 
trial of a hip replacement using a glass cup between the femoral head and acetabulum.
As expected these glass cups soon failed, and he tried the same method with cups of 
bakelite and vitallium in 1937.15 These cups were not fixated to the bone.
Total replacement of the femoral head was first described by the Judet brothers and 
Moore.16,17 The Judet brothers used a metal reinforced plexiglass sphere, fixated in the 
femoral neck. Moore used the same concept, but used a prosthesis made of vitallium. 
Most of these prosthetic implants failed due to central migration through the medial 
acetabulum wall.
The first experiments of Charnley consisted of jo int surface replacement with 
polytetrafluorethylene. Instant relief of pain was seen, but rapidly most patients
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developed femoral head necrosis. After this failed attempt he replaced the entire femoral 
head with a metal implant and the acetabulum with a polytetrafluorethylene cup, the 
first concept of a THA.13 Fixation of the implants to the bone was achieved with bone 
cement. The idea of cement fixation in orthopaedic implants came from Haboush.18 In 
the fifties, he used dental cement for prosthetic fixation. His results were discouraging 
due to the design of the implant. In 1959 Charnley designed a new and better concept of 
his THA and in 1963 the polytetrafluorethylene was replaced by polyethylene because of 
the markedly fast wear. Still, this 50-year old design is one of the most successful 
implants in the current prosthesiology.19,20
Since then different concepts, improvements and ideas have been developed in an 
attempt to improve the (long-term) survival outcome of THA in young patients. First, in 
the sixties Ring implanted uncemented cups with screw fixation.18 Ceramic components 
to reduce the rate of wear were first introduced by Mittelmeier in 1974.21 Improvements 
of the cement fixation were investigated by Slooff, for example.22,23 He replaced the 
original 'finger-packing' method of inserting the cement into the femoral canal by 
retrograde filling of the intramedullary canal with cement by using a cement syringe, the 
so called second generation cementing technique. In the last 4 decades many implant 
types and designs have been introduced on the market, each with their own advantages 
and disadvantages, different ways of fixation, shapes, and materials.
C urren t concepts
In general, two types of prosthetic fixation are being used: uncemented and cemented 
implants (Figure 2A-B). Stem fixation in uncemented implants is based on the bony 
ingrowth into or onto the surface of the implant. This can be enhanced with a porous 
coating or with bioinert or bioactive materials, like a hydroxyapatite coating. In cemented 
implants the function of the two-component acrylic bone cement that is being used is not 
to glue the implant to the bone, but rather filling the irregular gaps between the bone 
and implant, because a perfect anatomical fit is not possible. The optimal shape of the 
femoral component in cemented implants should transm it both torsional as well as axial 
load through the cement layer and bone, w ithout creating peak stresses and without 
micro movements which could damage the cement layer or bone. Two types of stem 
designs are used in cemented implants to achieve these goals: the 'loaded-taper' or 
'forced-closed' designs and the 'com posite-beam ' or 'shaped-closed' fixation.24-26 Taper- 
closed based stems should have a highly polished surface and are allowed to subside 
some millimetres within the cement mantle. Shape-closed designs do bind rigidly to the 
cement because movement of these stems within the cement mantle might result in 
damage of the cement which can result in loosening of the stem.
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Cup fixation can also be based on these two ways of fixation. The cemented cups are 
inserted in the acetabulum after removing the cartilage and sclerotic bone using a 
reamer, next the PMMA cement is pressurized in the acetabular bone and the cup is 
placed. Uncemented implants can be inserted with different techniques. Primary stability 
of press-fit cups is achieved with direct contact of a slightly over-sized cup within the 
under-reamed acetabulum. Another technique is to use a screw-in cup, these cups have 
a threaded design and the cups are screwed into the acetabulum. In both types of 
uncemented cups, additional screws can be used to optim ize primary stability. Long-term 
fixation is based on bony ingrowth into the rough surface in the same way as the femur.
Over time the original cementing technique has been changed. The first generation, 
so-called 'finger-packing', cementing techniques consisted of hand-mixing the two 
components in an open bowl. For the femur the cement was rolled by hand in the form of 
a doughy sausage and stuffed with a finger into the femoral canal before inserting the 
femoral stem. The cup was inserted in the acetabulum after a lump of cement was placed 
by hand in the prepared acetabulum .13 In the past decades, several improvements have 
been made to create the current generation cementing technique27: the use of an 
intramedullary femoral plug to improve filling and cement-interface strength,28 vacuum 
mixing of the cement to reduce porosity,29,30 pressurizing the cement for better cement 
penetration,31 the use of a modern cement gun for better filling and pressurisation,22 and 
pulse lavage to clean the recipient bone bed.27
Y oung  patients, w h y  a cha llenge?
Because of the favourable results of THA in the elderly population surgeons have started 
to implant THA in young patients. However, obtaining the same satisfying long-term 
survival of THA in young patients remains challenging. At the moment, stem survival is 
acceptable in most studies in general, but the survival of the cup is the weakest link in 
patients younger than 40 years.7,8,10,32-35 The reported differences in survival rates 
between the cup and stem are variable from 1% (97% [stem] versus 96% [cup]34) in 
one study to 11% (98.3% [stem] versus 87.6% [cup]10) in another study at 10 years. 
Despite attempts to improve cup designs and by using new materials, the acetabular 
component still shows lower survival rates than femoral implants.
Young patients must function longer with their THA than the typical elderly patient, 
and they are also engaged in higher levels of activity. This is associated with higher 
revision and reoperation rates.36-40 Therefore, this population needs durable implants 
with excellent long-term survival.
Another underestimated factor which is very challenging in these young patients is the 
pathogenesis of the hip disease which leads to the decision to implant a THA. In the older 
population, primary osteoarthritis is the major indication for implantation of a THA. In 
young patients the pathogenesis is based on secondary osteoarthritis. D ifferent diseases 
can cause secondary osteoarthritis: developmental dysplasia of the hips, rheumatoid 
arthritis, Perthes' disease, avascular necrosis, epiphyseal dysplasia, trauma, e.g. Most of 
these diseases are accompanied with bone stock loss of the acetabulum. This makes 
normal and stable implantation of the cup often very difficult and consequently obtaining 
a good long-term cup survival is becoming harder.
All these issues: higher activity levels, higher demands, and pre-existing bone stock loss 
make THA implantation in young patients with good long-term results a real orthopaedic 
challenge.
Bone Im paction  grafting
In case of bone stock loss during difficult primary acetabular reconstruction or a femoral 
or acetabular revision, bone impaction grafting can be used to restore this deficiency. 
Bone impaction grafting is a reconstruction technique that biologically restores bone 
stock loss. The use of morselized bone grafts was published in the seventies by Hastings 
and Parker.41 They reconstructed cavitar defects of the acetabulum in patients with
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rheumatoid arthritis using morselized bone grafts and cementing a vitallium cup. 
McCollum et al. adapted this technique using wafers of bone.42 Slooff et al. developed 
this technique into the current method of bone impaction grafting and introduced 
vigorous impaction of the grafts.43
The bone impaction grafting technique is performed as described below:
After resection of the femoral head, the acetabulum is prepared in the normal way, all 
cartilage, sclerotic bone and cysts are removed. Segmental defects of the acetabular rim 
and/or medial wall are first reconstructed with thin metal wire meshes, which are 
trimmed and adapted with special scissors and clamps to close the defect and contain the 
graft entirely. These meshes are fixated with several self drilling and tapping screws if 
needed (Stryker-Howmedica, Newbury, United Kingdom) (Figure 3A). When full 
containment with the wire meshes is achieved, a cavitary defect remains. Remaining 
sclerotic areas of the host bone are perforated with multiple small drill holes to enhance 
better vascularisation of the graft. The bone is cleaned using pulse lavage and trabecular 
bone chips of 0.7-1.0 mm are placed in the defect and impacted tightly using specially 
designed impactors (Figure 3B-C). The impactors increase in size and the size of the last 
used impactor responds to the size of the polyethylene cup with its cement layer.
Multiple layers of graft are impacted until the defect is completely solidly filled. A 
minimum layer of 5mm of impacted bone grafts is created. The bone chips are made of 
autograft and/or a combination of autograft and allogenic femoral heads. These femoral 
heads are morselized with a special bone mill or by hand using a large rongeur, after 
removal of the cartilage of the heads using a specially designed reamer set. We always 
intend to reconstruct the normal anatomical position of the centre of rotation using the 
transverse ligament as reference. Vacuum-mixed cement loaded with antibiotics is 
injected directly from a cement gun and the cement is pressurized by a special 
pressurizer. After 4-5 minutes of pressurizing a full polyethylene cup is placed in the 
cement layer and held in position until the cement is completely polymerized in about 9­
11 minutes (Figure 1D). The bone impaction grafting technique has been described in 
detail in the literature.44-48 Specimen retrieval studies have shown that the layer of 
impacted bone grafts, at least at the acetabular side, incorporates into normal trabecular 
bone.49,50 With the incorporation of these bone grafts a unique and strong construction of 
the cup, cement, impacted grafts, and pelvic bone is created.
On the femoral side, reconstruction with impacted bone grafts is performed in a 
sim ilar way during the femoral revision procedure using a specially designed set of 
instruments. After cleaning and reaming the femoral shaft, segmental defects are 
reconstructed with thin metal wire meshes. Often reconstruction of the calcar is 
necessary. A distal femoral plug is inserted with a guide wire attached in the femoral 
shaft at least 4-5cm below the most distal defect. Over this guide wire a phantom 
implant is used to impact the morselized bone grafts in the femoral shaft (Figure 4A-B). 
The bone grafts that are used in the distal femoral shaft are 50% smaller than the ones 
used in the acetabular reconstruction. The phantom impactor and the intended Exeter 
implant with its 2mm cement layer are of equal size. At the more proximal part of the 
femur, larger morselized grafts are used and these are solidly impacted around the 
phantom with special small impactors creating rotational stability of the final implant 
(Figure 4C). Finally the femoral implant can be inserted and cemented into the new 
reconstructed fem ur.51,52
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Figure 3A-D. The reconstruction of acetabular defects with bone impaction grafting.
Reconstruction of the defects with wire meshes (A), placing of the morselized bone grafts (B), Impaction of the 
bone grafts (C), and final result with a cemented polyethylene cup (D).53
Figure 4A-C. Femoral reconstruction of bone defects with bone impaction grafting.
Reconstruction of the most distal part (A), the phantom in situ for reconstruction of the middle part (B), and 
reconstruction of the most proximal part with special impactors (C).52
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O utline  o f the thes is
The aim of this thesis is to evaluate the hypothesis that the results of current cemented 
total hip arthroplasty in young patients are still satisfactory. The secondary objective is to 
evaluate the results of the use of impacted morselized bone grafts in the reconstruction 
of bone defects in these young patients. The Department of Orthopaedic Surgery of the 
Radboud University Nijmegen Medical Centre uses only cemented implants in all patients 
who need a total hip arthroplasty, even the young patients. Currently, there is a clear 
trend for using uncemented implants in these patients; some countries even abandoned 
the use of cemented implants in young patients because of the suggested disappointing 
results of cemented total hip arthroplasties in this population according to scientific and 
popular literature.
But are these results really disappointing? In order to achieve our goals and provide 
an answer to this question, several other questions arise and need to be addressed.
First, the results of cemented total hip arthroplasties are compared with the results of 
uncemented total hip arthroplasties. In C hapte r 2 we describe the results of a literature 
review about reported studies with a follow-up longer than 10 years to answer the 
question whether the results of cemented THA in young patients are really that 
disappointing. With this review we could confirm or invalidate the statement that 
cemented THA are inferior to uncemented THA.
After evaluating the published results we critically evaluated our own current results. 
Since 1997 we only use the Exeter stem (Stryker-Howmedica, Newbury, UK) implant. But 
are the medium-term results of this prosthetic implant in very young patients (under 40 
years) worrisome or promising? Do we need to continue our current practise or do we 
indeed need to, as the literature implies, switch to uncemented stems? These questions 
are answered in Chapter 3.
We use the bone impacting grafting technique in the reconstruction of all acetabular 
defects. The cups that need reconstruction have acetabular defects and are therefore 
more difficult and challenging total hip arthroplasties. It could be that the results of these 
cups are inferior to the results of the cups without bone impaction grafting. Are the 
results of cemented cups in young patients not good and are the results of reconstructed 
cups inferior to the cups without a reconstruction? In C h apte r 4 we compare the results 
of the cups reconstructed with and without bone stock loss and subsequent 
reconstruction of these defects with bone impaction grafting in patients under the age of 
40.
In Chapter 5 we present an overall outcome of the results of all total hip arthroplasties 
in the patients under the age of 40. Both cup and stem were assessed and all cemented 
designs used between 1988 and 2004 were included. Are the overall results of all 
cemented THA in our young patients comparable to those reported in the literature?
Using these criteria, it allows us to present the long-term results of cemented total hip 
arthroplasties in the very young patients of our population.
After addressing the above mentioned questions we extended our database with the 
patients operated between the age of 40 and 50 years in C hapte r 6. Are the results of 
these patients more like the normal, older total hip arthroplasty population or are their 
results more comparable to those of the very young population under the age of 40?
What are the long-term results of total hip arthroplasties with an acetabular 
reconstruction with bone impaction grafting in patients under the age of 50? To answer 
this question, we evaluated all patients under 50 years operated in our department since 
the development of this technique at our clinic. We started to use this technique in young
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patients in 1979. In C h apter 7 we describe the results of this reconstruction technique 
since its development.
C h ap te r 8 defines a new criterion: the revisability of a prosthesis. Are cemented THA in 
young patients revisable? In this chapter we describe the long-term results of all total hip 
arthroplasties in patients under the age of 50 and the short to medium term results of 
the revisions performed within this population. We would like to emphasize that not only 
the results of the primary total hip arthroplasty are important but also the results of the 
revisions of primary total hip arthroplasties in young patients.
Not only should the results of primary total hip arthroplasties be evaluated, but also the 
results of revision arthroplasty. The question "what the medium and long-term results 
are of cemented revision total hip arthroplasty in patients under the age of 60?" is 
answered in C h ap te r  9. Are these results acceptable or should we only use uncemented 
implants in the revision of failed primary total hip arthroplasty?
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A bstract
Background and purpose. We extracted from the literature all reported outcomes of 
uncemented and cemented total hip arthroplasties implanted in patients younger than 
50.
Methods. We searched Medline (1966- 1 January 2009) and PubMed for articles 
related to total hip arthroplasties in patients under 50 years. Reference lists were 
evaluated for relevant papers. In addition, we also used the data of the Swedish Hip 
register.
Results. 109 articles were found related to total hip arthroplasty in patients under 50 
years of age, 37 articles had a mean follow-up longer than 10 years. Although 
uncemented hip implants are widely used in patients under 50 years, there are only 2 
reports that fulfil the NICE criteria (follow-up of >10yrs and survival of >90%).
Interpretation. It must be concluded that in the current literature about total hip 
arthroplasty in young patients the current trends still are not supported by survival data 
in contrast to cemented hips. Additional information about the long-term results of newer 
implants is essential. In the current literature, most satisfying results are obtained with 
cemented implants.
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In troduction
The total hip replacement is one of the most successful and cost effective interventions of 
modern medicine [1,2]. The era of modern hip implants started with the development of 
the cemented total hip arthroplasty as developed by Sir John Charnley (1961). Soon 
after the introduction of these cemented total hip implants it became clear that the 
outcome of these cemented hip implants in younger patients was less favourable [3-5].
As a reaction to these disappointing results with cemented hips implants in young 
patients, surgeons and companies started to develop and use uncemented hip implants 
in these younger patients. These implants are based on the osseointegration of bone 
onto or into the outer shell of the implant. Therefore, these implants have a rough or 
coated outer surface (with hydroxyapatite for example). Within the shell, a polyethylene 
or ceram ic liner as bearing surface is placed. These uncemented hip implants are 
available in many modifications and these implants are on the market now for more than 
25 years. In many countries, these uncemented total hip implants dominate the market 
and are very frequently used in the younger patients with hip problems requiring a hip 
replacement. In some countries like the Unites States, cemented implants are hardly 
ever used in patients under 50 years. Over 90% of all THA inserted in North America are 
uncemented, while >90% of all THA implanted in Scandinavia and some countries in 
Europe are cemented: the so-called 'North Atlantic Divide'.
However, especially in young patients, surgeons should be interested in offering hip 
implants to young patients that will provide long-term success [6]. Most short-term  and 
intermediate-term studies are not helpful in differentiating failing components from 
components that have long-term success [6].
As a sequence of a discussion about the long-term  survival of uncemented and 
cemented total hip arthroplasties in young patients in 2005 [7,8], we have performed a 
literature review of all available studies about total hip arthroplasties in patients under 
the age of 50. The goal of this review was to study the current, updated, clinical evidence 
that supports the popularity of uncemented total hip prostheses in young patients under 
50 years.
Long-term outcome of hip prostheses is in generally defined as the outcome 10 years 
or more after surgery. For this review we adopted the criteria of the NICE 2003 report for 
a good long-term outcome of hip prostheses, which is defined as a survival rate of 90 
percent or more of the whole implant at 10 years after surgery [9]. We studied and 
describe the literature of all studies about total hip arthroplasties in patients under the 
age of 50 with a minimum follow-up of 10 years on average which fulfils the these NICE 
criteria of >90% survival after 10 years. Also, we have performed a statistical analysis of 
the results of uncemented and cemented outcomes, in studies with a mean follow-up 
longer than 10 years on average. With this review we would like to open the discussion 
about evidence based medicine in total arthroplasty in a special and high demanding 
population: patients under the age of 50.
M ethods
A system ic literature review was performed searching Medline and PubMed (1966- 1 
January 2009) for articles related to total hip implants in patients less than 50 years. 2 
groups of key words were used in combination with each other (group 1: less, 50, fifty, 
45, 40, forty, 35, 30, thirty, 25, 20, twenty, or young* and group 2: arthroplast*, hip, 
acetabul*, femor*, component*, cement*, uncement*, or noncement*). Asterisks were 
used to expand the search field of a key word. We also searched the reference list of 
selected papers for relevant other papers.
Inclusion criteria for the review were: primary total hip arthroplasty, age at index 
surgery <50, and minimum mean follow-up of 10 years. Additional, another inclusion 
criterion was used (adapted NICE-criteria of survival of >90% with endpoint revision for 
any reason of either component) for the descriptive review. We also included 
combinations of fixation techniques (multiple techniques). In the so called hybrid total 
hips uncemented cups are combined with cemented stems, in the reverse hybrid hips
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cemented cups are combined with uncemented stems. Exclusion criteria maintained 
were: studies with only bipolar or resurfacing arthroplasty, hip arthroplasty because of 
tumours, reports of only one component of a total hip arthroplasty or studies with 
incomplete data (for example studies only reporting aseptic survival). Revision was 
defined as the removal or replacement of one or more components of the arthroplasty. 
With this definition, liner exchanges in uncemented implants were also considered as a 
revision.
The retrieved articles of the search query were first scanned for relevance and subject. 
The remaining articles were evaluated on number of patients and arthroplasties, age of 
the population (mean and range), duration of follow-up, type of implant(s) used, surgical 
techniques used (cemented, uncemented, hybrid or multiple techniques) and survival 
outcome. In case the survival was only described in a graph, the 10 year survival was 
estimated from the graph. Authors of articles with satisfying long-term (>10 yrs) were 
contacted if the results at 10 years were not reported or no survival graph was present, 
to obtain the 10 years results of these studies. The articles were reviewed by two 
independent reviewers and both extracted data from  the articles.
For statistical analysis, update studies of previous reports were excluded from the 
statistical analysis in order to prevent inclusion of the same results more than 1 time, 
and only studies with endpoint revision for any reason were included. A Thunnel plot was 
used to outline any publication bias and we used a weighted regression analysis for 
testing significant differences in survival between the different fixation types, correcting 
for (if reported): population size, 95% confidence intervals, number of patients 
remaining after 10 years.
Resu lts
Papers
The search query resulted in 2999 hits and after evaluation and selection 109 studies 
reported survival results in patients under the age of 50. Of these 109 studies, 37 studies 
had a mean survival of >10 years, and 15 articles comply with the criteria of a reported 
survival of >90% after a mean follow-up of >10 years. Figure 1 shows the flowchart of 
the articles included in the search.
Table 1 shows the articles of total hip arthroplasty in patients under the age of 50, 
with a minimum average follow-up of 10 years, and with a survival of >90% with 
endpoint revision for any reason of either component. O f the 15 remaining studies, 1 was 
about uncemented implants, 13 were about cemented total hip arthroplasties and 1 
reported the use of multiple techniques (uncemented and hybrid implant fixation). No 
prospective comparable studies were available which fulfils the search criteria.
Uncemented total hip implants
Only one study about uncemented implants does fulfil the NICE criteria. In the study 
of McCullough et al. [10] a survival of 90% at 10 years is reported, with the use of a 
custom-made hydroxyapatite-coated femoral implant. They studied 42 hips in 25 patients 
with inflammatory polyarthropathy. The mean age in this study was 21 (11-35) years. 
Patients aged less than 16 years had the highest risk of failure of the femoral component 
(28.5% at 10 years). However, in normal standard orthopaedic practise it is very unusual 
to implant custom made prostheses.
Cemented total hip implants
Boeree and Bannister [11] reported the outcome of 46 cemented total hip implants in 34 
patients under 50 years. The average age was 38 (24-49) years. Diagnoses were a wide 
range of hip diseases, however most rheumatoid arthritis (12 hips) and congenital hip 
dysplasia (11 hips). The survival rate was 90% at 10 years, just fulfilling the NICE 
criterion.
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Figure 1. Results of the search query and selection after the use of the search criteria
Emery et al. [12] reported on 57 hips implanted in 46 patients under the age of 50 
years. The average age was 41 (17 to 49) years and the average follow-up was 13 years. 
Most frequent diagnoses were primary osteoarthritis in 23 hips, rheumatoid arthritis in 12 
hips and congenital hip dysplasia in 10 hips. The survival of the implant was 90% at 10 
years. After 10 years there is a large decline in survival with a survival of 68% at 15 
years.
Joshi et al. [13] reported on the long-term outcome of 218 cemented total hip 
arthroplasties in 141 patients under 40 years (mean 32, range 16-40 years). Indication 
for the hip implants was rheumatoid arthritis in 74 hips, congenital hip dysplasia in 47 
hips, ankylosing spondylitis in 41 hips and 56 had osteoarthritis. The survival of the 
implant with endpoint revision of any part of the prostheses was 93% at 10 years and 
75% at 20 years.
Keener et al. [14] reported the 25 years results after 93 cemented total hip 
arthroplasty in 69 patients less than 50 years. The average age was 42 (18-49) years. 
Diagnoses for the hip implant were multiple, but most congenital hip dysplasia (28 hips), 
primary osteoarthrosis (11 hips) and posttraumatic arthrosis (11 hips). Unfortunately, 
the survival rate at 10 years was not reported. Analyzing the reported survival curves, 
the 10 years survival fulfils the 90% criterion. The survival rate with endpoint revision for 
any reason was reported as 69% at 25 years and 60% at 30 years. The evaluated cohort 
in the study of Keener et al. was an update of the same cohort first reported by 
Callaghan et al. [15] and Sullivan et al. [16], all showing the same results after 10 years.
In the study of Kerboull et al. the results of 287 Charnley-Kerboull implants were 
reported [17]. The 222 patients had a mean age of 40 (15-50) years and were followed 
up to 25 years. They found no significant differences in the survival in patients under and 
above the age of 40. The only predictive factor of loosening they found was a wear rate 
higher than 0.1 mm per year.
Kobayashi et al. [18] reported the outcome of 66 cemented total hips in patients 
under 50 years. The average age was 37 (18-50) years. Most frequent diagnoses were 
rheumatoid arthritis (18 hips) and osteoarthrosis. Although they did report the survival of 
the cup and the stem separately, at 10 years the cup survival for any reason was 98% at 
10 years and the stem survival was not reported at 10 years but at 16 years to be 96%. 
Even in case these cup and stems revisions were done separately in patients, and even 
including one revision for septic loosening who was excluded by the authors, the 90%
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No. No. Mean age Follow-up Type of Survival THP endpoint
Hips Patients (range) (range) Implant any reason (95% C.I.)
42 25 21 (11-35) 11.2 (8-13) HA CAD- CAM 90% (78-97%)


































Singh et al.(2004) 38
46 34 38 (24-49) 12 (10-18) Charnley & Howse 90% (n/a)
93 69 42 (18-49) 20 (5-25) Charnley 90% (84-96%)
57 46 41 (17-49) 13 (0.3-21) Stanmore 90.8% (n/a)









Kerboull287 222 95.9% (92.8-98.4%)
66 n/a 37 (18-50) 14 (10-20) + Charnley 98.2% (n/a)
12.5 (10­
17)123 101 42 (n/a-50) Exeter 94.4% (89-98%)
31.7 (17­
39)226 161 19.7 (2-30) Charnley 93% (90-96%)
22.7 (0.1­
30.3)43 24 28 (19-39) Charnley 91% (82-100%)
89 67 42 (18-49) 18 (16-22) Charnley 90% (84-96%)
190 173 41 (18-50) 15.6 (1-31) Charnley 94.9% (89.7-100%)
292 195 38 (12-50) 15 (1-36) Charnley 93% (90-96%)
33 42 (22-49) 10 (5.3- HA JRI Hybrid: 100% (78­14.2) Furlong 100%)
Uncemented: 96% (75­
100%)
*: Updates of same cohort; t: deceased excluded HA: Hydroxyapatite-coated
survival at 10 years criterion is fulfilled. Revisions rates were highest in the patients with 
rheumatoid arthritis.
Lewthwaite et al. [19] present the results of the cemented Exeter hip in patients under 
the age of 50. They found a survival of 94.4% after 10 years, after evaluation of 123 hips 
in 101 patients. A rather significant part (44 patients) of their original population was 
excluded of the study. In 10 years, 6 hips were revised and 1 periprosthetic fracture 
occurred but the original components retained.
Sochart and Porter [20] reported the long-term results of 43 total hip replacements in 
24 young patients (mean age 28 years) who had ankylosing spondylitis at 18 to 30 years 
after surgery. Survival of the total hip replacement was reported at 91% at 10 years, 
73% at 20 years and 70% at 30 years.
In another report by Sochart and Porter they reported the long-term results of 226 
cemented total hip replacements in 161 patients in patients under 40 years [21]. The 
average age was 32 (17-39) years. Indication for the total hip was congenital dislocation 
of the hip in 60 hips, primary osteoarthrosis in 66 hips and rheumatoid arthritis in 100 
hips. Survival of the total hip replacement was 91% at 10 years, 67% at 20 years and 
65% at 25 years. Total hip implanted in patients with primary osteoarthritis had the 
worst results, 86% survival at 10 years.
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Wroblewski, Siney and Fleming report in two papers, probably based on one 
population under 50, a survival fulfilling the NICE-criteria. In the first paper a subgroup 
of 190 hips in 173 patients with low-wear rates achieve a survival of 95% at 10 years 
[22]. The second paper with 292 hips in 195 patients with inflammatory arthrosis shows 
a survival of 93% after 10 years [23]. They concluded that wear and aseptic cup 
loosening are the main long-term problems.
Hybrid total hip implants
There were no studies available with only hybrid implanting techniques that fulfilled the 
criteria
Multiple implantation techniques
Singh et al. [24] reported excellent survival rates in a population consisting of 38 hips in 
33 patients. All patients had an uncemented JRI Furlong hydroxyapatite coated stem, the 
first 14 hips received a cemented cup and the remaining 24 a screw-fit hydroxyapatite 
coated cup. The mean age was 42 (22-49) years with an average follow-up of 10 (5.3­
14.2) years. The reversed hybrid arthroplasties showed a survival of 100% at 10 years 
and the total uncemented arthroplasties 96% at 10 years.
Scandinavian Hip Registers
The Swedish register is the only register, which presents data of total hip arthroplasties 
inserted in patients younger than 50 years. The last available annual report of the 
Swedish National Hip Arthroplasty Register is from 2007 [25]. In this report, the survival 
of the cohort of all cemented and the cohort of all uncemented implants inserted in 
patients younger than 50 years in Sweden in the period 1992-2007 is reported using 
survival analyses for endpoint revision for any reason. At 10 years, both the cemented 
and the uncemented survival curves are lower than 90%, so the NICE criteria are not 
passed. At 16 years after implantation the survival of the cemented hip is for man 74.7% 
(95%C.I. 67.4-82.1) based on 1478 included hip arthroplasties and 72.5% (95%C.I. 
66.4-78.7) for women based on 1883 hips. The outcome of the uncemented implants 
however, is clearly worse. At 16 years after implantation the survival of the uncemented 
hip is for man 57.4% (95%C.I. 47.5-67.4) based on 1371 included hip arthroplasties and 
for women 54.3% (95%C.I. 46.8-61.7) based on 1347 hips. Unfortunately, no detailed 
reports on individual implants are available to specify the results of the newer 
uncemented implants.
Statistical analysis
For statistical analysis, first a Thunnel plot of all the studies with a follow-up longer than 
10 years with any survival rate was made (n=37) (Figure 2). The log of the number of 
patients included in the studies was related to the overall outcome (survival) of the THA 
with endpoint revision for any reason of either component. 37 studies with were included 
in the forest plot and the different fixation types were noted separately. No specific 
outliners were observed and therefore no publication bias is noticed.
Articles which were updates of other studies were not included in this statistical 
analysis (2 studies about cemented implants), 1 study about cemented implants did not 
report survival with endpoint revision for any reason and was excluded, and Singh et al. 
[24] reported in their study with multiple techniques the results of uncemented implants 
separately and therefore these results could be included. Finally, twenty-three studies 
with 3759 patients in total discussed the outcome of cemented THA (26 studies minus 2 
updates and 1 incomplete report), and 7 studies about uncemented implants with in total 
372 patients were included (6 studies plus the results of the uncemented implants of 
Singh et al.). A weighted regression analysis showed a significant better survival of the 
cemented THA in contrast to the uncemented THA: 87.7% (95%CI: 83.2-92.2%) versus 
75.2% (95%CI: 66.3-84.1%) (difference: 13.7% (95%CI: 9.7-17.7%); p< 0.001).
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Figure 2. Forest plot of the studies with a follow-up of more than 10 years.
D iscussion
Although uncemented implants are very popular in patients under 50 years of age and 
in some countries are exclusively used in these patients, there is limited clinical evidence 
that these implants really have improved the outcome for these patients at 10 years or 
more after surgery, based on the results reported.
Confusing in studying outcome studies of uncemented hips is the fact that revision of 
a failed insert of an uncemented metal shell is not always reported as a revision. Most 
uncemented cup implants exist of a metal outer shell and an insert of polyethylene. In 
many of these uncemented designs, this plastic inserts wears out and has to be replaced. 
If the metal shell is still well fixed in the bone, surgeons have the option to change only 
the insert. However, not all studies report this exchange as a revision, which can make a 
dramatic difference in the reported outcome (e.g. cup survival with endpoint revision of 
the metal shell at 14 years is 70%, however including liner exchange 54%(Capello et al. 
[26])).We agree with the Scandinavian Hip Registers that these liner exchanges should 
be included in the reported revision survival rates. The other confusing fact, both for 
surgeons but also for patients who are reviewing the literature using the internet, is that 
many outcome studies, uncemented and cemented, are reported on only the cup or only 
the stem survival. Although for scientific reasons focussing on one part of the implant is 
correct, it would be really an improvement to make the literature more clear to present 
in all abstracts of primary hip implants always the survival with endpoint revision of 
either component. Of course, patients will benefit only of a total hip implant if both 
components survive well. A confounding factor in our conclusions and statistical analysis 
could be that the underlying diagnoses of the hip disease and the activity level of these 
patients are not comparable between cemented and uncemented studies. The used
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studies were very heterogenic. Patients with primary osteoarthritis do worse, relative to 
patients with rheumatic diseases or other underlying hip diseases. However, as in many 
countries in all young patients uncemented implants are used, it is unlikely that this will 
bias the conclusion. Other lim itations are the fact that the long-term results of the newer 
generation uncemented implants are not published (yet) and that the results of studies 
with bad results are frequently not published.
In the review we found 9 studies about uncemented hips that had a minimum mean 
follow-up of 10 years [10,26-33]. However, only one met the NICE criteria, but this study 
is about custom made prosthesis in low demanding patients. Two important studies that 
did not fulfil the inclusion criteria should be discussed. Kim et al. reported a series of 118 
hips in 80 patients at a mean follow-up of 9.8 years [34]. Therefore this study was not 
included, however this study shows an excellent survival of an uncemented hip with a 
survival rate of 99%. These results are very promising and will fulfil the NICE criteria in 
the future. A problem observed in this study was the very high rate of polyethylene wear. 
The other report that should be discussed is the study of McAuley et al. [6]. This was not 
included initially because, due to a different method of reporting, the average follow-up 
was only 6.9 years. In the study they report a calculated survival rate of 89% at 10 
years, approaching the NICE criteria. This important study is the largest one available on 
561 uncemented hips in 488 young patients with the longest follow-up. The mean age of 
was 40 years (16-50 years). The main indications were osteoarthritis (249 hips) and 
osteonecrosis (111 hips). The survival rate at 15 years in their cohort was 60% with 
endpoint revision for any reason.
A good survival rate of >90% after a mean of 10 years follow-up is not a guarantee 
for good very long-term survival. An example is the study of Emery et al. [12]. After 10 
years their study showed a result of 90%, just fulfilling the criteria. But after 15 years 
their survival was 68%, a decrease of 22% in 5 years.
Because cemented total hip implants were already long in use before the implantation 
of contemporary uncemented hip implants started, long-term  reports on cemented hips 
exceeds the reported survival of uncemented implants. Survival data of cemented hips 
with endpoint any revision have been reported of 60% after 30 years (Keener et al.
[14]), 75% after 20 years (Joshi et al. [13]), again 75% after 20 years (Devitt et al.
[35]) and 73% at 20 years (Sochart and Porter [20,21]). These long-term survival data 
are superior to the longest report available of uncemented hips which has an endpoint 
revision for any reason at 15 years is 60% (McAuley et al. [6]). Although uncemented 
implants are use over 25 years, most first generation implants are abandoned. Modern 
uncemented implants seem to have a better survival, but they need to prove their value 
on the long-term follow-up. There are studies about the 2nd and 3rd generation 
uncemented implants with good short term results, like Delaunay et al. [36]. After a 
mean follow-up of 7.3 years they had a survival of 100%. Another example is the study 
of Kennedy et al. [37], they found a survival of 94% after 5 years, with a mean follow-up 
of 7.5 years. Therefore new or updated reports of newer uncemented implants in young 
patients are necessary to validate the use of uncemented implants in these patients. The 
new generation uncemented implants show promising short and mid-term survival rates. 
We hope we can give an update over 5 years including the long-term reports of these 
implants.
The Swedish hip register confirms the unsatisfying outcome of all arthroplasties in 
patients under 50 years. However, the reported survival curve of the uncemented 
implants is again inferior to the reported outcome of the cemented implants. These 
outcomes of these large cohorts of patients may be biased because older implants with 
inferior outcome may overshadow better results of some prostheses. In the Swedish 
report, no detailed information about individual implants is available for young patients.
The last few years there are other alternative bearing types available. The first reports 
of cross-linked polyethylene, ceram ic bearing and metal bearings seem to be promising
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in better survival because of less wear in THA patients. Probably these alternate bearings 
will make a difference in long-term survival in the future.
In conclusion, the outcome of both cemented and uncemented prosthesis in young 
patients is still disappointing. Most literature that does fulfil the criteria of a survival of 
>90% after 10 years are based on cemented implants. Long-term reports of uncemented 
(first generation) implants are available, but they do not meet the criteria with the 
exception of 2 studies. Additional reports about the long-term  results of newer 
uncemented implants are necessary to support their use in young patients.
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A bstract
We evaluated the outcome of 104 consecutive primary cemented Exeter femoral 
components in 78 patients (34 men, 44 women) under the age of 40 years who 
underwent total hip replacement between October 1993 and May 2004. The mean age at 
operation was 31 years (16 to 39). No hip was lost to follow-up, but three patients (four 
hips) died. None of the deaths were related to the surgery.
At a mean follow-up of 6.2 years (2 to 13), three femoral components had been 
revised for septic loosening. Using Kaplan-Meier survival analysis, the seven-year 
survival of the component with revision for any reason as the endpoint was 95.8% (95% 
confidence interval 86.67 to 98.7). The seven-year survival with aseptic femoral 
loosening as the endpoint was 100% (95% confidence interval 100).
The cemented Exeter femoral component in patients under the age of 40 shows 
promising medium-term results. As it is available in a wide range of sizes and offsets, we 
could address all types of anatomical variation in this series w ithout the need for custom 
made components.
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In troduction
The Exeter cemented femoral component developed in 1969 and was first implanted in 
November 1970.1 Since then there have been two minor changes in its design, two 
changes to the alloy and two to the surface finish, resulting, in 1988, in the production of 
the Exeter Universal femoral com ponent.1 This retains its original double tapered design 
and has a highly polished surface finish. Outcome studies of the Exeter prosthesis have 
been published for older patient populations,1,2 but the outcome in younger patients has 
not been published to date.
In this study we evaluated the clinical and radiological outcome of the Exeter Universal 
femoral component in 78 patients (104 hips) who were under the age of 40 years at the 
time of surgery.
Patients and M ethods
Between October 1993 and May 2004 we inserted 104 primary cemented Exeter 
Universal femoral components (Stryker Howmedica, Newbury, United Kingdom) in 78 
consecutive patients all of whom were under 40 years old at the time of surgery. All 
diagnoses were included and no patients were excluded. A cemented acetabular 
component was used in each case. Many patients in this age group have secondary 
osteoarthritis due to developmental dysplasia of the hip, inflammatory arthropathy, or 
avascular necrosis with loss of bone stock. We reconstructed the acetabulum with wire 
mesh, to contain sequential bone defects, and impaction bone grafting.3-5
There were 34 men (44%) and 44 women (56%), of whom 26 underwent a bilateral 
procedure. In total, 50 femoral components were implanted on the left side and 54 on 
the right. The mean age at the time of surgery was 31 years (16 to 39).
All patients included in this retrospective review were followed up on a regular basis. 
During follow-up, three patients (four stems) died, at 4.4, 5.3, 6.9 and 8.5 post­
operative years respectively, from causes unrelated to the surgery. None had required 
revision. All patients were followed for a minimum of two years, and no patient was lost 
to follow-up. The mean follow-up was 6.2 years (2 to 12.8).
The primary diagnosis was developmental dysplasia in 30 hips, rheumatoid arthritis in 
13 and corticosteroid-induced avascular necrosis in 23. Five hips were replaced for 
idiopathic avascular necrosis, five for Perthes' disease, and five for post-traumatic 
arthritis. Four hips were replaced for slipped capital femoral epiphysis and four for 
Morquio's disease. A further 15 hips were replaced for a variety of other diagnoses.
The majority of the operations (94 hips; 90%) were performed by or under the 
supervision of the two senior faculty surgeons (JWMG, BWS). In each case, a 
posterolateral approach was used without a trochanteric osteotomy. However, in one 
procedure a planned Sugioka osteotom y6 was converted to a total hip replacement (THR) 
and a trochanteric osteotomy had already been performed. In one other case an 
additional anterior approach was needed because of ankylosis of the hip. A total of 57 
hips had undergone surgery before THR, the number of previous operations ranged from 
one to eight.
All femoral components were inserted using a third generation cementing technique 
comprising bone lavage, a distal intramedullary plug and cement pressurisation. Simplex 
bone cement (Stryker-Howmedica) loaded with antibiotics was used in each case. 
Immediately before operation each patient received 2 g of cefazolin intravenously. 
Thromboprophylaxis in the form of low molecular weight heparin was given post­
operatively. Non-steroidal antiinflammatory drugs (NSAIDs) were used for seven days 
post-operatively to prevent heterotopic ossification. When NSAIDs were contraindicated 
(in four patients), one dose of 7 Gy radiotherapy was given post-operatively.
Patients w ithout bone grafts were mobilised under the supervision of a physiotherapist 
one or two days after surgery using two crutches. Full weight-bearing was allowed after 
six weeks. This protocol was adapted for patients who had an acetabular reconstruction 
depending on the type and extent of the reconstruction.
Routine follow-up was scheduled after six weeks, six, nine and 12 months, and yearly
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or biennially thereafter. Clinical evaluation was performed using the Harris hip score 
(HHS),7 the Oxford hip score (OHS),8 visual analogue scales (VAS) for pain at rest and 
during physical activity on a scale from 0 (no pain) to 100 (unbearable pain), and a VAS 
for satisfaction on a scale from 0 (not satisfied at all) to 100 (complete satisfaction). The 
anteroposterior pelvic and lateral hip radiographs of all femoral components were 
analysed on a consensus basis by two investigators (DCJDK and BWS). Radiological 
evaluation included an assessment of loosening of the component, its position, 
osteolysis, rounding-off at the calcar, migration, heterotopic ossification, cortical 
hypertrophy and/or atrophy and cement fractures. Radiolucent lines and osteolysis were 
recorded in accordance with the 14 femoral zones described by Gruen, McNiece and 
Am stutz.9 A valgus or varus position of the femoral component was evaluated if it lay 
within 3° of the femoral axis. Loosening was analysed using the criteria described by 
Harris, McCarthy and O 'Neill.10 In the event of such loosening, we categorised the mode 
of failure as described by Gruen et a l.9 Subsidence of 2 mm or more was registered as 
abnormal, as described by Loudon and O lder.11 Heterotopic ossification was defined 
according to the system of Brooker et a l.12 We defined revision as the removal and/or 
replacement of the component for any reason. Kaplan-Meier survival analysis was 
performed for all hips to calculate the cumulative survival with 95% confidence intervals 
(CI). The survival analysis was performed for four different endpoints: revision of the 
femoral component for any reason, revision for any reason excluding infection, revision 
for aseptic loosening, and radiological signs of loosening.
Resu lts
The mean operating time was 151 minutes (65 to 285). There were two intra-operative 
complications related to implantation of the femoral component. In one femur a hoop 
stem crack occurred during broaching. This was recognised intra-operatively and treated 
by cerclage wiring. A technical failure of the implantation technique was seen in one 
case. The component jammed during insertion, and its removal with some recementing 
was necessary for proper implantation. Post-operative rehabilitation was uneventful in 
both cases.
Functional outcome
The mean pre-operative HHS was 51 points (15 to 77) and improved to a mean of 89 
points (55 to 100) at final follow-up. The mean OHS improved from 39 points (28 to 52) 
to 19 points (12 to 45), where the best available score is 12 and 60 the worst. The mean 
postoperative VAS for pain at rest was 7 points (0 to 75). The mean post-operative VAS 
score for pain during physical activity was 19 points (0 to 90). The mean VAS for overall 
satisfaction was 87 points (20 to 100). One patient with secondary osteoarthritis after an 
acetabular fracture had persistent pain after THR. In the absence of evidence of failure of 
fixation or infection, this patient was referred for pain management.
Revisions
Three femoral components (3%) were revised, because of septic loosening at 2.2, 3.4 
and 6.1 years. The infecting organisms were Pseudomonas aeruginosa in one hip and 
Staphylococcus epidermidis in two. In one infected hip, revised after 2.2 years the 
infection was related to the surgery. The indication for this THR was an infected non­
union of a Sugioka osteotomy. The other two infected hips presented as an acute 
infection in patients with a previously well-functioning THR, one of whom was receiving 
steroids for systemic disease. No femoral component was revised for aseptic loosening.
Radiological outcome
Radiographs of all hips were available for analysis. The alignment of 83 femoral 
components was considered to be in a neutral position, but 21 had a deviation of > 3° 
from the neutral axis. Of these, 11 were in a varus and ten a valgus position. Most 
components had a stable radiological appearance during follow-up (Figure 1). Subsidence
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Figure 1A-C. Bilateral Exeter prosthesis in a 36-year-old woman with developmental dysplasia of the hip treated 
with extended acetabular reconstruction with wire meshes and bone impaction grafting (A) pre-operative 
anteroposterior pelvic radiograph, (B) immediate post-operative view, and (C) 11 years post-operatively with a stable 
view of the prostheses.
of more than 2 mm within the cement mantle occurred in three hips, none of which 
required revision. All three were asymptomatic. Migration of the femoral component with 
distal migration of the cement mantle was not seen. Femoral radiolucent lines were seen 
in six hips and involved a total of 16 zones. Four radiolucent lines were seen in zone 1, 
two in zones 7 and 8, and one in zones 2, 6 and 9 to 14. Two components had 
radiolucent lines in several zones. One of these has been revised for septic loosening. 
The other had progressive lines in zones 1, 2, and 6 to 8 for five years, but the patient 
reported only mild pain and no loss of function. One other hip had a progressive 
radiolucent line in zone 1.
Three components had showed one osteolytic zone in zones 1, 6 and 7, respectively. 
Rounding of the calcar was visible in 15 hips, but this did not produce any loss of calcar 
height in these hips. Hypertrophy and atrophy of the femoral cortex were present in one 
hip each. There were no fractures of the cement mantle or zones with sclerosis.
Other complications and re-operations not related to the femoral component 
In three patients a deep wound infection was suspected post-operatively. Treatment 
consisted of immediate surgical debridement combined with local and intravenous 
antibiotics. All three patients recovered, and none developed septic loosening. A 
superficial wound infection was seen in three hips, and in five hips there was a 
postoperative haematoma. One patient had an extensive haematoma four months after 
THR, due to excessive thromboprophylaxis. A transient femoral and/or sciatic nerve palsy 
occurred in five patients; in four, there was isolated sensory disturbance, and in one a 
combined motor and sensory palsy. All five had developmental dysplasia with high 
dislocation of the hip joint. In each case conservative treatment led to complete 
recovery.
A total of 12 patients (12 hips, 11.5%) had a dislocation. Nine were treated 
conservatively and stabilised. Three patients underwent re-operation. Two had a femoral 
head exchange at five and 28 days post-operatively and the third had a revision of the 
acetabular component after 3.5 years. All patients became stable after surgery.
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Heterotopic ossification was seen in 24 hips (23%); Brooker class 1 in eight;
Brooker class II in ten and Brooker class III in six. The presence of the heterotopic 
ossification did not restrict movement in any patient. There were five acetabular revisions 
(4.8%), four for aseptic loosening and one for pain because of an unknown cause. During 
surgery in this patient the acetabular component was stable, however, the patient was 
relieved of pain following revision.
Survival analysis
Using Kaplan-Meier survival analysis with revision of the femoral component for any 
reason as the endpoint, the survival rate was 97.8% (95% CI 91.6 to 99.5) at five years 
and 95.8% (95% CI 86.6 to 98.7) at seven years. With aseptic loosening of the femoral 
component as the endpoint, the survival rate was 100% (95% CI 100) at five and seven 
years, and with radiological loosening of the component as the endpoint, the survival was 
99% (95% CI 93.2 to 99.9) at five years and 96.7% (95% CI 86.1 to 99.3) at seven 
years (Table 1).
D iscussion
Although the Exeter Universal femoral component is widely-used, we believe this to be 
the first report of the medium-term results of its use in patients under 40 years of age.
In this group of patients, it has an acceptable survival rate at seven years post­
operatively. None of the femoral components failed due to aseptic loosening, and the 
three that were revised were all infected. Despite a trend to use uncemented implants in 
young patients,13-15 this study confirms that good results can be obtained with a 
cemented femoral component.
The wide range of available sizes and offsets (from 30.5 mm to 50 mm) meant that no 
custom-made components were needed. All patients were followed, and none were lost 
to follow-up, which is the ideal.16
One limitation of our study is the mean follow-up of 6.2 years, which means that the 
results are only medium-term. The number of hips with septic loosening was relatively 
high but this was associated with the surgery in only one patient, whereas the other two 
could be attributed to an acute haematogenous infection.
The dislocation rate of 11.5% was also relatively high. However, the reported 
incidence of dislocations in other series where a THR has been carried out in patients 
under 40 years varies between 0% and 18.2% .17-27 We do not think the dislocation rate 
is related to the type of femoral component but it could be related to the previous 
operations which had been undertaken in seven of the 12 patients. Fortunately, nine of 
the 12 patients could be treated conservatively.
Reviewing the literature on patients under 40 years in general, femoral component 
survival is acceptable in all series, using both cemented and non-cemented components. 
A study on uncemented components of different designs by Duffy et a l18 had a slightly 
lower survival rate than reported survival rates of cemented components of 86% at ten 
years, using revision due to aseptic loosening as the endpoint. However, McAuley et a l28 
had a survival rate of 98% of uncemented femoral components in their patient 
population under the age of 40 years at a mean follow-up of seven years. The most 
extensive data available relates to the Charnley femoral component. Joshi et a l,29 
reported a survival rate of the original Charnley component of 99% at five years and 
97% at ten years, with revision due to aseptic loosening as the endpoint. Chmell et a l17 
described a survival rate of 95% at ten years with a variety of cemented femoral 
components in patients under the age of 30 years. The outcome of the Exeter femoral 
component at seven years in our series seems to be comparable to that of other 
cemented components in patients under the age of 40 years.
The best-reported long-term results of THR in patients under 40 years showed that 
the Charnley component had a survival rate of 75% after 20 years, with revision for any 
reason as the endpoint and a survival of 86% after 20 years with revision for aseptic 
loosening as the endpoint.30
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There are several studies which report the survival of the Exeter femoral component in 
older patients.1,2,31-36 These give a survival rate for patients with a mean age between 61 
and 71 years ranging from 93% to 100% after ten years when femoral revision for 
aseptic loosening is taken as the endpoint. In our study group, the mean age was 31 
years and we had a survival of 100% after seven years, with revision for aseptic femoral 
loosening taken as the endpoint.
The Exeter universal femoral component survives well in the medium term in young 
patients, despite the assumption that this group is more active, and will have a higher 
rate of wear.37,38 Consequently, we will be keeping this cohort under review.
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A bstract
Although uncemented cup implants frequently are used in young patients, we believe 
long-term survival rates of cups in these patients are somewhat disappointing, and 
therefore we have continued to use cemented cups in primary THA, even in young 
patients. However, in cases of acetabular bone stock defects, we also use bone impaction 
grafting.
We prospectively followed 130 patients with 175 cemented cups; no patients were lost 
to followup. The mean age of the patients at surgery was 31 years (range,
16-39 years). An acetabular reconstruction with bone impaction grafting was performed 
in 84 hips (48%). The minimum followup was 2 years (average, 8.1 years; range, 2.0 -  
18.5 years).
Twenty-one of the 175 cups (12%) were revised at an average of 8.1 years (range, 
2 .0-18.5 years). Reasons for revision were infection (one early, seven late), recurrent 
dislocations (two), traumatic loosening (one), and aseptic loosening (10). The 10-year 
survival rate of all cemented cups with end point of revision for any cause was 85%. 
Survival with end point of aseptic loosening of all cups was 92%. Survival with end point 
of revision for aseptic loosening was 90% for the cups without impaction grafting and 
95% for the cups with impaction grafting.
We believe cemented acetabular cups in young patients have acceptable midterm 
survival; however, in the case of acetabular bone defects, we recommend reconstruction 
with impaction grafting.
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In troduction
Obtaining a satisfying long-term survival of THAs in patients younger than 40 years 
remains a challenge. Young patients must function longer with their THA than the typical 
patient who has a THA, and they also engage in a higher level of activity, which is 
associated with higher revision rates.19,27 Therefore, this population is more dependent 
on durable implants with excellent long-term survival. Although stem survival is 
acceptable in most studies, in general, cup survival is the weakest link in patients 
younger than 40 years.5,8,9,15,18,20,25 The difference in reported survival rates between the 
cup and stem varies from 1% (97% [stem] versus 96% [cup]18) to 11% (98.3% [stem] 
versus 87.6% [cup]20). Despite attempts to improve cup designs and using new 
materials in THA, the acetabular component still shows lower survival rates than femoral 
implants.
One popular option is to implant uncemented acetabular cups in young patients as 
part of a total uncemented THA or hybrid THA (uncemented cup, cemented stem). 
Although cement in young patients commonly is not used,1,24,35 we always have 
implanted cemented cups in patients of all ages, but with one substantial modification: in 
all patients with substantial acetabular bone stock deficiencies, we have reconstructed 
this bone stock loss using impaction bone grafting with a cemented cup. Secondary 
osteoarthritis resulting from underlying diseases in these young patients often is seen 
with associated loss of acetabular bone stock (for example, in developmental dysplasia of 
the hips and juvenile rheumatoid arthritis). With this approach using cemented cups in 
young patients for many years, we asked whether there were any differences between 
cemented cups in young patients (younger than 40 years) with and without 
reconstruction with impaction grafting concerning (1) clinical scores, (2) revisions, (3) 
complications, (4) radiographic appearances, (5) polyethylene wear, and (6) survival.
M ateria ls  and M ethods
We retrospectively reviewed prospectively collected data of all 130 patients (175 hips) 
who had a primary THA in our department between January 1988 and July 2004 and who 
were younger than 40 years at the time of index surgery. We used a cemented femoral 
stem and cemented acetabular polyethylene cup in all patients. In patients with 
acetabular bone deficiencies, these deficiencies were reconstructed with the impaction 
grafting technique. The decision to use bone impaction grafting was made based on the 
preoperative radiographs in combination with intraoperative findings. A trial cup was 
placed on the transverse ligament; in the case of a protrusion hip or a superolateral rim 
defect, a reconstruction was performed. Eighty-four hips (48%) had impaction grafting 
whereas 91 (52%) did not have impaction grafting. Because a cemented THA was our 
only treatment technique, patients with all diagnoses were included (Table 1). The 
majority (62%) of the patients had developmental dysplasia of the hips, rheumatoid 
arthritis, or corticosteroid-induced avascular necrosis.
Fifty-five (42%) patients were males and 75 (58%) were females. Eighty-nine (51%) 
THAs were on the left side and 86 (49%) were on the right. Forty-five (35%) patients 
had bilateral THAs. The average age of the patients at index surgery was 31.3 years 
(range, 16-39 years). The mean body mass index was 25.5 (range, 17.9-36.3). 
According to the classification of Charnley,7 46 hips were in Category A, 71 in B, and 58 
in C. We followed all patients in this prospective cohort on a regular basis and the 
minimum followup was 2 years (average, 8.1 years; range, 2.0-18.5 years) after 
surgery. During followup, six patients (eight hips) died of causes not related to the hip or 
hip surgery. All patients who died were followed on a regular basis and their data 
included; none had revision surgery. Of the original group of 175 cups, the data of only 
one patient were incomplete. Based on a telephone interview, the prosthesis of this 
patient functioned well; however, a recent radiograph was missing.
We categorized acetabular defects in accordance with the classification system of the 
American Academy of Orthopaedic Surgeons.10 Eighty-six hips (49%) had an acetabular 
deficiency. Type I segmental deficiencies occurred in 16 hips, Type II cavitary defects in
50 Total Hip Arthroplasty in Young Patients
Table 1. Indications for primary THA with and without reconstruction with bone impacting grafting.
Number of hips
Indication Without bone impaction With bone impaction
Totalgrafting grafting
Developmental dysplasia of the hip 10 32 42
Rheumatoid arthritis 17 10 27
Perthes' disease 4 4 8
Avascular necrosis of unknown cause 6 2 8
Epiphyseal dysplasia 5 2 7
Posttraumatic osteoarthritis 2 4 6
Bechterew's disease 3 2 5
Posttraumatic avascular necrosis 4 1 5
Morquio's disease 1 3 4
Epiphysiolysis 1 3 4
Septic coxitis 2 1 3
Protrusio acetabuli 0 3 3
Osteomyelitis 0 3 3
Spontaneous fusion hip of unknown cause 1 1 2
Osteogenesis imperfecta 0 2 2
Polycystic disease of unknown cause 2 0 2
Arthritis Psoriatic arthritis 0 1 1
Gigantism of unknown cause 0 1 1
Pseudohypoparathyroidism 1 0 1
Monoarthritis of unknown cause 0 1 1
Alcohol-induced avascular necrosis 1 0 1
Corticosteroid-induced avascular necrosis 31 8 39








Hypothalamus hormone substitution 1




Acute lymphatic leukemia 1
Meduloblastoma 1
Total 91 84 175
39 hips, and Type III combined deficiencies in 29 hips. One patient (two hips) had 
ankylosis of the hips, a Type V deficiency. Using impaction grafting, we reconstructed all 
deficiencies, including mild cavitary defects; however most were larger defects.
Differences between the two groups (with and without impaction grafting) were 
analyzed regarding diagnosis and gender (chi square test, both p = 0.001). In the group 
with an acetabular reconstruction, a larger proportion was female and was diagnosed 
with developmental dysplasia of the hips compared with the Group without 
reconstruction. There were no differences regarding age at surgery, side, bilateral THAs, 
followup, type of cup used, cup inner diameter, and body mass index between the two 
groups.
Two-thirds of the operations (67%) were performed by or under the supervision of 
two senior faculty orthopaedic surgeons (BWS, JWMG). A posterolateral approach without 
trochanteric osteotomy was used in all hips, with the exception of two. Intraoperatively, 
in one patient, a preplanned Sugioka procedure was converted to a THA; however, a 
trochanteric osteotomy already had been performed. In the other patient, a trochanteric 
osteotomy was performed in a technically demanding hip with a short femoral neck. In 
one patient, an additional anterior approach was needed because of ankylosis of the hip. 
All acetabular deficiencies were reconstructed (with the exception of one case) with 
impaction grafting using autografts and/or allografts in 84 hips (48%); this technique has
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been described in detail.28-30 Segmental bone defects first were reconstructed with wire 
meshes before the morselized bone graft was impacted and a conventional full 
polyethylene cup was cemented. In one patient, we reconstructed a lateral rim deficiency 
without impaction grafting using a solid autograft fixed with two screws. In one of the 
ankylosed hips (Type V deficiency), we did not use impaction grafting. We used allografts 
only with impaction grafting in four hips (4.8%), autografts only in 72 hips (85.7%), and 
combined allografts and autografts in eight hips (9.5%). Allografts were used when the 
original femoral head was not large enough to reconstruct the defect or in cases with 
pathologic femoral heads (for example, avascular necrosis of the femoral head). In three 
cases, instead of a solitary metal mesh, a solid fragment was used in combination with 
impaction grafting. In two of these cases, a minor segmental defect in the medial wall 
was closed using a cortical-trabecular fragm ent of a femoral head. A wire mesh was 
placed medial on top of the fragm ent and the acetabulum was reconstructed with 
impaction grafting. In the third case, a cortical head fragment was used to support the 
anterior rim together with a rim mesh in a reconstruction. The num ber of femoral heads 
used as grafts varied from one to four. In 40 hips (48%), metal wire mesh was used for 
acetabular reconstruction with impaction grafting (10 medial wall meshes, 39 rim 
meshes). In nine early cases, we placed a mesh on top of the bone graft just before 
cementation, but this mesh was not part of a segmental defect reconstruction. However, 
after we realized this mesh did not add any stability to the reconstruction and there were 
no signs of damaging of the graft or graft healing by direct contact with cement, we 
abandoned the use of a mesh for this purpose.
We used 79 (45%) Exeter™ Contemporary™ cups with an inner diameter of 28 mm (n 
= 75) and 22.225 mm (n = 5) (Stryker Howmedica, Newbury, UK), 71 (41%) Charnley® 
Elite™ cups with an inner diameter of 22.225 mm (n = 6) or 28 mm (n = 65) (DePuy, 
Leeds, UK), and 25 (14%) Müller/AlloPro cups with an inner diameter of 32 mm (n = 19), 
28 mm (n = 2), or 22.225 mm (n = 4) (Sulzer, W interthur, Switzerland). For the femoral 
component, we used an Exeter™ stem in 111 cases, a Charnley® Elite™ stem in 48 
cases, and a Müller stem in 16 cases. All femoral heads used were made of a cobalt- 
chrome alloy; no ceram ic implants were used.
We cemented acetabular components with a third-generation cementing technique. In 
the directly cemented cups, after reaming, multiple small drill holes were made with a 
2.6-mm drill. After using pulse lavage, vacuum-m ixed cement was injected directly from 
the cement gun and the cement was pressurized by a seal. In cases of reconstruction 
with bone grafts, we reamed the acetabulum, made multiple drill holes in sclerotic areas, 
and irrigated the acetabulum. Next the bone graft was impacted. Again, vacuum-m ixed 
cement was injected and pressurized and the cup was inserted. Before 1989, we used 
Palacos® bone cement (Merck, Darmstadt, Germany); however, since 1989, we have 
used Surgical Simplex® (Stryker Howmedica). In 165 cases (94%), cement loaded with 
antibiotics was used. All patients received antibiotic prophylaxis consisting of 2 g 
cefazolin intravenously just before surgery. Other precautionary measures to prevent 
infections were use of an operating theater with lam inar airflow and use of two pairs of 
sterile gloves.
Postoperatively, all patients received thrombosis prophylaxis with low-molecular- 
weight heparin for 6 weeks, or before 1999, with acenocoumarol (the individual dosage 
regimens regulated with regular coagulation tests) for 3 months. To prevent heterotopic 
ossification, we used nonsteroidal antiinflammatory drugs (NSAIDs) for 7 days. In six 
patients in whom NSAIDs were contraindicated, we administered one dose (7 Gy) of 
radiotherapy 1 day postoperatively.
Patients w ithout acetabular reconstruction were mobilized under supervision of a 
physiotherapist after 1 or 2 days. Full weightbearing was increased in 2 to 6 weeks with 
the aid of one or two crutches. The patients who underwent impaction grafting were 
mobilized according to a modified protocol; in the first 6 weeks, only 10% weightbearing 
was allowed and then 6 to 12 weeks of 50% weightbearing using two crutches was 
allowed. After 12 weeks, full weightbearing mobilization was allowed. Thirty-one hips had
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such an extensive reconstruction of major defects that several weeks of bed rest were 
maintained ranging from 1 to 6 weeks. We used this modified mobilization protocol to 
ensure graft incorporation before full weightbearing.
Routine follow-ups were scheduled at 6 weeks; 3, 6, and 12 months; and yearly or 
biannually thereafter. At our outpatient clinic, student researchers not participating in the 
treatment performed clinical analysis using the Harris hip score,17 the Oxford Hip 
Questionnaire Score (since 1998),11 and visual analog scales for pain during rest and 
physical activity on a scale from 0 (no pain) to 100 (unbearable pain). We report the 
clinical scores of all patients excluding the 21 patients whose hips were revised during 
followup.
All anteroposterior pelvis and lateral radiographs of all hips were analyzed on a 
consensus basis by two of the authors (DCJDK, BWS). Radiographic evaluation included 
assessment of cup position, loosening of the acetabular component, polyethylene wear, 
presence of osteolysis, structural quality of the bone graft, application and position of the 
meshes, migration, heterotopic ossification, and fracture of the cement, mesh, or 
prosthesis. Radiolucent lines and osteolysis were recorded according to the three 
acetabular zones as described by DeLee and Charn ley.12 Radiographic loosening was 
defined as 2 mm or greater demarcation in two or three zones around the acetabular 
component, progressive demarcation, 3 mm or greater component migration, 5° or 
greater component tilting, and/or cement or prosthesis fracture. We determined cup 
migration (> 3-mm shift in any direction or > 5° tilting) in relation to the interteardrop 
line instead of the Kohler line.16 Position of the cup of 45° ± 10° was considered 
normal.26 We calculated polyethylene wear using the method of Dorr and W an .13 All 
measurements were corrected for magnification. Heterotopic ossification was classified 
according to the system of Brooker et a l..6 Graft incorporation was defined as the 
presence of the crossing of trabecular bone on the bone-graft interface on the 
radiographs. Clinical failure was defined as the need for revision of the acetabular 
component for any reason.
We calculated Kaplan-Meier curves to study the survival (time to revision). The end 
points were (1) cup revision for any reason, (2) cup revision for any reason excluding 
infections, (3) cup revision for aseptic loosening, and (4) radiographic signs of cup 
loosening. With an average followup of 8.1 years, 30% of all patients had a followup 
longer than 10 years. The log-rank test was used to test the differences in survival 
between cups with and without impaction grafting. Differences in outcomes between the 
groups were determined with the Student's t-test (continuous variables after checking for 
normal distribution) or chi square test (nominal variables).
Resu lts
Clinical outcome
The outcome of the Harris hip score and the Oxford Hip Questionnaire Score improved (p 
< 0.0001) after surgery for both groups; there were no differences in preoperative and 
postoperative clinical outcomes between the cups with and without acetabular 
reconstruction (Table 2). The postoperative experienced pain score was low.
Revisions
The number of revisions in the groups with and without bone grafts was not different (p 
= 0.152). At last followup, 21 of the 175 cups (12%) had been revised, seven of which 
had reconstruction with impaction grafting (Table 3). Reasons for revision were infection 
(eight), recurrent dislocations (two), traumatic loosening (one), and aseptic loosening 
(10). Revision for aseptic loosening was performed in 10 acetabular implants (5.7%).
The cup only was revised in eight cases and the cup and stem were revised in two cases. 
Four of the 10 revised cups had reconstruction with impaction grafting and six cups were 
implanted with standard techniques without any graft. The failed cups reconstructed with 
impaction grafting were revised after 4.1, 9.8, 16.2, and 16.8 years (average, 11.7 
years). The six directly cemented cups were revised after an average of 4.0 years
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(range, 1.1-10.0 years). The time to revision for aseptic loosening was longer (p = 
0.032) for the reconstructed cups with impaction grafting than for the cups implanted 
with standard techniques. The eight infected hips (4.6%) all had revision because of 
culture-proven infection of the implant. The average time to revision for septic loosening 
was 5.3 years (range, 2.2-8.1 years). Staphylococcus epidermidis was isolated in three, 
Staphylococcus aureus in two, Proprioni in two, Pseudomonas aeruginosa in one, and 
Streptococcus oralis in one. As a result of recurrent dislocations, two cups (1.1%) were 
revised at 3.5 and 8.6 years after the index operation. One implant (0.6%) was 
radiographically and clinically loose after trauma and needed revision of both 
components.
Complications
We observed sim ilar (p = 0.959) numbers of overall complications in the groups with and 
without bone grafts. However, dislocations were more common (p = 0.045) in the Group 
without bone grafts than in the group with bone grafts (15 versus 5, respectively). 
Patients w ithout reconstruction with impaction grafting had an increased dislocation 
chance of 1:2.9. During followup, there were nine intraoperative complications and 30 
postoperative complications (Table 4). One additional stem was revised because of 
aseptic loosening and two femoral heads were exchanged because of recurrent 
dislocations. Seven hips underwent additional surgery because of postoperative 
complications (Table 4).
Radiographical evaluation
There were no differences between the cups with and without acetabular reconstruction 
concerning the occurrence of cup migration, radiographic loosening, or the presence of 
osteolysis, cysts, and abnormal cup position (Table 5). Cups with impaction grafting had 
fewer radiolucent lines (p = 0.02) and fewer lines in Zone I (p = 0.001) (Table 5). All 
lines, except two, were on the bone-cement interface. In 28 (48%) of the 58 cups with 
radiolucent lines, the lines were progressive. O f the 175 hips, 160 were radiographically 
stable (Figure 1). Fifteen cups were difficult to evaluate because of overlap of the metal 
mesh (11 Zone I; four Zones I + II). We observed graft osteolysis in only one patient 
with impaction grafting; all other grafts were fully incorporated. The hip revised because 
of traumatic loosening had a fracture in Zone II of the acetabulum; no other fractures 
were seen. Fifteen (8.6%) cups were radiographically loose, three had cup migration 
(after 1.8, 9.8, and 11.2 years postoperatively), and 12 had evident radiolucent lines in 
all zones and/or severe osteolysis; 12 of these cups were revised (Table 3).
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Values are expressed as median, with range in parentheses; VAS = visual analog scale; NA = not available.
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Table 3. Overview of the revised cups (n = 21).
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There was no difference in polyethylene wear rates between the cups with and without 
impaction grafting (p = 0.539 in 154 unrevised cups and p = 0.525 in the 21 revised 
cups) (Table 5). When looking at all cups (with and without acetabular reconstruction), 
the revised and radiographically loose cups had more wear compared with the cups that 
were not revised (both p < 0.0001). Patients with an abnormal position of the cup had 
sim ilar (p = 0.196) polyethylene wear rates to those who had a normal position. Analysis 
of polyethylene wear rates of cups with different inner diameters showed no differences 
(independent t test, 22 versus 28 mm: p = 0.135, 22 versus 32 mm: p = 0.484, 28 
versus 32 mm: p = 0.620).
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Figure 1A-C. The radiographs illustrate reconstruction of the acetabuli in a 34-year-old woman with 
bilateral DDH (Crowe Grade 3). (A) A preoperative anteroposterior radiograph shows the acetabuli. (B) An 
anteroposterior radiograph taken immediately postoperatively shows the THAs with the acetabuli 
reconstructed with impaction grafting. (C) An anteroposterior radiograph taken 12 years postoperatively 
shows the THAs remain radiographically stable, but Brooker Classes III (left) and I (right) heterotopic 
ossifications are visible.
Survival analysis
There were no differences in survival after 10 years between the groups with and without 
bone impaction grafting (Table 6). The midterm survival rates of all cemented 
polyethylene cups varied from 85% to 92% at 10 years with four end points (Table 6; 
Figures 2 and 3). Cup survival with an end point of radiographic loosening was 89%
(95% confidence interval, 83% -95% ).
D iscussion
The use of cemented THA in young patients is not very popular and most surgeons will 
use uncemented or resurfacing hips in these patients. However, we have continued to 
use only cemented implants in THA even in young patients. In our view, the real 
challenge in THA in these young patients is to manage the commonly seen acetabular 
deficiencies. In cases of acetabular defects, we reconstruct these deficiencies with 
impaction bone grafting. We questioned whether there was a difference in clinical 
outcome, revisions, complications, radiographic appearances, polyethylene wear, and 
survival between the cups implanted with an acetabular reconstruction with impaction 
grafting and those implanted with standard cementing techniques.
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Table 4. Overview of complications.
Type of complication Number
Intraoperative complications (n = 9)
Entrapment of sciatic nerve during reposition, permanent damage 1
False route femur 1




Suspicion of breakthrough of sterility 2 
Postoperative complications (n = 30)
Superficial wound infection 3
Single dislocation 9
Recurrent dislocations 6
Sensory nerve palsy 4
Sensory and motor nerve palsy 1
Hematoma 6
Bleeding after 4 months 1 
Heterotopic ossifications (n = 44)
Brooker Class I 15
Brooker Class II 19
Brooker Class III 10 
Postoperative complications leading to revision (no cup revision) (n = 3)
Stem revision for aseptic loosening 1
Head exchange because of recurrent dislocations 2 
Postoperative complications requiring surgical intervention (no revision) (n = 7)
Deep wound infection 4
Heterotopic ossifications 1
Traumatic dislocation 1
Persistent motor and sensory nerve palsy 1
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Figure 2A-B. Kaplan-Meier survival curves with 95% confidence intervals (broken lines) of all cups with end 
points of (A) revision for any reason and (B) revision for aseptic loosening are shown. The vertical bars 
indicate the censored data points.
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Figure 3A-B. Kaplan-Meier survival curves of cups without impaction grafting (thick broken 
line, 95% confidence intervals in thin broken lines) and cups with impaction grafting (thick solid line, 95% 
confidence intervals in thin solid lines) with end points of (A) revision for any reason and (B) revision for 
aseptic loosening are shown.
Our study has several limitations: short followup, lack of assessment of activity levels, 
clinical interobserver variability, heterogeneous group, no comparison with other 
reconstruction techniques, and different types of implants used. With no patients lost to 
followup, our followup is representative and reliable for the midterm results,22 and 
longterm followup (> 15 years) was not available at the time of this review. Our results 
can be biased by an important factor we did not evaluate: the level of activity.
Theoretically, with restoration of the affected hip(s) into well-functioning artificial 
jo ints, most patients will increase their level of activity. However, young patients 
undergoing THA with acetabular deficiencies and therefore more complex reconstructions 
could still have a lower level of activity after surgery relative to primary cemented cups.
However, the average wear of the cups with impaction grafting was the same as the 
cups without impaction grafting (both 0.08 mm/year). Provided that activity is a major 
cause of polyethylene wear, this might imply the level of activity is sim ilar in these two 
groups. Several studies suggest the revision and polyethylene wear rates are correlated 
to level of activ ity.2,19,27'31'38 Additional research on level of activity and impaction grafting 
in young patients is necessary to confirm  this hypothesis. The clinical questionnaires 
were obtained by student researchers who did not participate in the treatment. Multiple 
researchers were involved in the data collection and interobserver variability has not 
been tested; however, all researchers were trained and supervised to obtain these 
questionnaires correctly.
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Table 5. Radiographic findings of all cups (n = 175) and cups with (n 
with bone impaction grafting.








Zone I + II 4
Zone II + III 5
Zone I + III 5








Zone III 0 
Cup position 
Neutral position (35°-55°) 160
Abnormal position 15
Vertical (> 55°) 12
Horizontal (< 35°) 3 
Polyethylene wear
Mean nonrevised cups 0.08
(mm/year) 0
Mean revised cups 0.21
(mm/year) 4

































































Table 6. The 10-year survival rates of all cups and cups with and without reconstruction with bone impaction 
grafting using Kaplan-Meier estimates.*
End point
cu Without bone With bone Log-rank p 
cups impaction grafting impaction grafting value
Revision for any reason 85% (78%-92%) 79% (68%-90%) 91% (82%-99%) 0.21
Revision for any reason 
excluding infections 
Revision for aseptic 
loosening
91% (85%-97%) 87% (78%-99%) 94% (87%-100%) 0.56
92% (87%-98%) 90% (81%-99%) 95% (89%-100%) 0.73
*95% confidence interval in parentheses.
The clinical scores were comparable between the two groups and comparable to 
published scores (Table 7). Although the cups reconstructed with bone impaction grafting 
were the more demanding procedures, no clinical differences were seen.
Although revision rates in both groups were comparable, the time to revision was longer 
in the cups reconstructed with bone impaction grafting. We have no clear explanation for 
this observation; possibly the cement-bone interface was better in cups with bone 
impaction grafting with better interdigitation of the cement into the bone.36 This also may 
explain the lower incidence of radiolucent lines in the cups reconstructed with bone 
impaction grafting. The number of revisions for septic loosening was relatively high 
during this midterm followup study (4.6%). Only one septic loosening likely was related 
to the surgery; we considered all other infections acute hematogenous infections of 
previously well-functioning prostheses. The use of corticosteroids and newer rheumatic 
disease-modifying drugs, which were used in most of the infection cases, can explain this 
higher risk of infection.3,4 Sochart and Porter33 had only two infections in their study, but
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Table 7. Reported outcomes of the Harris hip score in young patients <40 years for primary THA.
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„  .. . Preoperative Postoperative Paired t-test p Study Questionnaire v .
'   ^ score score value
Chiu et al.8 Harris hip score 44 (26-74) 88 (74-99) <0.001
Duffy et al.15 Harris hip score 51 92 <0.001
Current study
With bone impaction grafting Harris hip score 48 (15-81) 92 (35-100) <0.001
Without bone impaction grafting Harris hip score 50 (28-82) 96 (12-100) <0.001
Values are expressed as median (current study) or means (other studies), with range in parentheses.
both were in patients with rheumatoid arthritis. Still, our revision rate for septic loosening 
of 4.6% is relatively high in contrast to other studies, such as that of Joshi et a l.,18 with 
an infection rate of 1.3%. Remarkably, many septic loosenings occurred late (> 2 years 
postoperatively).
The cups reconstructed with impaction grafting showed fewer complications by having 
fewer dislocations than the cups implanted by standard techniques. This might be 
attributed to the different mobilization protocol for the patients who received cups with 
impaction grafting. Immobilization is associated with lower dislocation rates.21 The overall 
dislocation rate in our study was 11.4%, which is relatively high. However, subluxation 
rates in young patients having THA have been reported to be as much as 18.2% .14 The 
overall complication rate of 17% (30 postoperative complications) is also relatively high. 
Joshi et a l.18 reported a complication rate of 11.5% in cemented hips and Duffy et a l.15 
reported a complication rate of 12% during the perioperative period.
As expected, revised and radiographically loose cups showed more polyethylene wear. 
This is consistent with previous reports showing wear particles are associated with 
osteolysis in THA. The average wear rate of the cups of 0.08 mm/year is within the 
normal lim its, keeping in mind that wear in younger patients can be 33% to 40% higher 
than wear in older patients.27 In a large study of 226 hips in patients younger than 40 
years with a Charnley® prosthesis, Sochart and Porter33 reported an average wear rate of 
0.08 to 0.10 mm/year in the nonrevised cups, which is comparable to our results. Wan et 
al.37 found a correlation between inclination of the cup and higher/lower wear rates. 
However, we did not observe higher wear with abnormal position or inner cup diameter.
The observed overall midterm survival of cemented polyethylene cups in patients 
younger than 40 years in our study was acceptable. Especially in these young patients, 
there is a need for total hip implants with proven long-term survival.20 Although the use 
of uncemented prostheses in these young patients is very popular, literature regarding 
long-term outcome of THA in patients younger than 40 years concerns mainly studies of 
cemented implants and less about uncemented implants (Table 8).5,8'9'15'18'20,25'32-34 A 
limitation of the reported midterm or long-term results of uncemented cups is the fact 
that in these studies first generation uncemented cups were used. The long-term 
outcome of improved newer uncemented cup designs remains unclear. Most of these 
older cup designs no longer are available. The only report of uncemented cups at 15 
years after surgery with an end point of revision for any reason showed a survival rate of 
54% .20 This is less favorable than the results of cemented cups at that time (Table 8). 
Sochart and Porter34 had survival rates of 71% and 68% at 20 and 25 years, 
respectively, for cemented Charnley® cups. The survival of the acetabular uncemented 
cups with an end point of revision for aseptic loosening in patients younger than 40 years 
reported in one study was 85% ,15 in contrast to a survival rate of 96% after 10 years of 
the Charnley® cups in the study by Joshi et a l..18 We found a survival rate with 
cemented cups of 92% at 10 years with an end point of revision for aseptic loosening.
A remarkable finding of our study was the survival of cups with acetabular 
reconstructions with impaction grafting was at least comparable to the survival of 
standard cemented cups, especially considering the more difficult hips of our study 
population needed reconstruction with impaction grafting. Our data on the cemented 
cups with impaction grafting showed sim ilar survival, where rather lower survival rates
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would be expected. The outcome of these cups reconstructed with impaction grafting 
even fulfilled the NICE criteria (a survival of > 90% after 10 years),23 with a survival rate 
of 91% at 10 years with an end point of revision for any reason. The survival rates of the 
cemented cups in our study are comparable to those reported for cemented cups.8,18,34 
Although cemented cups are not commonly used in young patients, our data suggest 
cemented conventional polyethylene cups are still a good option in THA in young 
patients. Even reconstruction of (severe) acetabular deficiencies with impaction grafting 
and a cemented conventional polyethylene cup produced very acceptable survival rates, 
comparable to the rates of cemented cups implanted in acetabuli without deficiencies 
with standard cementing techniques.
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Odent et al.25 62 6 (3-13)
Cemented
Bizot et al.5 41 7.7 (0-19)*
Chiu et al.8 47§ 14.9 (7-21)
Chmell et al.9 66 15.1 (11-22)
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*Values are expressed as mean, with range in parentheses; +values are expressed as percentage, with 95% confidence interval in parentheses; ^deceased and revised excluded; §lost to followup, 
deceased excluded, only Chinese patients; AML = anatomic medullary locking; PCA = porous-coated anatomic; Excl inf = excluding infections; H-G = Harris-Galante; SE = standard error.
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Sam envatting
Doel. Bepalen van de langeterm ijnresultaten van primaire gecementeerde 
totaleheupprothesen bij patiënten die ten tijde van de operatie jonger dan 40 jaar zijn. In 
geval van een botdefect aan komzijde werd deze eerst gereconstrueerd met 
geïmpacteerde botsnippers voor het plaatsen van een gecementeerde cup.
Opzet. Analyse van een vervolgde patiënten cohort.
Methode. Analyse vond plaats van patiëntengegevens die tussen 1 januari 1988 en 30 
juni 2004 een primaire gecementeerde totaleheupprothese kregen en een leeftijd hadden 
van 40 jaar of jonger. Hoofddoel was het bepalen van de tijd tot revisie. De overleving 
werd berekend met Kaplan-Meiermethode.
Resultaten. In totaal werden 175 heupprothesen bij 130 patiënten geïncludeerd. 
Acetabulaire reconstructie met geïmpacteerde botsnippers werd verricht in 84 heupen 
(48%). De gemiddelde leeftijd bij operatie was 31 jaar. Zes patiënten zijn overleden 
tijdens follow-up (8 heupen), niemand hiervan heeft een revisie gehad. De gem iddelde 
follow-up was 8,1 (uitersten 2,0-18,5) jaar. Er zijn 24 heupen (14%) gereviseerd. 
Redenen voor revisie waren: septische loslating (8), recidiverende luxaties (4), 
traumatische loslating (1) en aseptische loslating (11). De overleving na 10 jaar was 
83% (95%B.I. 76-90%). De aseptische overleving was 92% (95%B.I. 86-98%). 
Aseptische overleving van de cups met en zonder BIG was respectievelijk 95% (95%B.I. 
89-100%) en 90% (95%B.I. 81-99%) ( p=0,73)
Conclusie. Vervanging van het heupgewricht bij patiënten onder de 40 jaar door een 
gecementeerde totaleheupprothese laat goede langeterm ijnresultaten zien. Acetabulaire 
botdefecten gereconstrueerd met geïmpacteerde botsnippers bij deze patiëntengroep 
laten goede resultaten zien.
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A bstract
A Total hip arthroplasty with cement in patients under 40 years of age and if indicated, a 
reconstruction with impaction grafting of bone defects.
Objective. To determine the long-term results of primary cemented total hip arthroplasty 
in patients under the age of 40 at index surgery. In case of acetabular deficiency, a 
reconstruction with bone impaction grafting was performed first before a cemented cup 
was implanted.
Design. Analysis of a followed patient cohort.
Methods. All clinical data and radiographs were analysed of patients who received a 
primary cemented total hip arthroplasty under the age of 40, between 1 January 1988 
and 30 June 2004. The main goal of this study was to determine the survival with 
endpoint revision, using Kaplan Meier analysis.
Results. 175 consecutive total hip arthroplasties were implanted in 130 patients. Bone 
impaction grafting was performed in 84 patients (48%). The average age at index 
surgery was 31 years. Six patients (8 hips) died during follow-up. None were revised. 
Mean follow-up was 8,1 (range 2,0-18,5) years. In total, 24 hips (14%) were revised. 
Reasons for revision were: septic loosening (8), recurrent dislocations (4), traumatic 
loosening (1) and aseptic loosening (11). The 10-years survival was 83% (95%C.I. 76­
90%) with endpoint revision for any reason and 92% (95%C.I. 86-98%) with endpoint 
revision for aseptic loosening. Aseptic survival of the cups with and without bone 
impaction grafting was respectively 95% (95%C.I. 89-100%) and 90% (95%C.I. 81­
99%) (p=0,73).
Conclusion. Hip replacement with cemented total hip arthroplasty in patients under the 
age of 40 shows good long-term results. Acetabular deficiencies reconstructed with 
impacted bone grafts in these patients show good results.
68 Total Hip Arthroplasty in Young Patients
Het plaatsen van een totaleheupprothese bij arthrose van de heup wordt al meer dan 50 
jaar uitgevoerd. In Nederland worden jaarlijks bijna 21.000 totaleheupprothesen 
geplaatst. Hoewel slechts een klein aantal van deze heupprothesen wordt geïmplanteerd 
bij patiënten jonger dan 40 jaar, is er wel een groot probleem met de overleving van 
deze heupprothesen.
Bij jonge patiënten kunnen verschillende soorten heupprothesen worden gebruikt, er 
zijn 2 grote groepen te onderscheiden: gecementeerd en ongecementeerd. De overleving 
van gecementeerde prothesen bij jonge patiënten is helaas slechter in vergelijking met 
de overleving van totaleheupprothesen in de normale, oudere patiëntenpopulatie.1-3 Als 
oplossing zijn prothesen met een alternatieve fixatie techniek ontwikkeld, de 
ongecementeerde prothesen (gebaseerd op botingroei). In sommige landen is dit het 
enige type heupprothese die gebruikt wordt bij jonge patiënten. Echter, 
literatuuronderzoek heeft aangetoond dat de langeterm ijnresultaten van 
ongecementeerde totaleheupprothesen geen verbetering laten ten opzichte van 
gecementeerde heupprothesen bij patiënten onder de 50 jaar.4
W aar primaire coxarthrose de meest gestelde diagnose is bij de oudere patiënten, is 
secundaire coxarthrose op basis van een onderliggende heupafwijking de meest 
voorkomende indicatie voor een totaleheupprothese bij jonge patiënten. Deze 
onderliggende aandoeningen gaan vaak gepaard met (fors) botverlies, vooral aan de 
kom (acetabulaire) zijde. Dit maakt de implantatie van een totaleheupprothese in deze 
specifieke groep lastig en draagt bij aan de teleurstellende resultaten.
In het Universitair Medisch Centrum St Radboud te Nijmegen worden deze acetabulaire 
defecten al ruim 20 jaar gereconstrueerd met geïmpacteerde botsnippers, zowel bij 
jongere als oudere patiënten.5,6
Onze primaire hypothese is dat gecementeerde heupprothesen bij jonge patiënten een 
goede optie zijn met een goede overleving van de prothese, maar wel moeten 
komdefecten, als deze er zijn, op biologische wijze worden gereconstrueerd. Secundair 




Alle patiënten die in onze kliniek in de periode van januari 1988 tot en met juni 2004 
onder de leeftijd van 40 jaar een primaire gecementeerde totaleheupprothese hebben 
gekregen zijn geïncludeerd. De minimale follow-up bedroeg 2 jaar, hierdoor weten wij 
zeker dat alle heupen minimaal 1 tot 1,5 jaar maximaal belast zijn. Geen enkele patiënt 
werd geëxcludeerd. Analyse vond plaats van alle verzamelde klinische, poliklinische en 
radiologische follow-up gegevens. Patiënten die meer dan 2 jaar niet op controle waren 
geweest werden opgeroepen ter evaluatie.
Opera tie techniek
Na resectie van de heupkop werd het acetabulum geprepareerd. Als er geen botdefect 
aan de komzijde was werd direct een polyethyleen cup gecementeerd. Indien er wel een 
botdefect aanwezig was, werd dit defect ingeschaald volgens de classificatie van de 
American Academy of Orthopaedic Surgeons (Tabel 1).7 Bij acetabulaire defecten werden
Tabel 1. Classificatie van acetabulaire botdefecten volgens de American Academy of Orthopaedic Surgeons.7
Type___________________________Defect omschrijving
Type I Segmentaal defect Het ontbreken van wand of rand. Dit kan perifeer (superieure, anterieure
en/of posterieure rand) en/of centraal (afwezigheid van mediale wand) zijn. 
Type II Cavitair defect De wand of rand staat nog wel, echter er is sprake van een volumemetrisch
defect. Ook hier onderscheid tussen perifeer en centraal 
Type III Gecombineerd defect Er is sprake van zowel een segmentaal als een perifeer defect.
Type IV Bekken discontinuïteit De voorste of achterste pijler van het acetabulum is onderbroken of afwezig
waardoor er geen continuïteit van het acetabulum is.
Type V Arthrodese Benige verbinding tussen acetabulum en femur.
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wanddefecten (segmentale defecten) eerst gereconstrueerd met metaalgazen.
Vervolgens werden botsnippers in het defect gelegd, welke daarna met speciaal 
instrumentarium stevig werden geïmpacteerd, zodat het defect opgevuld wordt met een 
stevige bodem bottransplantaat (Figuur 1). Tenslotte werd een standaard 
polyethyleencup gecementeerd. Als bron voor de botsnippers werd meestal de eigen 
heupkop gebruikt, soms waren één of meerdere donor heupkoppen uit de botbank nodig 
om het defect geheel op te vullen. Deze techniek is eerder in dit tijdschrift uitgebreid 
beschreven.8-9 Femoraal werd ook op gestandaardiseerde wijze altijd een gecementeerde 
steel geplaatst. Gebruikte prothesen waren: Exeter (Stryker-Howmedica, Newbury, 
Groot-Brittannië), Charnley (DePuy, Leeds, Groot-Brittannië) en Müller (Sulzer, 
W interthur, Zwitserland). Alle patiënten kregen preoperatief antibiotische profylaxe tegen 
infecties.
Nabehandeling
Patiënten zonder acetabulaire reconstructie werden 1 tot 2 dagen postoperatief 
gemobiliseerd onder leiding van een fysiotherapeut. Volledig belasten was toegestaan 
vanaf 6 weken na de operatie. In geval van een kom reconstructie met botsnippers was 
in de eerste 6 weken 10% belasten toegestaan. In de 6 daaropvolgende weken werd dit 
uitgebreid tot 50%, na 12 weken werd volledig belasten toegestaan. Patiënten met een 
uitgebreide acetabulaire reconstructie en patiënten met een reconstructie geopereerd 
voor 1990 kregen soms eerst een periode van bedrust van enkele dagen tot maximaal 6 
weken voorgeschreven. Alle patiënten ontvingen postoperatief een trombose profylaxe 
en een profylaxe voor het tegengaan van periarticulaire ossificaties.
Patiënten werden postoperatief klinisch en radiologisch vervolgd na 6 weken, 3, 6, 9, 12 
maanden en daarna jaarlijks of tweejaarlijks. Poliklinisch werden vragenlijsten 
afgenomen: de 'Harris Hip Score' (HHS), de 'Oxford Hip Questionnaire Score' (OHQS) en 
Visual Analoque Scales (VAS) betreffende pijn en tevredenheid. De Harris Hip Score en
Figuur 1A-C. Reconstructie van een acetabulum defect met geïmpacteerde botsnippers: (a) Weergave van 
acetabulair defect met een segmentaal defect van de mediale wand en craniale rand; (b) status na 
reconstructie en plaatsen van de cup; (c) dwarsdoorsnede van de opbouw met reconstructie van de mediale 
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de Oxford Hip Questionnaire Score zijn internationaal gebruikte vragenlijsten die ingaan 
op pijn, functionaliteit, hulpmiddelen, loopafstand en mank lopen. De meest recente 
klinische en radiologische gegevens werden gebruikt bij de evaluatie. Helaas waren niet 
van alle patiënten alle vragenlijsten te achterhalen, het aantal beschikbare vragenlijsten 
is weergegeven bij de resultaten. Eindpunt van follow-up was het verw ijderen of 
reviseren van één of meerdere onderdelen van de totale heupprothese (kom, steel en/of 
kopje).
Statistische analyse
De overleving van de totaleheupprothesen werd met behulp van de Kaplan-Meier 
methode berekend. Eindpunten voor analyse waren: revisie voor alle redenen, alle 
revisies uitgezonderd de revisies wegens infectie en alle revisies wegens aseptische 
(mechanische) loslating. Met overleving wordt de periode bedoeld dat de 
totaleheupprothese niet is verwijderd of gereviseerd. Statistische verschillen werden 
berekend met de Log-rank test of de Student t-test.
R esu ltaten
Tijdens de onderzoeksperiode zijn 175 primaire gecementeerde totaleheupprothesen bij 
130 patiënten onder de 40 jaar geplaatst. De gem iddelde leeftijd ten tijde van de 
operatie was 31,3 jaar (uitersten 16-39). Demografische gegevens en onderliggende 
diagnosen zijn weergegeven in Tabel 2.
Tijdens follow-up zijn 6 patiënten (8 heupen) overleden aan oorzaken niet gerelateerd 
aan de operatie of prothese. De gem iddelde follow-up, inclusief overleden en 
gereviseerde patiënten, bedroeg 8,1 jaar (uitersten 2,0-18,5).
In totaal hadden 86 van de 175 heupen (49%) een kom defect ten gevolge van hun 
onderliggende aandoening (Tabel 2). Van alle defecten zijn er 84 gereconstrueerd met 
geïmpacteerde botsnippers. Bij 2 heupen werd er afgeweken van het protocol en werd er 
een acetabulaire reconstructie verricht met een solide bottransplantaat.
Berekende overleving van de prothese
De overleving van de prothese na 10 jaar met als eindpunt revisie voor welke reden dan 
ook was 83% (95% B.I. 76-90%) (Kaplan-Meier)(Figuur 2A, tabel 3). Na uitsluiting van 
revisies wegens infectie was 89% (95%B.I. 83-95%) revisievrij na 10 jaar. De overleving 
van alle heupprothesen met eindpunt revisie voor aseptische (mechanische) loslating was 
92% (95%B.I. 86-98%) na 10 jaar (Figuur 2B). Analyse van alle stelen met als eindpunt 
revisie wegens aseptische steelloslating liet een overleving van de prothese zien van 
98% (95%B.I. 96-100%) na 10 jaar. De cups hadden een revisie vrije overleving van 
92% (95%B.I. 87-98%) na 10 jaar als men kijkt naar de aseptische cuploslatingen. De 
cups zonder bottransplantaat en cups met bottransplantaat lieten een overleving van de 
prothese zien van 90% (95%B.I. 81-99%) en 95% (95%B.I. 89-100) na 10 jaar met als 
eindpunt revisie voor aseptische loslating. Aangaande de tijd tot aseptische loslating is 
het verschil tussen de groepen met en zonder bottransplantaat niet statistisch significant 
(Log-Rank, p=0,73). Ter vergelijking vonden we middels Cox regressie dat de hazard 
ratio van de cups met bottransplantaat 0,80 (95%B.I. 0,22-2,87; p=0,73) is. Hierbij 
dient wel verm eldt te worden dat het maar de vraag is of aan de voorwaarde voor Cox- 
regressie voldaan is (Figuur 2C).
Klinische vragenlijsten
Van de patiënten die geen revisie hadden ondergaan (151 heupen) zijn de klinische 
scoringslijsten geanalyseerd. De mediane preoperatieve HHS was 50 (gemiddeld 49,4; 
uitersten 15-82; n=94), op een schaal van 100 (goed) tot 0 (slecht). De mediane HHS 
verbeterde postoperatief naar 94 (gemiddelde 88,0; uitersten 12-100; n=137). De 
mediane OHQS was 38 (gemiddeld 39,1; uitersten 12-52; n=23) preoperatief, op een
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Aantal patiënten zoekgeraakt tijdens follow-up 0
























Corticosteroïden geïnduceerde avasculaire kopnecrose 39
Reumatoïde artritis 27
Ziekte van Perthes 9







Postoperatief waarvoor chirurgische interventie (geen revisie) 7
Revisies 24
schaal van 12 (goed) tot 60 (slecht). Deze verbeterde naar een mediaan van 16 punten 
(gemiddelde 18,7; uitersten 12-45; n = 135). De mediane VAS voor pijn tijdens rust op 
een schaal van 0 (geen pijn) tot 100 (ondragelijke pijn) was postoperatief 0 (gemiddelde 
7,4; uitersten 0-75). De VAS voor pijn tijdens inspanning had postoperatief een mediaan 
van 4 (gem iddelde 18,7; uitersten 0-100). De mediane VAS voor tevredenheid (0 is niet 
tevreden, 100 is tevreden) was postoperatief 90 (gemiddelde 86,2; uitersten 0-100).
Revisies
Van de 175 heupen zijn er 24 gereviseerd (14%). Acht heupen (4,6%) ondergingen 
revisie wegens een infectie. De gemiddelde tijd tot revisie bedroeg 5,3 jaar (uitersten 
2,2-8,1). Eén heup zat septisch los binnen 2 jaar, deze infectie kan gerelateerd worden 
aan de operatie. De overige infecties worden beschouwd als een acute hematogene 
infectie van een goed functionerende prothese.
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Tabel 3. Aantal patiënten resterend en gereviseerd gedurende de follow-up.





















Ten gevolge van recidiverende luxaties zijn 4 heupen (2,3%) gereviseerd. Eén heup 
(0,6%) zat los na een trauma, beide onderdelen werden gereviseerd na 10,3 jaar goed 
gefunctioneerd te hebben. Elf heupen (6,6%) zijn gereviseerd wegens 
mechanische/aseptische loslating. In 2 gevallen zat zowel de steel als de cup los na 6,4 
en 16,2 jaar. Eén steel is gereviseerd na 2,7 jaar wegens aseptische loslating. In 8 
heupen moest er een cuprevisie plaatsvinden voor aseptische loslating. Dit gebeurde na 
gemiddeld 6,0 jaar (uitersten 1,1-16,8). Van alle 10 cups die gereviseerd waren, hadden 
4 cups een reconstructie gehad met geïmpacteerde botsnippers en 6 cups hadden geen 
reconstructie nodig. De gemiddelde tijd tot revisie voor de cups met en zonder 
reconstructie waren respectievelijk 11,7 jaar (uitersten 4,1-16,8) en 4,0 jaar (uitersten
1,1-10,0), dit verschil is significant (p=0,032).
Complicaties
Er zijn 9 peroperatieve complicaties opgetreden, 30 postoperatieve complicaties en 7 
postoperatieve complicaties waarbij chirurgisch ingrijpen noodzakelijk was (met 
uitzondering van de complicaties die revisie als gevolg hadden). De meest voorkomende 
complicaties waren luxaties (n = 15) en hematoomvorm ing (n=6).
Beschouw ing
Deze studie laat zien dat gecementeerde totaleheupprothesen bij jonge patiënten 
bevredigende resultaten geven. Naar onze mening moeten eventuele botdefecten aan de 
komzijde worden hersteld met behulp van geïmpacteerde botsnippers. Het is vervolgens 
opvallend dat de totale heupprothesen waarbij een acetabulaire reconstructie 
noodzakelijk was even goed presteren als zonder reconstructie. Deze biologische 
reconstructie techniek is dus aantrekkelijk om technisch lastige casus te behandelen.
Overleving in de literatuur
Volgens de NICE-criteria mag men van een goede prothese verwachten dat de overleving 
na 10 jaar minimaal 90% is.10 De 10-jaars resultaten van gecementeerde 
totaleheupprothesen bij patiënten onder de 40 jaar die gepubliceerd zijn variëren van 73 
tot 93%, met als eindpunt revisie voor welke reden dan ook.11-17 De gepubliceerde 
resultaten van ongecementeerde totaleheupprothesen bij jonge patiënten variëren van 
67 tot 85% .18-20 Er zijn dus geen resultaten gepubliceerd van ongecementeerde
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Figuur 2A-C. Kaplan-Meier survival analyses van: (A) Alle totaleheupprothesen met als eindpunt revisie voor 
welke reden dan ook; (B) alle heupprothesen met als eindpunt revisie wegens aseptische loslating; (C) de cups 
met reconstructie met botsnippers (solide lijn) en cups zonder reconstructie (onderbroken lijn).
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totaleheupprothesen bij patiënten onder de 40 jaar met een overleving van 90% of meer 
na 10 jaar. Dit is opvallend omdat uit de gegevens van het Zweedse heupregister 
(www.jru.orthop.gu.se) blijkt dat het gebruik van ongecementeerde heupprothesen bij 
jonge patiënten ju ist toeneemt.
De overleving van de totaleheupprothese in onze studie met eindpunt revisie voor 
welke reden dan ook was 83% na 10 jaar en de aseptische overleving van de stelen en 
cups waren 98% en 92% na 10 jaar. Deze resultaten zijn vergelijkbaar met die van de 
gepubliceerde gegevens van de gecementeerde Charnley prothesen, welke toch als de 
prothesen met de beste lange termijn resultaten worden beschouwd.11-14,17
De zwakste schakel
Uit de meeste studies blijkt dat de acetabulaire cup de zwakste schakel is van een 
totaleheupprothese. De revisiepercentages van de cups zijn doorgaans hoger dan die van 
de stelen.12-20 Er zijn geen studies bekend waarbij de ongecementeerde cups een 
overleving hadden die voldeed aan de NICE-criteria, dit in tegenstelling tot studies met 
gecementeerde cups.11,12,17 De cups in deze studie die een acetabulaire reconstructie 
hebben gehad met geïmpacteerde botsnippers lijken het beter te doen dan de cups 
zonder een bottransplantaat, met een overleving van 91% tegenover 79% (aseptisch: 
95% tegenover 90%) na 10 jaar.
Het herstellen van acetabulaire defecten met geïmpacteerde botsnippers is geen 
eenvoudige techniek. Het reconstrueren van acetabulaire defecten met geïmpacteerde 
botsnippers is vooral een aantrekkelijke operatietechniek bij jonge patiënten. Immers, de 
onderliggende heupaandoeningen bij deze patiënten die verantwoordelijk zijn voor het 
optreden van arthrose op jonge leeftijd gaan vaak gepaard met fors acetabulair 
botverlies. Bij deze jonge patiënten valt in de toekomst zeker een revisie te verwachten 
als men kijkt naar de levensduur van een totaleheupprothese. Het lijkt aantrekkelijk om 
ju ist bij deze patiënten een biologische reconstructie van de al aanwezige botdefecten te 
verrichten, in plaats van het botdefect op te vullen met cement of een grotere 
aangepaste cup. Dit om een heuprevisie in de toekomst beter mogelijk te maken.
Sterke en zwakke punten
De patiënten in deze studie zijn door verschillende ervaren chirurgen geopereerd in het 
UMC St. Radboud met een gestandaardiseerd behandelingsprotocol. Alle onderliggende 
diagnoses zijn geïncludeerd, geen enkele patiënt is geëxcludeerd. Alle patiënten kregen 
een volledig gecementeerde prothese en in geval van een acetabulair defect werd deze 
altijd met een bottransplantaat gereconstrueerd. Dit betekent dat er geen selectiebias is 
betreffende de keuze van operatie techniek. Ook waren alle gegevens van alle patiënten 
beschikbaar voor analyse (met uitzondering van 1 recente röntgenfoto van 1 patiënt) 
waardoor het onderzoek als compleet en betrouwbaar mag worden beschouwd. Echter 
een deel van de vragenlijsten ontbrak, mede doordat de OHQS pas later in onze kliniek is 
geïntroduceerd en het niet gestructureerd afnemen van de vragenlijsten vroeger. 
Daarentegen, zien wij dat al de patiënten waarbij het m isgaat in onze klin iek blijven voor 
een eventuele revisie, dus de uitkomsten zouden bij het compleet zijn van de 
vragenlijsten alleen positiever uitvallen.
Een beperking van deze studie is dat een aantal verschillende typen 
totaleheupprothesen zijn geïncludeerd. Hoewel ze allemaal volledig gecementeerd zijn, 
waren er verschillende merken en typen aanwezig. We hebben niet gekeken naar verschil 
in activiteitsniveau of (over)gewicht. Deze factoren kunnen echter wel een rol spelen bij 
de mate van overleving en vereisen verder aanvullend onderzoek.21,22
C onclusie
Uiteraard moet het besluit om een totaleheupprothese te plaatsen bij jonge patiënten 
zeer zorgvuldig overwogen worden door de patiënt en arts, maar de resultaten van 
gecementeerde totaleheupprothesen bij patiënten die ten tijde van de operatie jonger
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dan 40 jaar zijn, eventueel in combinatie met reconstructie van acetabulaire defecten 
met geïmpacteerde botsnippers laten een goede langeterm ijnoverleving zien van de 
prothesen.
76 Total Hip Arthroplasty in Young Patients
R eferenties
1. Chmell MJ, Scott RD, Thomas WH, Sledge CB. Total hip arthroplasty with cement for juvenile rheumatoid 
arthritis: results at a minimum of ten years in patients less than thirty years old. J Bone Joint Surg Am 
1997;79:44-52.
2. Schmalzried TP, Huk OL. Patient factors and wear in total hip arthroplasty. Clin Orthop Relat Res 
2004;418:94-7.
3. Kobayashi S, Eftekhar NS, Terayama K, Joshi RP. Comparative study of total hip arthroplasty between 
younger and older patients. Clin Orthop Relat Res 1997;339:140-51.
4. Schreurs BW, Busch VJJF, Veth RPH. Keuze van heupprothese voor patiënten jonger dan 50 jaar. Ned 
Tijdschr Geneeskd 2007;151:1918-22.
5. Schreurs BW, Slooff TJJH, Gardeniers JWM, Buma P. Acetabular reconstruction with bone impaction grafting 
and a cemented cup. Clin Orthop Relat Res 2001;393;202-215.
6. Schreurs BW, Busch VJJF, Welten ML, Verdonschot N, Slooff TJJH. Acetabular reconstruction with impaction 
bone grafting and a cemented cup in patients younger than fifty years old. J Bone Joint Surg Am 
2004;86:2385-92.
7. D'Antonio JA, Capello WN, Borden LS, Bargar WL, Bierbaum BF, Boettcher WG, Steinberg ME, Stulberg SD, 
Wedge JH. Classification and management of acetabular abnormalities in Total hip arthroplasty. Clin Orthop 
Relat Res 1989;243:126-37.
8. Busch VJJF, Gardeniers JWM, Slooff TJJH, Veth RPH, Schreurs BW. Goede langetermijnresultaten van een 
gecementeerde totaleheupprothese in combinatie met een acetabulumreconstructie met geïmpacteerde 
botsnippers bij patiënten jonger dan 50 jaar. Ned Tijdschr Geneeskd 2007; 151:1935-40.
9. Schreurs BW, Waal Malefijt MC de, Heereveld HA van, Slooff TJJH, Gardeniers JWM, Veth RPH. 
Totaleheupprothesen bij reumatoïde artritis na acetabulumreconstructie met geïmpacteerde botsnippers en 
een gecementeerde polyethyleenkom: weinig aseptische komloslatingen. Ned Tijdschr Geneeskd 
2001;145:1008-12.
10. National Institute for Clinical Excellence (NICE). Guidance on the selection of prostheses for primary hip 
replacement. London: NICE;2003.
11. Sochart DH, Porter ML. Long-term results of total hip replacement in young patients who had ankylosing 
spondylitis. J  Bone Joint Surg Am 1997;79:1181-9.
12. Sochart DH, Porter ML. The long-term results of Charnley Low-friction Arthroplasty in young patients who 
have congenital dislocation, degenerative osteoarthritis, or rheumatoid arthritis. J Bone Joint Surg Am 
1997;79:1599-1617.
13. Sochart DH, Porter ML. Long-term results of Charnley low-friction arthroplasty in patients aged less than 30 
years. J Arthroplasty 1998;13:123-31.
14. Torchia ME, Klassen RA, Bianco AJ. Total hip arthroplasty with cement in patients less than twenty years 
old. J Bone Joint Surg Am 1996;78:995-1003.
15. Bizot P, Banallec L, Sedel L, Nizard R. Alumina-on-alumina total hip prostheses in patients 40 years of age 
or younger. Clin Orthop Relat Res 2000;379:68-76.
16. Chiu KY, Ng TP, Tang WM, Poon KC, Ho WY, Yip D. Charnley total hip arthroplasty in Chinese patients less 
than 40 years old. J Arthroplasty 2001;16:92-101.
17. Joshi AB, Porter ML, Trail IA, Hunt LP, Murphy JC. Long-term results of Charnley low-friction arthroplasty in 
young patients. J Bone Joint Surg Br 1993;75:616-23.
18. McAuley JP, Szuszczewicz ES, Young A, Engh CA. Total hip arthroplasty in patients 50 years and younger. 
Clin Orthop Relat Res 2004;418:119-25.
19. Duffy GP, Berry DJ, Rowland C, Cabanela ME. Primary uncemented total hip arthroplasty in patients <40 
years old. J Arthroplasty 2001;16:140-4.
20. Chiu KY, Tang WM, Ng TP, Poon KC, Ho WY. Cementless total hip arthroplasty in young Chinese patients. J 
Arthroplasty 2001;16:863-70.
21. Zahiri CA, Schmalzried TP, Szuszczewicz ES, Amstutz HC. Assessing activity in joint replacement patients. J 
Arthroplasty 1998;13;890-895.
22. Sechrest VF, Kyle RF, Marek DJ, Spates JD, Saleh KJ et al. Activity level in young patients with primary total 
hip arthroplasty: a 5-year minimum follow-up. J Arthroplasty 2007;22;39-47.
Chapter 5: Een Heupprothese bij Patiënten Jonger dan 40 jaar 77
78 Total Hip Arthroplasty in Young Patients
Chapter 6: Good Results of THA in Patients Between 40 and 50 Years 79
Chapter 6
Good results with cemented total hip arthroplasty in patients 
between 40-50 years of age 
168 hips followed for 2-19 years
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A bstract
Background and purpose. Total hip arthroplasties in young patients have lower long-term 
survival rates relative to older patients. We have evaluated the use of a unique treatment 
protocol in patients aged between 40 and 50 years. In all cases we used a cemented 
THA, in case of acetabular deficiencies we used also impacted bone grafts together with a 
cemented cup.
Methods. In 140 consecutive patients who were between 40 and 50 years at index 
surgery 168 cemented total hip prostheses were evaluated after a mean follow-up of 10 
(2-19) years. Acetabular deficiencies were reconstructed with wire meshes and impacted 
bone grafts and a cemented cup (70 hips). During follow-up 18 patients (27 hips) died, in 
this group 3 hips (3 patients) were revised. No patient was lost to follow up. In all 
surviving patients clinical assessment was performed with hip scores questions and all 
radiographs were evaluated.
Results. All clinical questionnaires showed an improved clinical hip score. 29 hips 
(17%) were revised after a mean of 8 (0.3-18) years. Kaplan-Meier survival analysis 
showed a survival of 88% (95%CI 82-94%) after 10 years with revision for any reason of 
either component. Survival with endpoint revision for aseptic loosening of either 
component was 94% (95%CI 90-99%) after 10 years.
Interpretation. Cemented implants in young patients have satisfying long-term  results. 
Reconstruction of acetabular deficiencies with impacted bone grafts show promising 
results.
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The outcome of total hip arthroplasty who are younger than 50 years is less favorable 
than in older patients.1 Therefore, many designs and modifications have been tried during 
the last 25 years to improve the outcome in younger patients, including cemented hips, 
uncemented hips, hybrids and resurfacing hip arthroplasty.
We have consequently used cemented total hip implants with a metal on polyethylene 
bearing also in younger patients. In cases of acetabular bone stock loss, which is 
common in these patients, we have reconstructed the bone defects using bone impaction 
grafting and a cemented cup. We have used this method for the last 30 years; which 
guarantees no selection bias using also other techniques in selected patients. As a 
referral centre we accept all patients, do not refer patients and we are not performing 
surgery on patients who are part of this cohort outside our center.
We analyze the outcome in all patients who were between 40 and 50 years at the time 
of surgery during January 1988 to July 2004.
Patients and m ethods
Patients
All patients aged between 40 and 50 years who underwent a primary THA between 
January 1988 and July 2004 at our Department are included in the study. All indications 
were included, with the exception of oncologic cases. We only used a cemented THA and 
in case of acetabular deficiencies, these defects were reconstructed with bone impaction 
grafting together with a cemented cup. 168 consecutive hips in 140 patients (74 female) 
were operated (Table 1). 28 patients had a bilateral THA. The mean age at index surgery 
was 46 (40-49) years. 58 patients were class A, 13 B, 49 BB, and 48 C according to the 
modified Charnley classification.2
During follow-up 18 patients (27 hips) died, all due to causes not related to the 
arthroplasty. All these patients were followed until death and their data are included. 
Two patients (2 hips) were unable to have a clinical and radiological review, both were 
interviewed by telephone and stated that the hip was functioning well. The mean follow- 
up of all patients was 9.7 (2.0-19.3) years. The follow-up of patients available for review 
(deceased and revised patients excluded) was 10.3 (2.7-19.3) years.
Implants
We used only cemented implants. Femoral stems inserted were: Exeter (n=75) (Stryker 
Howmedica, Newbury, U.K.), Charnley / Charnley Elite / Charnley Elite+ (n=22, 31, and 
23 respectively) (DePuy, Leeds, U.K.) and Müller Straight Stem (n=17) (Sulzer, 
W intherthür, Switzerland). The Charnley stems were the only collared stems used. Mean 
follow-up was 16 years for the Müller implants, 12 years for the Charnley implants, and 6 
years for the Exeter implants.
The acetabular components used were: Exeter / Contemporary cups with inner 
diameter 28mm (n=63) and 22mm (n=1) (Stryker Howmedica, Newbury, U.K.),
Charnley / Charnley Elite / Charnley Elite+ / Ogee cups with inner diameter 22.225mm 
(n = 10) or 28mm (n=72) (DePuy, Leeds, U.K.) and Müller cups with inner diameter 
28mm (n=3) and 32mm (n=19) (Sulzer, W intherthür, Switzerland). All cups were made 
of conventional high molecular weight polyethylene and all femoral heads were made of a 
cobalt-chrome alloy; no metal backed liners and ceram ic femoral heads were used.
72 hips (43%) had an acetabular deficiency. According to the AAOS classification3 19 hips 
had a segmental defect (type I), 41 a cavitair defect (type II), and 12 a combined 
segmental and cavitair defect (type III).
Surgery
All patients were given prophylactic antibiotics prior surgery. All but 1 operation 
(anterolateral approach) were performed using a posterolateral approach. No 
trochanteric osteotom ies were performed. In the 72 hips with acetabular deficiencies, 
the defect was reconstructed in 70 hips with bone impaction grafting and if indicated 
metal meshes.4 In 2 hips with segmental rim defects the defect was reconstructed with a
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Table 1. Indications for primary total hip arthroplasty.
Indications No. of hips
Congenital hip dysplasia 39
Rheumatoid Arthritis 24
Perthes' disease 5




Posttraumatic avascular necrosis 5









Alcohol induced avascular necrosis 1
Corticosteroids induced avascular 33necrosis




























solid graft. In 2 cases only allograft was used because the femoral head was not suitable 
for grafting; in 67 cases autograft was used; in 3 cases both allo- and autograft was used 
because of an extensive acetabular defect.
Both prosthetic components were inserted with 2nd or 3rd generating cementing 
techniques with vacuum mixed antibiotic loaded cement, cement pressurizing with a 
cement gun, pulse lavage, and a distal intramedullary femoral plug. Patients with large 
acetabular reconstructions were mobilized with partial weight bearing, increased to full 
weight bearing after 12 weeks. Cases of an extensive acetabular reconstruction had a 
bed rest period up to maximal 6 weeks. Postoperatively, patients received oral 
anticoagulants for 3 months or low molecular heparin for 6 weeks. N SAID's were given to 
prevent heterotopic ossifications.
Clinical evaluation
All patients were periodically followed at our out-patient clinic with an interview, physical 
exam ination and radiographs. Clinical outcome was evaluated with several 
questionnaires: the Harris Hip Score (HHS),5 the Oxford Hip Questionnaire Score (OHQS, 
since 1998),6 and Visual Analogue Scales (VAS, 0-100) assessing pain at rest, pain 
during physical activities (worst score 100) and satisfaction (best score 100). Clinical 
questionnaires were obtained by independent researchers at our out-patient clinic.
Radiographical evaluation
All pre- and postoperative anteroposterior and lateral radiographs of every patient were 
assessed for: position,7 incorporation of grafts, acetabular defects,3 position of wire 
meshes, heterotopic ossifications,8 polyethylene wear,9 rounding-off of the calcar, and 
radiolucent lines. Loosening of the cup was defined as a demarcation in >2 zones around 
the acetabular component of >2 mm, progressive demarcation, component migration of 
>3 mm, component tilting of >8° and/or cement/prosthesis fracture. We recorded the 
acetabular radiographic changes according to the zones of DeLee and Charn ley.10 
Determination of cup migration was measured in relation to the inter-teardrop line 
instead of the Kohlerline.11 Definite loosening of the stem was defined according the 
criteria of Harris et a l..12 Femoral radiographic changes were recorded by the Gruen 
zones. All measurements were corrected for radiographic magnification.
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Figure 1A-C: A 43-year-old female with developmental dysplasia of the hips with high dislocation. Preoperative 
(A), direct postoperative after primary THA with distalization and reconstruction of the cup to its anatomical 
centre of rotation giving a neurological deficit(B), postoperatively after cup revision 2 years later with 
cranialization of the cup (C), and 12 years postoperative after cup revision (D).
Statistics
Kaplan-Meier cumulative survival analysis was used to calculate survival rates. Endpoints 
used for survival analysis were: revision for any reason, revision for any reason excluding 
infections, revision for aseptic loosening and radiographic loosening. Survival rates were 
calculated for the whole THA and cup and stem separately. The survival rates at 10 and 
12.5 years are reported, because up to 12.5 years more than 25% of the patients were 
still remaining in the study population. The Student t-test and Chi-square test were also 
used in statistical analysis. For finding differences in survival the log-rank test was used. 
A p-value of <0.05 was considered significant.
Resu lts
Clinical results
All clinical postoperative questionnaires scores improved. The median HHS improved 
from 51 (2-79; n = 110) points to 94 (10-100; n = 126) points (p<0.001). The median 
OHQs (best score is 12 and the worst score 60) improved from 38 (12-57; n=24) points 
to 16 (12-45; n = 121) points (p<0.001). The median postoperative VAS scores for pain 
at rest, pain during physical activity and satisfaction were 0 (0-80; n = 126) points, 0 (0­
90; n = 126) points, and 100 (0-100; n = 124) points respectively.
Revisions
After a mean follow-up of 9.7 (2 -19.3) years, 29 hips (17%) were revised (Table 2). 
Mean time to revision was 8.1 (0.3-18.4) years. Main reasons for revision were septic 
loosening (n = 5), recurrent dislocations (n=5) and aseptic loosening (n = 15). No 
statistically significant differences were found between the cups with and without 
impacted bone grafts in time to revision and the number of revisions. Remarkably, all the 
hips revised for septic loosening and all the cups revised because of recurrent 
dislocations were THA without an acetabular reconstruction. Of the hips revised because 
of infection, only 1 patient had had an infection within 2 years (0.9 years). All other 
revisions were performed because of late infections. 2 stems fractured, in 1 case an 
Exeter stem and in the other a Charnley Elite stem. In one patient with a high dislocation 
of the hip because of developmental dysplasia (Figure 1A) an acetabular reconstruction 
was performed at the original centre of rotation and the cup was distalized (Figure 1B).
84 Total Hip Arthroplasty in Young Patients
As a result of this distalization, tension on the sciatic nerve resulted in a persistent 
sensory and motor deficit. After 2.4 years the cup was revised to a higher position 
(Figure 1C) and the neurological deficit partly recovered. The percentages of revisions 
were equally spread during time for implant types and diagnoses.
Radiographic results
The most recent radiograph was missing in 2 patients. 23 hips were radiographical loose. 
In 16 cases the cup, in 6 cases the stem and in 1 case both stem and cup were 
radiographical loose. O f these 23 hips, 18 were revised.
The average wear of the non-revised hips was 0.11 (0.00-1.23) mm/yr and the 
average wear of the revised hips was 0.26 (0.00-1.04) mm/yr (p<0.001). Excessive 
wear of >0.1 mm/yr was observed in 77 hips (23 revised and 54 non-revised, p<0.001). 
The wear of cups reconstructed with impacted bone grafts and cups implanted without 
bone grafts were similar. An abnormal position of the cup was not associated with higher 
wear. Radiographical loose cups showed higher wear rates in contrast to radiographical 
stable cups (average 0.23 vs. 0.13 mm/yr, p=0.01).
All grafts incorporated and none showed osteolytic signs. However, in some cases the 
used meshes blurred the examination of the incorporation of the grafts. Cups 
reconstructed with impacted bone grafts showed less radiolucent lines and less 
acetabular osteolysis. 51 hips had heterotopic ossifications. 25 Brooker class I, 16 class
II, and 10 class III.
Complications
In addition to the 5 revisions done for recurrent dislocations, 14 other patients (8%) had
1 or more hip dislocation, all were treated non-operatively. 2 patients had pain and 
limited hip motion and had heterotopic ossifications excised. 4 patients had temporary 
nerve palsies (3 cases with developmental dysplasia of the hips and 1 case after septic 
coxitis at childhood age). A postoperative superficial wound infection occurred in 4 
patients and healed with antibiotics. In 1 case a postoperative hematoma was evacuated 
because of pressure on the sciatic nerve. Cement leakage through DHS screw holes at 
the greater trochanter was removed because of pain in 1 patient.
Survival analysis
Kaplan-Meier survival analysis with endpoint revision for any reason of any component 
was 88% at 10 years and 80% at 12.5 years (Table 3). Excluding the infections the 
survival rates increased to 91% at 10 years and 83% at 12.5 years. Survival with 
endpoint revision for aseptic loosening of any component was 94% at 10 years and 89% 
at 12.5 years (Figure 2). There were no statistically significant differences in survival 
between the different Charnley classifications. With endpoints revision for any reason 
and revision for aseptic loosening the survival rates were sim ilar in patients with a 
bilateral or unilateral THA (p=0.3 and p=0.5), therefore no outcome bias concerning 
bilateral or unilateral THA is present.13
Table 2. Reasons for revision and components revised.
Reason for revision THA Cup Stem Total Mean time till revision (range)
Aseptic loosening 9 5 1 15 10.4 (2.5-18.4)
Septic loosening 5 0 0 5 5.0 (0.9-12.9)
Recurrent dislocations 0 4 1 5 4.1 (0.3-11.4)
Fracture 0 0 2 2 8.5 (6.6-10.4)
Traumatic loosening 0 1 0  1 15.0
Neuropathy 0 1 0  1 2.4
Total 14 11 4 29 8.1 (0.3-18.4)
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Figure 2. Kaplan-Meier survival curve with endpoint revision for aseptic loosening of any component. (95% 
confidence intervals in broken lines).
D iscussion
We believe our findings are relevant and reliable because we report a large series of 
consecutive total hip implantations with no patients lost during follow-up.14 The used 
approach was the only technique, so no selection bias was created. Our study is not a 
single surgeon study, the operations were performed by multiple surgeons.
A lim itation of our study is the short follow-up in some patients. Another lim itation is 
that we used different kinds of implants over time; however all were cemented with a full 
polyethylene cup. The Exeter stems had shorter follow-up, thus the long-term follow-up 
is mostly depending on the results of the Charnley and Müller implants. Nowadays, we 
only use the Exeter stem, Exeter / contemporary cups routinely in primary, and also 
Müller (32mm) cups in revision arthroplasties. Because of the wide range of sizes and 
off-sets of the Exeter stem no custom-made implants are necessary.
Several studies have shown that an acetabular reconstruction with bone impaction 
grafting creates a unique bone-cement-cup interface.15,16 This could be an explanation of
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the smaller amount of radiolucent lines we found in the cups reconstructed with bone 
impaction grafting as also reported by De Kam et a l.17
Notably, the outcome in our patients who had a cemented THA and cups reconstructed 
with bone impaction grafting are sim ilar to the results of Charnley THA in older
patients.18,19,20,21
Good results of cemented THA all with the original Charnley prosthesis in patients 
under the age of 40 with a mean follow-up longer than 10 years varies between 85% and 
93% .22,23,24,25 In another study, the survival of cemented Charnley-Kerboull THA in 
patients below and above the age of 40 was the same (90% vs. 89% at 20 years).19
We have found no reports on uncemented implants in patients under the age of 40, 
with a mean follow-up longer than 10 years, and with a survival rate of more than 90% 
at 10 years with endpoint revision for any reason of any component. If the age lim it is 
increased to include patients under 50, only 1 study report a survival rate of >90% after 
10 years of custom made uncemented implants in 33 patients.26 McAuley et a l.27 
reported 85% survival at 10 years with endpoint revision for any reason of any 
component, in patients below 40 years of age after a mean follow-up of 7 years. In a 
study on uncemented THA in patients <55 years in the Finnish Arthroplasty Register the 
survival at 10 years of different kinds of uncemented THAs varied between 62% and 
86% .28
In a meta-analysis of published literature comparing cemented and uncemented 
THA,29 no advantage was found for either procedure when failure was defined as revision 
of any component or revision of one specific component. They did find a superior survival 
with cemented fixation in studies including patients of all ages as compared to studies 
that only studied patients 55 years of age or younger.
H igher wear rates and higher revision rates in young patients are partly contributed to 
higher activity levels.30,31 We found sim ilar survival rates in the different Charnley 
categories. However, we did not asses activity levels with proven methods like 
questionnaires or accelerometers.
Despite the fact that our clinic is a training university hospital and that these 
institutions are known to have higher revision rates,32 our results are sim ilar to those 
obtained with the Charnley cemented THA in younger patients. Our results emphasize the 
value of cemented THA in this age specific patient population. Reconstruction of 
acetabular defects with bone impaction grafting seems to be a promising technique.
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Thirty years experience with bone impaction grafting of 
acetabular deficiencies in combination with a total hip 
arthroplasty in young patients under fifty years
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A bstract
Background. The long-term survival of total hip arthroplasties in younger patients is often 
disappointing, which can be partly explained by the higher activity levels. However, often 
these patients have already at the implantation of the primary total hip acetabular 
deficiencies, which hamper proper implantation of the cup essential for satisfying 
prosthesis survival. For thirty years, we have used a biological acetabular-reconstruction 
technique with bone-impaction grafting in all patients under 50 years with an acetabular 
deficiency at surgery, always in combination with a cemented total hip implant.
Methods. We evaluated all 177 primary cemented hips implanted in 150 consecutive 
patients who all were younger than 50 years at surgery with an acetabular reconstruction 
by bone-impaction grafting surgically treated between 1978 and 2004. Mean follow-up 
was 10.3 years (range, 2.0-28.3 years) with no patient lost to follow-up. Mean index 
surgery age was 38.1 years (range, 16-49 years). Clinical, radiological, and statistical 
analysis of all patients was performed.
Results. Twenty-eight of 177 hips were revised at a mean of 10.5 years (range, 5 days 
to 23.2 years). Reasons for revision were: aseptic loosening (n=17), septic loosening 
(n = 3), recurrent dislocations (n = 3), traumatic loosening (n = 2), neuropathy (n = 1), wear 
(n = 1), and fracture (n = 1). Ten-year and 15-year survival of the total hip with endpoint 
revision of any component for any reason was 91% and 78%, respectively. Ten-year 
survival with endpoint aseptic loosening was 96% for the cup and 97% for the stem.
Conclusion. Performing a total hip implant in combination with bone impaction grafting 
in younger patients with acetabular bone stock loss seems to be an attractive approach 
as the long-term results are acceptable and fulfill the NICE-criteria, showing a ten -year 
survival of more than 90% with endpoint revisions for any reason.
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Based on the excellent results of THA in older patients,1,2 nowadays THA are used more 
frequently in younger patients (less than 50 years of age) with pain and limited hip 
motion. However, despite many efforts, the long-term results of THA in younger patients 
often are disappointing. In most of the times this lack of success is attributed to the 
increased demands with higher levels of activities in these younger patients.3-5 Another 
explanation however, is the surgical difficulty sometimes experienced in these younger 
patients. Younger patients often have secondary osteoarthritis because of other 
underlying diagnoses like developmental dysplasia of the hips, inflammatory arthritis, or 
avascular necrosis. This secondary osteoarthritis is frequently accompanied by loss of 
acetabular bone and sometimes even pelvic discontinuities or the absence of supportive 
rims or walls. One of the major challenges of implanting a total THA in younger patients 
is therefore the management of these acetabular deficiencies.
Since 1979 we have the philosophy that these acetabular deficiencies in younger 
patients should be reconstructed at insertion of the primary hip implant using a biological 
reconstruction technique.6 From that time on, all cases with bone stock loss have been 
reconstructed by impacting trabecular autograft bone chips and, if needed, allograft bone 
chips into the defect. This technique facilitates also good supporting bone bed that can 
fully contain the cup. Reconstruction with bone impaction grafting restores acetabular 
bone stock loss and facilitates the reconstruction of the original centre of rotation.7,8 
Another possible advantage of this biological approach is the anticipation of a future 
revision. Due to the younger age of patients and the limited lifespan of a THA, a revision 
of a THA in a young patient is inevitable. With restoration of the acetabular bone stock, a 
probably better basis for future revision is created.
In this study, we present the results of all primary THA with acetabular 
reconstructions with bone impaction grafting in patients under the age of 50 years since 
the development of this operative technique 30 years ago in our hospital implanted 
between 1979 and 2004, with a minimum follow-up of two years. In all cases we 
combined this biological reconstruction technique with a cemented total hip arthroplasty 
with a metal on polyethylene bearing. We describe the survival rates, revisions, 
radiographic analysis, and clinical analysis of all younger patients who ever received 
operations with this technique at our centre.
M ateria ls  and Patients
The study was performed after approval by our institutional review board. 
Retrospectively, we reviewed prospectively collected data from all consecutive patients 
who had a primary THA with an acetabular reconstruction with impacted morselized bone
Table 1. Primary indications for total hip arthroplasties.
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grafts because of an acetabular defect at our department between 1978 and 2004, and 
who were younger than 50 years of age at the time of index surgery. We included 177 
hips in 150 patients. All indications were included and no patients were excluded. No 
patient was lost to follow-up. All total hip implants had a cemented femoral stem and a 
cemented acetabular polyethylene cup. Of the 150 patients, 54 (36%) were male and 96 
(64%) female. Twenty-seven patients had a bilateral reconstruction with bone impaction 
grafting. Eighty-three hips were placed on the left side and 94 on the right side. Mean 
age at index surgery was 38.1 years (range, 16-49 years). According to the American 
Academy of Orthopaedic Surgeons (AAOS) classification for acetabular defects,9 34 
(19%) hips had a segmental defect (type I, rim or wall missing), 97 (55%) a cavitair 
defect (type II, volumetric defect with intact walls and rims), 45 (25%) a combined 
segmental and cavitair defect (type III), and 1 (0.6%) hip had a bony ankylosis (type V). 
Primary diagnoses were mainly developmental dysplasia of the hips (29%), rheumatoid 
arthritis (18%), and avascular necrosis of the femoral head (12%) (Table 1).
Surgical technique o f bone impaction grafting
After resection of the femoral head, the acetabulum was prepared and all cartilage and 
cysts were removed. If needed, segmental defects of the acetabular rim and/or medial 
wall are first reconstructed with flexible wire meshes, which are trimmed and adapted 
with special scissors and clamps to contain the defect entirely, and fixed with several 
self-tapping screws (Stryker-Howmedica, Newburry, United Kingdom)(Figure 1A). After 
containment with the wire meshes, only a cavitary defect remains. Sclerotic areas are 
perforated with multiple small drill holes to enhance better vascularisation of the graft. 
The socket is rinsed with pulse lavage and trabecular bone chips of 0 .7-1 .0  mm are 
placed and tightly impacted with specially designed impactors (Figure 1B-C). The 
impactors increase in size and the size of the last impactor used corresponds to the size
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of the polyethylene cup with its cement layer. Multiple layers of graft are impacted until 
the defect is completely filled. The bone chips are made of autograft from the resected 
femoral head and, if needed, from fresh frozen human femoral head allografts obtained 
from a bone bank. The femoral heads are morselized with a special bone mill or by hand 
with a rongeur. We tried to reconstruct the anatomical position of the centre of rotation 
with the transverse ligament as reference. Vacuum-m ixed cement loaded with antibiotics 
was used and the cement was pressurized into the trabecular bone and graft. Finally a 
full polyethylene cup is placed and held in position with a pusher until the cement is 
polymerized (Figure 1D). Before 1989, we used Palacos bone cement (Merck, Darmstadt, 
Germany); from 1989 forward, we used Surgical Simplex (Stryker-Howmedica,
Newburry, UK). The bone impaction grafting technique has been described in detail in the 
literature.10,11
The femoral component was also inserted using pulse lavage, a distal intramedullary 
femoral plug, vacuum-m ixed cement, and pressurizing the cement with a cement gun 
and seal.
During this long time period, we used several kinds of implants. All implants were fully 
cemented and the cups used were made of conventional polyethylene. Only cobalt- 
chrome and no ceram ic femoral heads were used. For the acetabular reconstruction we 
used 62 (35%) Exeter/Contemporary cups (Stryker Howmedica, Newbury, UK), 69 
(39%) Charnley/Elite cups (DePuy, Leeds, UK), and 46 (26%) Müller/Allopro cups 
(Sulzer, W interthur, Switzerland). As a femoral component, we used an Exeter stem in 
90 (51%) cases (Stryker Howmedica, Newbury, UK), a Charnley/Elite stem in 49 (28%) 
cases (DePuy, Leeds, UK), and a Müller stem in 38 (21%) cases (Sulzer, W interthur, 
Switzerland). Our standard head size was 28mm, in some small acetabuli we used a 
22.225 mm heads. All Müller/Allopro cups had an internal diameter of 32 mm.
Postoperative treatment
Patients received antibiotics for 24 hours to prevent infections. Postoperatively, all 
patients received thrombosis prophylaxis with low-molecular-weight heparin for 6 weeks, 
or before 1999 with oral anticoagulants for 3 months according to our postoperative 
protocol. To prevent heterotopic ossifications, we prescribed nonsteroidal 
antiinflammatory drugs (NSAIDs) for 7 days. When NSAIDs were contraindicated, one 
dose (7 Gy) of radiotherapy was given postoperatively.
Patients were mobilized under the supervision of a physiotherapist in an individual 
mobilization protocol. Patients with simple minor cavitair defects were mobilized after 2 
days. In case of extended reconstructions, 10% partial weight bearing was allowed for 6 
weeks and 50% for another 6 weeks before full weight bearing was permitted. Patients 
with massive reconstructions had a period of bed rest of up to 6 weeks to achieve full 
graft incorporation before weight bearing mobilization. Also in the early years of this 
technique all patients had a 6 weeks bed rest period.
Clinical and radiographical analysis
Routine follow-up visits were scheduled after 6 weeks, 3, 6, and 12 months; and yearly 
or biannually thereafter. At our out-patient clinic, independent student researchers 
performed clinical analyses using the Harris hip score.12 Clinical scores of all patients at 
their last review excluding the revision patients were given. Clinical failure was defined as 
the removal or replacement of one or more components of the THA for any reason.
Anteroposterior and lateral radiographs of the THA were obtained and analyzed for the 
radiographical analysis. All radiographs were evaluated on cup position, meshes, graft 
incorporation, migration of either component, polyethylene wear according to Dorr et 
a l.,13 and radiological loosening. Radiological loosening/failure was defined as 
demarcation in two or three zones around the acetabular component of 2 mm or greater, 
progressive demarcation, component migration of 3 mm or greater, component tilting of 
5° or greater, and/or cement or prosthesis fracture. Radiological failure of the stem was 
defined according to the definitions of Harris et a l..14
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Statistical analysis
We used Kaplan-Meier curves to calculate the cumulative survival (time to revision). The 
endpoints were (1) revision for any reason; (2) revision for any reason excluding 
infections; and (3) revision for aseptic loosening. With an average follow-up of 10.3 
years, more than 20% of all patients had a follow-up longer than 15 years. This means 
our results are representative for the 15-year long-term survival. To test any significant 
differences, the student t-test or the Chi-square test was used after checking for normal 
distribution. All calculations were performed with SPSS 16.0.
Source o f funding
Although none of the authors has or will receive benefits for personal or professional use 
from a commercial party directly or indirectly related to the subject of this article, 
benefits have been or will be received from Stryker-Howmedica (Newbury, United 
Kingdom), but will be directed solely to a research fund, foundation, educational 
institution, or other non-profit organisation with which one or more of the authors (BWS, 
JWMG) are associated.
Resu lts
All 177 hips in 150 patients were included for evaluation. No patient was lost during 
follow up. In 2 patients, a recent radiograph was missing for the radiological evaluation, 
and their THA function was based on a telephone interview. Mean follow-up was 10.3 
years (range, 2.0-28.3 years). During follow-up, 13 patients died (accounting for 15 
hips) from causes unrelated to the surgery. All data until death were used in the 
analyses.
Clinical outcome scores improved significantly after surgery. The median HHS 
improved from 47.5 (range, 2-81; n=80), to 91 (range, 10-100; n = 152) postoperatively 
(p<0.001).
Twenty-eight of 177 hips (16%) were revised after a mean of 10.2 (range, 0.1-22.5) 
years (Table 2). Reasons for revision included aseptic loosening (n=17), septic loosening 
(n = 3), recurrent dislocations (n = 3), traumatic loosening (n = 2), neuropathy (n = 1), wear 
(n = 1), and fracture (n = 1). In ten cases, both the cup and stem were revised; in three 
cases only the stem, in fourteen cases only the cup, and in one case only the femoral 
head (Table 2). Average time to revision of the cups because of aseptic loosening was 12 
(range, 2.6-21.2) years. Only one cup was revised solely because of wear after 23.2 
years. Three THA (1.7%) were revised because of culture-proven infection after 3.4, 6.1, 
and 14.5 years, respectively (Table 2). These infections can be defined as haematogenic 
infection of a well-functioning prosthesis.
Radiological evaluation of all radiographs showed that most hips were radiographically 
stable (Figure 2 and 3), but nine cups were radiographically loose. All radiographically 
loose cups ere revised. Seven stems were radiographical loose of which 6 were revised. 
One stem was fractured after 10 years. The average wear of the non-revised cups was
0.08 mm/year and the wear of the revised cups was 0.17 mm/year (significant 
difference, independent t-test: p=0.001).
Survival analysis of all 177 hips with endpoint revision for any reason of either 
component showed a survival of 91% and 78% after 10 and 15 years, respectively 
(Table 3, Figure 4). Aseptic survival of the THA was 95% and 85% after 10 and 15 years, 
respectively (Figure 5). Survival with endpoint aseptic loosening of the reconstructed 
cups was 96% and 86% after 10 and 15 years, respectively, in this study (Table 3,
Figure 6). Survival with endpoint aseptic loosening of the cemented stems in this study 
was 97% and 90% after 10 and 15 years, respectively. There was no difference in 
survival with respect to sex (log-rank, p=0.087), AAOS type (log-rank, p=0.995), age 
less than or greater than 40 years (log-rank, p=0.524), or type of cup (log-rank,
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p=0.420). There was a significant difference in survival regarding the different types of 
stem used; the Müller stems had better survival (log-rank, p=0.045).
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Table 3. Cumulative survival with endpoints revision for any reason, revision for any reason excluding 
infections, and aseptic loosening.
Component Any reason Aifecteans0 excluding Aseptic loosening
10 years 15 years 10 years 15 years 10 years 15 years
THA, Mean 90.8 77.9 92.1 79.0 95.1 84.8
(95%CI) (85.8-95.8) (68.1-87.7) (87.3-96.9) (69.2-88.8) (91.1-99.1) (76.0-93.6)
Stem, Mean 95.2 87.2 96.6 88.5 97.4 90.3
(95%CI) (91.2-99.2) (79.2-95.2) (93.2-100) (80.7-96.3) (94.4-100) (82.7-97.9)
Cup, Mean 91.9 80.7 93.2 81.9 95.7 86.3
(95%CI) (87.1-96.7) (71.1-90.3) (88.6-97.8) (72.3-91.5) (92.9-98.5) (77.5-95.1)
Figure 2. AP radiographs of a 35 years-old female with developmental dysplasia of the hip. Preoperative AP 
radiographs of the left hip to be reconstructed (A), immediately postoperative (B), and 14 years postoperative 
(C) showing a radiological stable view.
D iscussion
To our best knowledge, this is the first study focused on the outcome of total hip 
arthroplasty in a specific and highly demanding group of younger patients; those with 
pre-existing acetabular bone stock loss. It is remarkable that, using a biological approach 
with acetabular bone impaction grafting and a cemented total hip arthroplasty in this 
very young group of patients, the survival with endpoint revision for any reason was 
more than 90% at 10 years, thereby fulfilling the standards defined by the National 
Institute of Clinical Excellence (NICE) that states that a good prosthesis should have a 
survival of more than 90% after 10 years with endpoint revision for any reason.15
The study is based on 30-years experience using a biological method, which can 
reconstitute bone stock. During these 30 years, there has been only one modification of 
the technique. Initially, a metal mesh was placed on top of the impacted bone grafts to 
prevent extensive contact between the bone cement and bone grafts because there was 
some concern whether extensive contact between the graft and the cement would harm 
graft incorporation.16 However, we have abandoned this mesh since 15 years as we 
realized that this mesh was useless. In our study group we found no statistical difference 
between the reconstructions with or w ithout mesh on the top of the impacted bone graft. 
Techniques with a proven long-term survival are needed, especially in younger 
patients.15,17 Our paper is a single institution report presenting the outcome of all cases 
with bone impaction grafting performed by several different surgeons in patients less
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than 50 years of age over the 30-year period that we have used this technique. It is still 
the only technique we use in these cases. The follow-up is complete, and all cases, 
including the initial patients operated on before we gained extensive experience in the 
technique, are included. Since no case was lost, the reliability of our data according to 
Murray et al. is h igh.18 Because we are a referral centre, we accept all cases and do not 
refer cases to other institutions. We have used bone impaction grafting in about 40% of 
all patients who were less than 50 years of age. If there is no bone deficiency, we 
perform a standard, cemented, total hip implant.
A lim itation of the study is that, during this very long follow-up, several types of 
cemented cups and stems were used. However, in our current practice we still use two of 
these cups (Exeter contemporary cup and Muller cup) and the Exeter stem. Because all 
primary diagnoses are included, the primary diagnoses in our population are very 
heterogeneous; however, all had acetabular bone stock deficiencies. Since the bone 
impaction grafting technique is the only technique we use in the reconstruction of 
acetabular deficiencies, it is impossible to make comparisons between different 
reconstruction techniques in our department. One may argue that we also included 
smaller cavitary defects reconstructed by bone impaction grafting, which could also be 
addressed by more cement or non-cemented cups. However, we compare our data to 
reports based on the outcome of total hips in patients less than 50 years of age that are 
not focused on patients with bone deficiencies. A drawback of the method is that patients 
have to use crutches for 3 months, in extensive cases sometimes we use a 6 weeks bed 
rest period.
Although acetabular bone stock deficiencies are frequent in younger patients with 
secondary osteoarthritis, it is remarkable that no other studies are focused on the 
outcome of reconstructions in patients less than 50 years of age with these bone stock 
defects. Currently, noncemented total hip implants are very popular in younger patients, 
implants.15,17 Remarkably, screening the literature on 01-01-2009 there is only one
Figure 3. AP radiographs of a 19 years-old female with developmental dysplasia of the hip. Preoperative AP 
radiographs of the left hip to be reconstructed (A), immediately postoperative (B), and 7 years postoperative 
(C) showing a radiographically stable view.
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Figure 5. Kaplan-Meier survival analysis with endpoint revision of either component for aseptic loosening.
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report of uncemented total hip arthroplasty, and no reports of metal-on-metal 
resurfacing total hip arthroplasty techniques, that have a reported minimal survival rate 
of 90% at 10 years in patients less than 50 years of age .19 There are reports based on 
cemented implants that do fulfil these criteria; however, these reports do not focus on 
younger patients with acetabular bone stock loss, although a certain subset of these 
patients will have pre-existing bone stock loss.20-22 There have been long-term reports on 
the application of bone impaction grafting in primary total hip prostheses, but most 
reports do not focus on the outcome of this technique in younger patients.23,24 We have 
reported the outcome of the bone impaction grafting technique in young patients 
previously; however, the earlier study was based on a limited number of 42 acetabular 
reconstructions in both primary (n=23) and revision hips (n = 19), and only the outcome 
of the acetabular component was reported.25 At 10 years, the survival rates for the cup 
were 92% (95% CI 83.5-100% ) and 97% (95% CI 92.1-100% ) with endpoint revision 
for any reason and revision for aseptic loosening, respectively. This is comparable to the 
outcome of the cup in the current study (92% and 96%) based on many more cases.
An attractive aspect of the technique is that the bone stock loss is reconstructed by bone 
transplantation. There is evidence, both from animal studies and human biopsies, that 
these bone grafts do indeed incorporate into normal human bone.7,8 By using this 
approach, the outcome of future revisions is probably less demanding because more 
bone may be available.
Achieving good survival rates for total hip arthroplasties in younger patients is 
difficult. Acetabular deficiencies make this challenge even harder. Younger patients are 
dependent on proven long-term survival of prostheses and the outcome of both the 
femoral and acetabular component is important. The latter is often a flaw in many 
reports on total hip arthroplasty, because they are often focused on one component. This 
study shows that the use of bone impaction grafting is very attractive in total hip 
arthroplasty in younger patients with acetabular deficiencies. Bone impaction grafting 
restores the loss of bone stock and creates a natural, anatomic, biomechanical situation 
and produces satisfactory survival rates, which fulfill the NICE-criteria 10 years after 
implantation.
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S um m ary
Background. Surgeon's always must take into account that a primary total hip 
arthroplasty (THA) in a young patient will be revised in the future, this because of the 
long life expectancy of young THA patients and the lim ited durability of prosthetic 
implants in these patients. Therefore we would like to accentuate the revisability of a 
primary THA in this specific and high demanding patient population.
Methods. 343 consecutive THA in 270 patients under the age of 50 years were 
evaluated. We also assessed the results of the revised THA (n=53) within the same 
population. Clinical, radiographical and survival of primary and revision THA were 
evaluated.
Findings. With no patient lost during follow-up, 53 primary hips were revised after a 
mean follow-up of 8.9 (range 2.0-19.3) years. Survival with endpoint revision for any 
reason of either component was 86% after 10 years for primary THA. The average 
follow-up of the revisions of this population was 4.2 (range 0.1-14.8) years and 3 hips 
needed a repeat revision. Survival was 91% after 5 years for the revision THA. As well 
after primary as revision THA showed good clinical outcome.
Interpretation. Cemented implants in young patients show satisfying results as well in 
primary as revision THA with good survival and clinical outcome. Keeping in mind that 
the young patient will outlive their primary THA, the primary has to be revisable and the 
results of the revision THA must be as good as the primary THA. Bone defects in primary 
and revision THA can be successful managed with impacted bone grafts, w ithout the 
need for augments, cages or larger implants.
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In troduction
The success of total hip arthroplasty (THA) started in the 1960s and early 1970s and are 
mainly attributed to the investigations of Sir John Charnley, which included the use of 
cement in combination with low-friction arthroplasty based on the articulation of a metal 
head with a polyethylene cup.1 Restoration of jo in t movement, relief of pain, and full 
participation in normal daily activities is achieved with the replacement of a restricted hip 
jo in t due to end-stage hip disease. This approach is so successful that the total hip 
arthroplasty is cited as the operation of the last century.2
However, long-term survival data of total hip arthroplasties in younger patients are 
still inferior to the survival data in patients who are over 70 years at the moment of 
surgery and especially patients who are younger than 50 years at the moment of surgery 
are very challenging. These patients often have secondary osteoarthritis due to an 
underlying hip disease, which is frequently accompanied with acetabular bone stock loss. 
In these cases with acetabular bone stock loss, creating a stable position of the cup is 
more difficult. In addition, these younger patients have higher activity levels putting 
increased demands on their hip implants. These factors lim it the long term survival of 
their hip arthroplasties.
For these younger patients, there is a clear need to use reconstruction techniques and 
hip implants with a proven long-term survival rate.3 However, even if the techniques and 
implants are chosen based on these criteria many patients will face a revision of their 
prosthesis during their living as the life expectancy of the patients is longer than the 
survival of their hip implants. For these younger patients, in addition to the outcome of 
their primary implant there is also a need to have outcome data of these subsequent 
revisions. The question in these young patients is if we can keep them mobile for longer 
periods. However, these data are not available in literature so far.
For more than 30 years we use standardized approach in all patients under 50 years 
who have osteoarthritis of the hip.4 We use always a cemented total hip prosthesis. In 
cases of acetabular bone stock we always have reconstructed this defect using a 
biological attractive technique by a bone impaction grafting in combination with 
cemented cup.
If during the follow-up a revision was needed we again used a standard protocol. At 
revision most failed hips arthroplasties had bone stock loss, both on the femoral and 
acetabular side due to the loosening process. We always used a cemented hip prosthesis 
for revision surgery in all cases. However, in case of bone defects observed at revision 
surgery, these were reconstructed first with bone impaction grafting on both the 
acetabular and femoral side.5-7
In the current unique study we will present the outcome of 343 consecutive total hip 
arthroplasties implanted in 270 patients in the period 1988-2004 who were all younger 
than 50 years at the moment of surgery. We will present the long term survival data of 
this cohort. In addition we will also present the outcome of all failed hip arthroplasties of 
this cohort after their revisions of this cohort, which are unique data in literature.
M ethods
Study group
Retrospectively, we reviewed the prospectively collected data of all consecutive patients 
(270 patients, 343 hips) who had a primary cemented THA at our department between 
1988 and 2004 and who were younger than 50 years at the index surgery. All indications 
and all patients were included. No patient was lost to follow-up. All THAs had a cemented 
femoral stem and a cemented acetabular polyethylene cup, a totally cemented total hip 
was the only technique we used. Mean age at index surgery was 38.3 years (range, 16­
49 years). According to the classification of the American Association of Orthopedic 
Surgeons (AAOS) for acetabular defects8, 35 (10.2%) hips had a segmental defect (type
I, rim or wall missing), 80 (23.3%) a cavitar defect (type II, volumetric defect with intact 
walls and rims), 41 (12.0%) a combined segmental and cavitar defect (type III), and 2 
(0.6%) hips a bony ankylosis (type V). All acetabular bone defects were reconstructed
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Table 1. Primary diagnosis for primary THA.
Diagnosis Number of cases
Developmental dysplasia of the hip 82






Avascular necrosis of unknown origin 14
Protrusio acetabuli 11





Polycystic hip disease 2
Fusion of the hips of unknown origin 2
Osteogenesis imperfecta 2




Synovitis Villonodularis Pigmentosa 1
Total 343
with the bone impaction grafting method and this technique was used in 155 cases 
(45.2% ).4,5 Primary diagnoses were mainly developmental dysplasia of the hip (23.9%), 
corticosteroid induced avascular necrosis (20.9%) and rheumatoid arthritis (14.9%) 
(Table 1).
Surgical technique at the primary total hip
All but one operation were performed using a posterolateral approach, in one case an 
anterolateral approach was used. After resection of the femoral head, the acetabulum 
was prepared and all cartilage and cysts were removed. If no acetabular defects were 
seen multiple drill holes were made to facilitate the intrusion of bone cement and the 
acetabulum was washed. In case of bone defects, segmental defects of the acetabular 
rim and/or medial wall are first reconstructed with flexible metal wire meshes, which are 
trimmed and adapted with special scissors and clamps to contain the defect entirely, and 
fixed with several self-tapping screws (Stryker-Howmedica, Newburry, United Kingdom) 
(Figure 1A). After creating containment with the wire meshes, only a cavitary defect 
remains. Sclerotic areas are perforated with multiple small drill holes to enhance better 
vascularisation of the graft. The socket is rinsed with pulse lavage and trabecular bone 
chips of 0.7-1.0 mm are placed and tightly impacted with specially designed impactors 
(Figure 1B-C). Multiple layers of graft are impacted until the defect is completely filled. 
The bone chips are made of autograft from the resected femoral head and when more 
bone is needed bone chips were made of fresh frozen human femoral head allografts 
obtained from a bone bank. The femoral heads are morselized with a special bone mill or 
by hand with a rongeur. The impactors increase in size and the size of the last impactor 
used corresponds to the size of the polyethylene cup with its cement layer. We tried to 
reconstruct the anatomical position of the centre of rotation with the transverse ligament 
as reference. Vacuum-mixed cement loaded with antibiotics was used and the cement
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was pressurized into the trabecular bone in hip w ithout bone defect and into the graft 
reconstruction is case of a bone reconstruction by bone impaction grafting. Finally a full 
polyethylene cup is placed and held in position with a pusher until the cement is 
polymerized (Figure 1D). Before 1989, we used Palacos bone cement (Merck, Darmstadt, 
Germany); from 1989 forward, we used Surgical Simplex (Stryker-Howmedica,
Newburry, UK). The bone impaction grafting technique has been described in detail in the 
literature.4,5,9 The femoral component was also inserted with a third-generation 
cementing technique that included pulse lavage, a distal intramedullary femoral plug, 
vacuum-mixed cement, and pressurizing the cement with a cement gun and seal.
Implants used
During the studied time interval we used several kinds of implants. All implants were fully 
cemented and the cups used are made of conventional polyethylene. Only cobalt-chrome 
heads were sued. On the acetabular side we used 143 (42%) Exeter/Contemporary cups 
(Stryker Howmedica, Newbury, UK), 153 (45%) Charnley/Elite cups (DePuy, Leeds, UK), 
and 47 (14%) Müller/Allopro cups (Sulzer, W interthur, Switzerland). As femoral 
component we used in 186 (54%) cases an Exeter stem, in 142 (36%) cases a 
Charnley/Elite stem and in 33 (10%) cases a Müller stem. The inner diameter of the cup 
was in 26 cases 22.2mm (8%), 28mm in 279 hips (81%) and 32mm in 38 cases (11%).
Postoperative treatment
Patients received antibiotics (cefazolin) for 24 hours to prevent infections.
Postoperatively, all patients received thrombosis prophylaxis with low-molecular-weight 
heparin for 6 weeks or, before 1999, with oral anticoagulants for 3 months according to 
our postoperative protocol. To prevent heterotopic ossifications, we prescribed
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nonsteroidal anti-inflammatory drugs (NSAIDs) for 7 days. When NSAIDs were 
contraindicated, postoperatively one dose (7 Gy) of radiotherapy was given.
The mobilization protocol was related to the extent of the reconstruction. Patients with 
simple minor cavitary defects were mobilized after 2 days. In case of extended 
reconstructions 10% partial weight bearing was allowed for 6 weeks and 50% for another 
6 weeks before full weight bearing was allowed. Patients with extensive reconstructions 
using several femoral heads had a bed rest up to 6 weeks to facilitate some graft stability 
before weight bearing mobilization.
Surgical technique at the revision total hip
In all cases with a failed cemented total hip, a work-up was performed to diagnose a 
possible septic loosening. In case of septic loosening we used a 2 stage approach with 
removal of the implant and all cement. Based on the cultures patients were treated with 
antibiotics for 3 months and next a reimplantation was planned.
In all other cases a one stage revision was performed. First the implant was removed 
including the cement, than a new cemented implant was inserted. However, if there was 
bone stock loss on both the femoral as the acetabular side this was reconstructed with 
impacted bone grafts first. Segmental defects of the acetabulum and femur were 
reconstructed with metal wire meshes remaining a contained cavitary defect. Trabecular 
bone chips of 0.7-1.0 cm are placed into the defect and tightly impacted with specially 
designed impactors into the acetabulum. We used the same reconstruction technique for 
the acetabular side in both primary and revision THA in case of acetabular defects. On 
the femoral side, bone chips of 0.3 to 0.5 cm were impacted with specially designed 
femoral metal impactors. The bone chips are made of fresh frozen human femoral head 
allografts obtained from a bone bank. The femoral heads are morselized with a special 
bone mill or by hand with a rongeur. Next again a cemented implants was inserted. For 
after treatment we follow the same protocol as had been followed in the primary cases.
Clinical and radiographical analysis
Routine follow-up visits were scheduled after 6 weeks; 3, 6, and 12 months; and yearly 
or biennial thereafter. Clinical outcome was evaluated with several questionnaires: the 
Harris Hip Score (HHS)10, the Oxford Hip Questionnaire Score (OHq S, since 1998)11and 
Visual Analogue Scales (VAS) assessing pain at rest, pain during physical activities and 
satisfaction (for pain on a scale from 0 (no pain) to 100 (unbearable pain). Clinical 
questionnaires were obtained by independent researchers at our out-patient clinic. For 
review, all medical files and questionnaires were evaluated.
A clinical failure was defined as the removal or replacement of one or more 
components of the THA for any reason. Anteroposterior and lateral radiographs of the 
THA were obtained and analyzed for radiographical analysis. All radiographs were 
evaluated on: position of cup, stem and meshes, incorporation of the graft, migration of 
either component, polyethylene wear according to Dorr et a l.12, and radiological 
loosening. Radiological loosening/failure is defined as demarcation in two or three zones 
around the acetabular component of 2 mm or greater, progressive demarcation, 
component migration of 3 mm or greater, component tilting of 5° or greater, and/or 
cement or prosthesis fracture. Radiological failure of the stem was defined according to 
the definitions of Harris et a l..13
Statistical analysis
We used Kaplan-Meier analysis to calculate the cumulative survival (time to revision) of 
both the primary hip as well as of the revised hip implant until re-revision. The end 
points were: (1) revision for any reason; (2) revision for any reason excluding infections; 
and (3) revision for aseptic loosening. To test any significant differences, the Student t- 
test or the Chi-Square test is used after checking for normal distribution. All calculations 
are made with SPSS 16.0. A p-value of <0.05 was considered significant.
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Resu lts
Primary THA
All 343 hips in 270 patients were available for evaluation; no patient was lost during 
follow up. However, in 3 patients a recent radiograph was missing for the radiological 
evaluation, but based on a telephone interview, in all 3 patients the hip was clinically 
functioning well. The mean follow-up at review of the 343 hips was 8.9 years (range, 
2.0-19.3 years). During follow-up 24 patients died (35 hips), all data until death were 
available and are used for analysis. O f these 35 hips of deceased patients, 3 were 
revised. O f the whole group of 343 hips, 53 hips were revised during follow-up.
Clinical outcome o f primary THA
Clinical outcome scores improved significantly after surgery. The median HHS improved 
from 50 preoperatively (mean 49.1; range, 2-82; n=175) to 93 (mean 86.0; range 9 ­
100; n=270) postoperatively (paired t-test: p < 0.001). The median OHQS improved 
from 38 (mean 38.0; range 12-57; n=48) to 16 (mean 19.0; range, 12-55; n=262) 
postoperatively (paired t-test: p < 0.001). The median VAS satisfaction postoperatively 
was 90 (mean 85.5; range 0-100; n=259). The median VAS pain at rest and pain during 
physical activities were respectively 0 (mean 8.3; range 0-90; n=266) and 0 (mean 
18.2; range 0-100; n = 266).
Revisions o f primary THA
Fifty-three of 343 hips (16%) were revised after a mean of 7.1 year (range, 0.01-18.4 
years) after the primary THA. Reasons for revision were: aseptic loosening (26), septic 
loosening (13), recurrent dislocations (9), traumatic loosening (2), neuropathy of the 
sciatic nerve due to overstretching of this nerve after a reconstruction of a high hip 
center (1), and fracture (2). In 25 cases both the cup and stem were revised, in 21 cases 
the cup, in 5 cases the stem, and in 2 cases only the femoral head was exchanged (Table 
2).
Radiological evaluation of all radiographs showed that most hips were radiographical 
stable, but 44 cases of the 343 hips were radiographical loose according to the used 
definitions. Revision of one or more components was performed in 36 of the 44 cases. 
The average wear of the non-revised cups was 0.09 mm/yr and the wear of the revised 
cups was 0.22 mm/yr (independent t-test: p <0.001).
Survival analysis o f primary THA
Survival analysis of all 343 hips with endpoint revision for any reason of either 
component showed a survival of 86% after 10 years (Table 3, Figure 2). Survival of the
Table 2. Overview of all revisions of Primary THA and Re-revisions of revision THA.
Reason for (re-)revision Number of cases Mean time till revision(range) in years
Primary THA
Aseptic loosening 26 8.9 (1.1-18.4)
Septic loosening 13 5.0 (1.3-12.9)
Recurrent dislocations 9 3.7 (0.01-11.4)
Fracture 2 8.5 (6.6-10.4)
Traumatic loosening 2 12.6 (10.2-15.0)
Neuropathy 1 2.4
Total 53 7.1 (0.01-18.4)
Revision THA
Aseptic loosening 1 12 .3
Septic loosening 2 1.6 (0.6-2.6)
Total 3 5.2 (0.6-12.3)
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stem and cup with endpoint aseptic loosening was 100 and 93% respectively after 10 
years. THA with Bone impaction grafting had a survival of 90% (SE 2.8) in contrast to a 
survival of 82% (SE 3.4) of the cups without an acetabular revision with endpoint 
revision for any reason (log-rank test, p=0.156) at 10 years. All survival rates are shown 
in Table 3.
Revision THA
All 53 revision cases in 50 patients were available for evaluation and all but 2 were 
performed in our department; no patient was lost during follow up. Only one repeat 
revision (re-revision) was performed in a clinic elsewhere. All clinical and radiographical 
data were available for review. Indications for revision are mentioned before (Table 2). In
2 cases no revision THA was implanted and a Girdlestone situation was created. Both 
cases were revised because of infection and there was a persistent chronic infect, so 
implantation of a new THA was not attractive. 37 of the 45 (82%) cup revisions were 
reconstructed with impacted bone grafts, and 16 of the 26 (62%) femoral stem revisions 
were reconstructed with femoral bone impaction grafting. Mean follow-up of the revised 
hips was 4.2 years (range 0.1-14.8). During follow-up 3 patients died (3 revision THA) all 
data until death are used for analysis, none have had a repeat revision. Mean age at 
repeat revision was 46.5 years (range 25.8-65.7).
Follow-up in years
Figure 2. Kaplan-Meier survival analysis with endpoint revision of either component for any reason.
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Table 3. Overview of all survival rates classified by the different endpoints.
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Clinical outcome o f revision THA
The median HHS after revision was 97 (mean 87.2; range, 24-100; n=43). The median 
OHQS was 14 (mean 20.1; range 12-51; n=43). The median VAS satisfaction 
postoperatively was 89 (mean 78.6; range 0-100; n=42). The median VAS pain at rest 
and pain during physical activities were respectively 0 (mean 15.8; range 0-80; n=43) 
and 0 (mean 20.1; range 0-95; n=43).
Re-revisions o f revision THA
A repeat revision was necessary in 3 of the 53 revision hips (5.7%). Reasons for repeat 
revision were: infection (n=2) and aseptic cup loosening (n = 1). The re-revisions for 
septic loosening were revised after 0.6 and 2.6 years. Both cases have had a revision of 
the primary THA because of septic loosening. One patient have had 4 repeat revisions in 
total and still functions with a THA, the other patient have had 3 repeat revisions and in 
the last one a Girdlestone was created because of a persistent chronic infection. The re­
revision because of aseptic cup loosening was revised after 12.3 years. The reason for 
revision of the primary THA was infection, but the intraoperative cultures taken during 
repeat revision were negative. During repeat revision the acetabulum was reconstructed 
with bone impaction grafting and the cup was replaced.
Survival analysis o f revision THA
Survival analysis of all 51 revision THA with endpoint revision for any reason of either 
component showed a survival of 91% after 5 years. Survival of the stem and cup with 
endpoint aseptic loosening was both 100. All survival rates are shown in Table 3.
D iscussion
In this paper we introduce a new dimension in reporting the outcome of total hip 
replacements in patients under 50 years. In young patients there is a great need for 
techniques and implants with proven long term outcom es.3 Clearly, this is an important 
strategy to enhance outcome data in younger patients. However, as many of these young 
patients will still outlive their prosthesis, surgeons should also consider what the outcome 
is after a revision. If certain types of prosthesis fail with extensive bone stock loss 
hampering the implantation of a revision implant, the outcome of the inevitable revisions 
will be less successful. Therefore, we decided to report a large cohort of consecutive total 
hip arthroplasties and the outcome of the subsequent revisions of the failed implants.
The original cohort of 343 hip prosthesis in 270 patients is quite unique as we are one 
of the few centers worldwide who always inserts cemented implants in all patients and at 
all ages. Also we have used one biological approach in these young patients as in all
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cases with acetabular bone stock loss, a reconstruction with impacted bone grafts. The 
follow-up is complete for all patients which make our conclusions reliable.14 In this 
multisurgeon single institution study, no cases were excluded and as a referral centre we 
accept all cases. Also, it is remarkable that almost every revision is performed in our 
centre. In all revisions we again used the same technique and again cemented implants. 
With this biological approach we try to reconstruct the bone loss often seen at revisions. 
Using this technique we prevent the use of larger implants, a technique often used in 
revision surgery. We think that especially in young patients, one has always to bear in 
mind the next hip revision and how to facilitate this future problem.
The outcome of the primary cemented implants following this treatment strategy is 
satisfying, with endpoint revision for any reason showing a survival at 10 years of 86%. 
This is comparable to other stud ies.15-21 O f the 343 hips implanted 13 (3.7%) ended in a 
septic loosening. However of these 13 infections 12 occurred more than 2 years after 
implantation and should be considered as heamotogenic infects. Most of these patients 
had rheumatoid arthritis and were using immunosuppressive drugs. The outcome of both 
the femoral component as well as the acetabular component with endpoint aseptic 
loosening at 10 years is excellent.
The most interesting part of this study is the outcome of the failed prosthesis. At final 
follow-up, only 2 of the 343 total hip arthroplasties resulted in a final Girdlestone 
situation, both for infection. In fact, these were not reimplantated due to persisting signs 
of infection. The outcome of the 51 revisions performed within this cohort was 91% 
survival at 5 years with endpoint a re-revision. There were 3 re-revisions. However, 2 of 
the 3 failures were septic failures and were originally revised for the indication of septic 
loosening, so these 2 cases should be considered as failed treatments of previous 
infections. Excluding these 2 septic failures, only one of the 49 revisions had a re-revision 
and this was a re-revision for an aseptic cup failure at 12 years after the revision. At 5 
years the survival of the revised hips is 100% with endpoint aseptic loosening. There are 
only a few reports of the outcome of revision THA in young patients. Stromberg et a l.22 
reported a survival of 76% after 8 years with endpoint revision for aseptic loosening of 
either component in 70 revision THA in patients under the age of 55. Other reports about 
revision THA in young patients are only about the acetabular component. Comba et a l.23 
reported a survival of 89% after 7.2 years of the acetabular component with endpoint 
revision for any reason in a study about 30 revision THA. These results are comparable to 
those of Raut et al..24 In this study of 87 revision THA in patients under 56 years, a 
survival of 90% was seen of the acetabular component with the same endpoint and 67% 
of the patients had an excellent clinical assessment. The results of the revision THA in 
our population seems to be promising, but longer follow-up is necessary.
As pointed out by McAuley et al. especially in young patients there is a need for total 
hip implants with proven long-term outcomes. Using the NICE criteria that at least a 
survival of 90% or more is needed at 10 years with revision for any reason of either 
component, it is possible to select implants and prostheses from literature that fulfill 
these criteria.25 So far, the nowadays very popular uncemented implants often used in 
young patients are not represented in this selection. Also our study fails to pass the NICE 
criterion as our survival at 10 year was only 86%. However, we have pointed out that 
with this protocol using cemented implants it is possible to revise a failed implant with 
again a satisfying clinical outcome and a very acceptable midterm survival rate. In young 
patient we think that this new dimension of reporting the survival of THA is essential to 
prove that with a certain implant philosophy it is possible to keep these young patients 
mobile, also on the long term.
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A bstract
Background. These days, total hip arthroplasties (THA) are more implanted in young 
patients. Due to the expected lifespan of a THA and the life expectancy of young 
patients, a future revision is inevitable. Indirectly increasing the number of revisions in 
these patients. Therefore we evaluated the results of revision THA in patients under the 
age of 60 years. However, we used a unique protocol in which we used in all cases of 
acetabular and/or femoral bone deficiencies reconstruction with bone impaction grafting.
Methods. To determ ine the mid- to longterm results of cemented revision total hip 
arthroplasties in patients under the age of 60, all clinical data and radiographs were 
analysed of patients operated between 1992 and 2005. Patients with multiple previous 
revisions were also included. Only cemented components were used. During this period 
146 consecutive revision total hip arthroplasties were implanted in 129 patients. This 
included 124 cup and 106 stem revisions. The average age at index surgery was 47 
years. No case was lost. Mean follow-up was 7.6 (range, 2.0-16.7) years.
Results. Outcome of clinical questionnaires improved significantly after revision THA. 
During follow-up 19% (28 hips) needed a repeat revision (aseptic loosening 13, septic 
loosening 10, recurrent dislocations 2, traumatic loosening 2, and abductor contracture 
1). Seven of 146 cases (4.8%) ended finally in a permanent Girdlestone. Seventeen 
(14%) of the 124 cups were radiographically loose, 11 were revised. Four (4%) of the 
106 stems were radiographically loose, 2 were revised.
The 10-years survival was 78% with endpoint revision for any reason and 87% with 
endpoint revision for aseptic loosening. 28 hips needed repeat revision after the index 
revision. No significant differences in survival were found looking at the different 
indications for revision
Conclusions. The survival of cemented revision THA in patients under the age of 60 is 
satisfying. Reconstruction of acetabular and femoral bone deficiencies with bone 
impaction grafting is a promising and biological attractive technique in this young and 
high demanding population and enhances the revisability of a THA.
Level o f Evidence. Level III, therapeutic study. See the Guidelines for Authors for a 
complete description of levels of evidence.
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The use of total hip arthroplasty (THA) in young patients is increasing.1 Surgeons are less 
reluctant to implant these devices because of the satisfying results in older patient 
populations. This trend is encouraged by the orthopaedic industry with new implant 
designs and newer bearing surfaces claim ing better long-term results. But because of the 
higher activity levels and secondary osteoarthritis higher revision rates of THA in young 
patients are seen. With the increased number of primary implants and the higher revision 
rates, the incidence of revision THA in young patients is also increasing. In most of the 
times, loosening of THA involves bone stock loss. Young patients often have already 
acetabular deficiencies before primary THA due to secondary osteoarthritis. A failure of 
the primary THA can result in even larger acetabular bone stock loss, making these 
revisions sometimes very difficult. Femoral revisions have also to deal with femoral bone 
stock loss.
Several techniques have been described for the revision of a primary THA with varying 
results like a high hip center, cages, bulk grafts, and bilobed or augmented cups.2-10 Each 
technique has its own advantages and disadvantages. Despite the extensive reports of 
the different techniques used in revision THA, the reports about outcome of revision THA 
in young patients (<60) is very lacking.
In 1979 Slooff et al. introduced the use of bone impaction grafting in hip revision 
surgery11 and several groups have reported good results with this technique during 
primary and revision THA.12-17 Gie et al. improved the reconstruction technique of 
femoral defects with impacted bone grafts.18 This technique is very attractive for revision 
THA in young patients, because of its potential to biological restore bone deficiencies.
19,20 In case of acetabular or femoral deficiencies, we have always used bone impaction 
grafting during revision THA at our clinic.
The purpose of this study is to report the clinical results, repeat revisions, radiographic 
results, and survival of a population consisting of patients younger than 60 years old who 
underwent a cemented revision of one or more components of their THA.
M ateria ls  and M ethods
We retrospectively reviewed all patients who have had a revision THA in our department 
between January 1992 and December 2005, and who were younger than 60 years at 
index surgery. Previous revisions or other hip operations were no exclusion criteria. THA 
implanted because of oncologic indications were excluded. We reviewed all patients' 
records and radiographs for clinical and radiological data. Failure was defined as the 
removal or repeat revision of the revised component(s). In this period 146 revisions in 
129 patients were performed. O f the 146 revisions, 76 were performed on the left side 
and 71 on the right side; 13 patients have had a bilateral revision. Seventy-four patients
THA = both cup and stem revised
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were female and 55 male. Four patients have had two revisions on the same side of 
different components during the research period. The mean age at index surgery was 
47.3 years (range, 25-59 years). The mean follow-up was 7.6 years (range, 2.0-16.7 
years). During follow-up 10 patients (12 revisions) died, two of these patients (2 hips) 
have had a repeat revision after respectively 1.1 and 2.2 years. All patients who died 
were followed on a regular basis and their data included. No patient was lost during 
follow-up and no data of any patient was missing.
Indications for revision THA were mainly aseptic loosening (n=94), septic loosening 
(n = 29) and recurrent dislocations (n = 12) (Table 1). In 87 cases all components, in 37 
cases only the cup, in 19 cases only the stem and in 3 cases only the femoral head were 
revised. The majority of all revisions were performed by or under supervision of two 
senior faculty orthopaedic surgeons (BWS, JWMG). All approaches were performed 
posterolateral except one (straight lateral).
Surgical technique
All acetabular deficiencies were reconstructed with impaction grafting using auto- and/or 
allografts. This technique has been described in the literature in de ta il.14,21,22 Segmental 
bone defects were first reconstructed with wire meshes before the morselized bone graft 
was impacted and a conventional full polyethylene cup was cemented (Figure 1A-D). 
Femoral deficiencies were also reconstructed with bone impaction grafting, details of this 
technique are also found in the literature .18,23-25 We categorized acetabular defects in 
accordance with the classification system of the American Academy of Orthopaedic 
Surgeons.26 In total, 116 of the 124 revised cups (94%) had an acetabular deficiency. 
Type I segmental deficiencies occurred in 14 hips, Type II cavitary defects in 28 hips, 
and Type III combined deficiencies in 73 hips. A type IV pelvic discontinuity was present 
in 1 case. Using impaction grafting we reconstructed all deficiencies, including mild 
cavitary defects; however most were larger defects. In 61 of the 106 stem revisions 
femoral reconstruction with bone impaction grafting was performed. As source fo r the 
impaction grafting 1 to 5 femoral heads were used. Only cemented components were 
used. We cemented acetabular and femoral components with a third-generation 
cementing technique with antibiotic loaded cement. Before 1989, we used Palacos® bone 
cement (Merck, Darmstadt, Germany); from 1989 on, we used Surgical Simplex® 
(Stryker Howmedica, Newbury, UK). All patients received antibiotic prophylaxis 
consisting of 2g cefazolin intravenously after cultures. Other precautionary measures to 
prevent infections were the use of an operating theatre with laminar airflow and the use 
of two pairs of sterile gloves.
In the 124 cup revisions we used 58 (47%) Exeter™ Contemporary™ cups with an 
inner diameter of 28 mm (n = 57) or 22.225 mm (n = 1) (Stryker Howmedica, Newbury, 
UK), 18 (15%) Charnley®/Elite™ cups with an inner diameter of 22.225 mm (n = 2), 28 
mm (n = 15) or 32 mm (n = 1) (DePuy, Leeds, UK), and 48 (39%) Müller/AlloPro cups 
with an inner diameter of 22.225 mm (n = 2), 28 mm (n = 2) or 32 mm (n = 44) 
(Sulzer, W interthur, Switzerland).
For the 106 revised femoral components, we used an Exeter™ stem in 100 cases 
(94%), a Charnley® / Elite™ stem in 4 cases (4%), and a Müller stem or W aldem ar-Link 
stem (Link, Hamburg, Germany) both in 1 case (1%). All femoral heads used were made 
of a cobalt-chrome alloy; no ceram ic implants were used.
Post operative treatment
Postoperatively, all patients received thrombosis prophylaxis with low-molecular-weight 
heparin for 6 weeks, or before 1999 with acenocoumarol (the individual dosage regimens 
regulated with regular coagulation tests), for 3 months. To prevent heterotopic 
ossification, we used nonsteroidal anti-inflammatory drugs (NSAIDs) for 7 days. Patients 
with a direct cementation were mobilized under supervision of a physical therapist 1 or 2
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(A) Visualisation of the segmental rim defect with the 
trial socket after acetabular reaming and 
preparation. A combined (type 3) defect is present.
(C) Impaction of morselized bone grafts with 
impactors. Multiple layers of grafts are impacted with 
great force giving a stable reconstruction.
(B) Reconstruction of the rim with a wire mesh and 
fixation of this mesh with screws in all corners. The 
thin medial wall is reinforced with a wire mesh. With 
the reconstruction of the rim a cavitar defect is 
remaining.
(D) Finally, a full polyethylene cup is cemented onto 
the impacted bone graft. Note that the defects are 
fully reconstructed and there is good containment of 
the cup. The neck of the femoral stem is positioned 
anterior of the acetabulum during the cup revision.
Figure 1. Acetabular reconstruction with bone impaction grafting.
days postoperative. Full weightbearing was increased in 2 to 6 weeks with the aid of one 
or two crutches. The patients who underwent impaction grafting were mobilized 
according to a modified protocol; in the first 6 weeks, only 10% weightbearing was 
allowed and then 6 to 12 weeks of 50% weightbearing using two crutches. After 12 
weeks, full weightbearing mobilization was allowed. In case of extensive reconstruction of 
major defects several weeks of bed rest were maintained ranging from 1 to 6 weeks. We 
used this modified mobilization protocol to ensure graft incorporation before full 
weightbearing.
Routine followup visits were scheduled at 6 weeks; 3, 6, and 12 months; and yearly or 
biannually thereafter. At our outpatient clinic, student researchers not participating in the 
treatment performed clinical analysis using the Harris Hip Score (HHS),27 the Oxford Hip 
Questionnaire Score (OHQS; since 1998),28 and Visual Analogue Scales for pain during 
rest and physical activity on a scale from 0 (no pain) to 100 (unbearable pain) and for 
satisfaction on a scale of 0 (not satisfied at all) and 100 (complete satisfaction).29-33
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Radiological analysis
All anteroposterior pelvis and lateral radiographs of all hips were analyzed on a 
consensus basis by two of the authors (DCJDK, BWS). Radiographic evaluation included 
an assessment of cup position, loosening of the acetabular component, polyethylene 
wear, presence of osteolysis, structural quality of the bone graft, application and position 
of the meshes, migration, heterotopic ossification, and fracture of the cement, mesh, or 
prosthesis. Radiolucent lines and osteolysis were recorded according to the three 
acetabular zones as described by DeLee and Charnley.34 Radiographic loosening was 
defined as demarcation in two or three zones around the acetabular component of 2 mm 
or greater, progressive demarcation, component migration of 3 mm or greater, 
component tilting of 5° or greater, and/or cement or prosthesis fracture. We determined 
cup migration (> 3-mm shift in any direction or > 5° tilting) in relation to the 
interteardrop line instead of the Kohler line.35 Position of the cup of 45° ± 10° was 
considered normal.36 We calculated polyethylene wear using the method of Dorr and 
W an.37 Radiographic evaluation included an assessment of loosening of the femoral 
component, stem position, osteolysis, rounding-off of the calcar, migration, cortical 
hypertrophy and/or atrophy, and cement fractures. Radiolucent lines and osteolysis were 
recorded in accordance with the 7 femoral zones described by Gruen et a l..38 A valgus or 
varus position of the femoral stem was evaluated as normal within a 3° margin.
Loosening of the femoral component was analyzed by the criteria of Harris et a l..39 
Subsidence of 2mm or more was registered abnormal as described by Loudon et a l..40 All 
measurements were corrected for magnification. We classified heterotopic ossification 
according to the system of Brooker et al..41 Graft incorporation was defined as the 
presence of the crossing of trabecular bone on the bone-graft interface on the 
radiographs.
Statistical analysis
We calculated Kaplan-Meier curves to study the survival (time to revision). The end 
points were: (1) revision for any reason, (2) revision for any reason excluding infections, 
(3) revision for aseptic loosening, and (4) radiographic signs of THA loosening.
Differences in outcomes between the groups were determined with the Student's t-test 
(continuous variables after checking for normal distribution) or the chi square test 
(nominal variables). Differences in survival were calculated with the log-rank test. All 
statistical analyses were performed with SPSS 16.0.
Resu lts
Outcome o f clinical questionnaires
The outcome of the Harris Hip Score improved significantly after surgery (paired sample 
t-test, p < 0.001), but the difference in the Oxford Hip Questionnaire pre and 
postoperative was not significant (paired sample t-test, p = 0.324) (Table 2). The 
postoperative experienced pain was low and patients were satisfied. Patients who needed 
a repeat revision showed no significant increase of the HHS and OHQS at final follow-up 
with a median preoperative score HHS and OHQS of 57 and 42 versus 86 and 23 
postoperative, respectively (paired sample t-test, p = 0.122 and p = 0.138).
Repeat revisions
Nineteen percent of all revisions needed a repeat revision (Table 3). Mean time to repeat 
revision was 5.6 years (range, 0.6-14.1 years). Reasons for repeat revision were: aseptic 
loosening (13), septic loosening (10), recurrent dislocations (2), traumatic loosening (2), 
and abductor contracture (1). In 17 cases both components, in 3 cases the stem and in 8 
cases the cup needed repeat revision. O f the 10 hips needing repeat revision because of 
septic loosening, 5 were primarily revised for septic loosening. Five cases were converted 
to a permanent G irdlestone situation (4 infections, 1 traumatic loosening in a patient with 
no compliance). In 5 cases the repeat revision failed, of these 5 patients 2 cases resulted
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in a permanent Girdlestone (Figure 2). Finally, 7 of 146 (4.8%) revisions ended in a 
permanent Girdlestone.
Table 2. Outcome of clinical questionnaires.
Values are expressed as median, with range in parentheses; VAS = visual analog scale; NA = not available.
Table 3. Indications for repeat revision and component(s) revised.
Figure 2. Flowchart about the revisions during follow-up.
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Table 4. Radiographical findings of all evaluated revisions (n = 146).











>3 5° 7 Varus (>3°) 15
35°-55° 101 Neutral 85










Vert ical 11 Subsidence 26








Type 1 18 15
Type 2 11 8
Type 3 4 5
Type 4 1 1
None 88 75
Fractures
Mesh(fi xation) 2 Trochanter 5








Without repeat revision 0,11
Range (0-1,21)





Medial & rim 29
Cortical hypertrophy n/a Yes 10
No 94
Cortical atrophy n/a Yes 2
No 102
Sclerosis n/a Yes 0
No 104
Rounding-off n/a Yes 2
No 102
n/a = not applicable
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Results o f radiological analysis
Twenty-one (17%) of the 124 revised cups were radiographically loose, 13 of these loose 
cups have had a repeat revision. Four (4%) of the 106 revised stems were 
radiographically loose, 2 of these stems have had a repeat revision. Radiographical 
follow-up was complete in 143 cases. O f 2 deceased patients all radiographs were 
missing and the THA could not be evaluated radiographically. Analysis of the 
postoperative radiographs was performed of the 124 revised cups and 106 revised stems 
(Table 4). Four cups were difficult to evaluate because of the overlap of the metal mesh. 
Twenty-one cups showed radiolucent lines, 17 were progressive. All but 3 radiolucent 
lines were on the bone-cement interface. In 110 cases of reconstruction with bone 
impaction grafting, the graft showed signs of fully incorporation, the graft was lytic in 2 
cases. Average wear was 0.12 mm/yr for the cups who did not needed repeat revision, 
and 0.17 mm/yr for the cups who needed a repeat revision (Independent sample t-test, 
p = 0.507). There was not a significant difference in average wear between the cups 
which were radiological stable en the radiological loose cups (independent sample t-test, 
p = 0.284).
Results o f survival analysis
No differences in survival were found between the THA and cups revised because of 
aseptic loosening or septic loosening with endpoint revision for all reasons (log-rank test, 
p = 0,452 and p = 0.312) and endpoint revision for aseptic loosening (log-rank test, p = 
0.258 and p = 0.746). The cumulative survival of all revisions with endpoint revision for 
all reasons of either component was 78% after 10 years (Table 5). Survival with endpoint 
aseptic loosening of the THA, cup, and stem was respectively 87%, 91%, and 94% after 
10 years (Table 5). Radiographical survival after 10 years with endpoint radiographical 
loosening was 76.3% (SE 5.7) for the cups and 94.0% (SE 3.1) for the stems.
D iscussion
The aim of this study is to report the clinical results, repeat revisions, radiographic 
results, and survival of a population consisting of patients younger than 60 years old who 
underwent a cemented revision of one or more components of their THA. Because of the 
increasing use of primary THA in young patients and the lim iting reports of results after 
revision THA in these young patients.
In our study 19% of all revisions needed a repeat revision. It is well known that age is 
an important factor for the success of a revision THA. Young patients have a higher risk 
for recurrent loosening.43 The main reason for repeat revision was aseptic and septic 
loosening. It is remarkable that 5 of the 10 repeat revisions for septic loosening were 
also primarily revised because of an infection. To prevent a recurrence of an infection we 
performed only 2-stage revisions in the suspicion of infection. A revision THA was only 
implanted when cultures and lab tests showed no signs of infection. At final follow-up 
only 7 of 146 cases (4.8%) ended in a permanent G irdlestone and thus in a definitive 
failure of the THA. This is a low rate and we think it is because of the advantages of the 
used reconstruction methods. With bone impaction grafting the bone deficiencies are 
biologically restored, which creates a better position for a future repeat revision and 
therefore improves the revisability of a THA.20 Other revision techniques like long distal 
fixated uncemented implants, bilobed cups, cages or augments do not naturally restore 
the bone deficiencies.
An additional 6 cups and 2 stems were radiographical loose besides the THA that 
already needed a repeat revision. With endpoint radiographical loosening the survival of 
the cups was 82% and 94% for the stems. Raut et a l.44 reported a cup survival of 75% 
with endpoint radiographical loosening after 6 years. With the use of the so called 
second-generation cementing techniques, the number of radiographical loose THA en the 
appearance of radiolucent line is decreased.45
The HHS and OHQS improved for patients w ithout repeat revision. This is in line with 
reported clinical outcome in the literature.21,42
126 Total Hip Arthroplasty in Young Patients


























Standard error in brackets
Table 6. Review of the literature about revision THA <60 years.
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* = Only patients included with revision because of aseptic loosening, ** = Only patients included with revision 
because of aseptic loosening and patients with inflammatory diseases excluded. - = Not reported.
Our results of cemented revision THA in young patients are very acceptable. These 
results are at least comparable or even better compared to those reported in the 
literature. Only a few studies do report the results of revision THA in patients under the 
age of 60 years (Table 6). Most of these studies included only patients which were 
revised because of aseptic loosening instead of all reason for revision.13,43,44 We found no 
significant difference in the survival of THA revised because of aseptic or septic 
loosening. Only one other study evaluated the results of all revisions.42 In our opinion, 
none of these studies are complete; often only aseptic survival, m id-term results, or the 
outcome of one component is reported. Raut et al .44 studied the outcome of 87 revised 
cups because of aseptic loosening after a mean follow-up of 6 years. They found a 
survival of 90% with endpoint revision for all reasons after 6 years. Patients with an 
inflammatory disease were excluded. Stromberg et al.43 reported an outcome of 80% 
after 8 years in a study about 48 cups revised because of aseptic loosening. They 
excluded patients with an inflammatory disease too. In another study about 30 cups who 
were revised because of aseptic loosening, a survival outcome of 89% was found after 
7.2 years with endpoint revision of the cup for all reasons.13 When we specially look at
6 8 8
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the cups revised because of aseptic loosening (n = 81) in our study a survival is found of 
90%, 88%, and 86% after 6, 7, and 10 years with endpoint revision for any reason. The 
survival of these cups with endpoint revision for recurrent aseptic loosening the survival 
is 99%, 97%, and 94% after 6, 7, and 10 years. Just one study report the results of 
uncemented implants in revision THA in young patients. Thorey et a l.42 reported a 
revision rate of 5% of the uncemented Bicontact stem after a mean follow-up of 8 years 
with endpoint revision for any reason. No results about cup revisions were given. 
Schreurs et a l.21 reported the use of bone impaction grafting in acetabular revision THA 
in young patients before. They found a survival of 89% and 100% with endpoints 
revision for all reasons and revision for aseptic loosening after 10 years.
As far the authors are aware of, this is the largest and the only study about revision 
THA in young patients with survival analysis of both components and different endpoints 
with mid- to long-term follow-up. The survival of cemented revision THA in patients 
under the age of 60 is satisfying. Reconstruction of acetabular and femoral bone 
deficiencies with bone impaction grafting is a promising and biological attractive 
technique in this young and high demanding population and enhances the revisability of 
a THA.
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Summary
In the Netherlands, almost 21.000 total hip arthroplasties are implanted every year. The 
total hip arthroplasty is one of the most successful medical interventions of the last 
decades. For over 50 years, total hip arthroplasties have been implanted in patients and 
because of the good results over the last 3 decades, this operation is more frequently 
performed in young patients (under 50 years). The results of total hip arthroplasties in 
older patients are in general very good, but the results in young patients are more 
variable. Different factors are responsible for this unfavourable outcome.
Young patients are more active and they engage in higher and longer activity levels. A 
higher activity level is associated with higher revision rates. This could be attributed to 
the higher wear rates of the polyethylene cups or inserts (PE wear). Young patients have 
increased demands and they put higher loads on the prosthesis. They participate in more 
extensive and heavy activities.
Young patients commonly have secondary osteoarthritis and acetabular bone 
deficiencies due to underlying diseases like developmental dysplasia of the hips or 
rheumatoid arthritis. In contrast to the older population, these defects are more common 
in young patients. In our view, before implantation of the acetabular component these 
bone defects must first be reconstructed. At the Radboud University Nijmegen Medical 
Centre these defects are always reconstructed with metal meshes, impacted bone grafts 
and a cemented full polyethylene cup. This technique has been designed, developed, 
refined, used and studied in our Orthopaedic Centre since 1979. The results of the bone 
impaction grafting technique are excellent in older patients.
The objective of this thesis is to evaluate the results of cemented primary total hip 
arthroplasties in young patients under 40 and 50 years of age and the results of 
cemented revision total hip arthroplasties in patients under 60. A second objective is to 
evaluate the use of acetabular reconstructions with impacted bone grafts within these 
patient populations in both primary and revision THA.
In Chapter 2 the theoretical basis of this thesis is described. Using a literature review, 
all long-term studies concerning THA results are evaluated. Only studies with a mean 
follow-up of more than 10 years were selected. Our search query resulted in 2999 hits. 
After screening these hits, only 109 articles about total hip arthroplasties in patients 
under the age of 50 fulfilled our criteria in general. However, only 37 out of 109 articles 
(34%) had a mean follow-up of more than 10 years and were selected. The results of 
these studies were compared with the NICE-criteria. The NICE study group defines that a 
prosthesis should have a survival rate of more than 90% after 10 years with endpoint 
revision for any reason. Subsequently, only 15 out of the 37 studies complied with the 
NICE-criteria. 13 of these studies describe the results of cemented implants, 1 of 
uncemented implants, and in 1 study multiple techniques were used.
In a comparison of all studies with a mean follow-up longer than 10 years, this review 
shows that the cemented prostheses have significant better survival rate than 
uncemented implants in patients under 50 years.
The Exeter™ (Stryker-Howmedica, Newbury, UK) prosthesis is an implant that is being 
used worldwide in large numbers. The Exeter prosthesis was introduced in our clinic in
1991 and has been our standard prosthesis in primary total hip arthroplasty at the 
Radboud University Nijmegen Medical Centre since 1998. Analysis of the results of the 
Exeter stem in patients under the age of 40 is presented in Chapter 3.
In this study 104 Exeter stems in 78 patients were evaluated. The mean age at 
surgery was 31 years (range 16-39 years). After a mean follow-up of 6.2 years (range 2­
13 years), 3 femoral stems (3%) were revised. All revisions were performed because of 
infection and septic loosening. After 7 years the survival rate of all femoral implants was 
96% (95%CI 87-99%) with endpoint revision for any reason. No aseptic loosenings were 
seen, given a survival of 100% after 7 years with endpoint revision because of aseptic 
loosening.
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The cemented Exeter stem gives excellent mid-term results in very young patients 
under the age of 40. These results compare nicely with the long term results of the 
Exeter implant published by the Exeter hospital in the UK, the originators of the implant.
Chapter 4 describes the results of conventional cemented polyethylene cups. In general 
literature, higher revision rates are found for the acetabular cup than for the femoral 
stem. The acetabular cup is the weakest link of a total hip arthroplasty. In our study, 175 
cups in 130 patients under the age of 40 were evaluated. The mean age was 31 years 
(range 16-39) and the mean follow-up was 8.1 years (range 2.0-18.5 years). In this 
study group a total of 84 hips (48%) had an acetabular defect which needed 
reconstruction with bone impaction grafting.
In 21 cases (12%) a cup revision was needed. 8 cups were revised because of 
infection, 2 because of recurrent dislocations, 1 because of a traumatic loosening, and 10 
due to aseptic loosening. Four out of 10 revised cups because of aseptic loosening have 
had an acetabular reconstruction with impacted bone grafts. These cups implanted in 
more difficult and defected acetabuli were revised after a mean follow-up of 11.7 years. 
The remaining 6 cups without acetabular reconstruction, plain primary cups, were revised 
after a mean of 4.0 years. The difference is statistically significant (p=0.032). After 10 
years the survival rate of all cups was 85% (95%CI 78-92%) with endpoint revision for 
any reason. With aseptic loosening as endpoint, 90% (95%CI 81-99%) of the cups 
without a reconstruction was revision free after 10 years. Of the cups with an acetabular 
reconstruction with impacted bone grafts, 95% (95%CI 89-100%) was revisions free 
after 10 years. This was not a statistically significant difference (p=0.73).
Cemented polyethylene cups in patients under the age of 40 show good results on the 
long-term. The cups with an acetabular reconstruction with impacted bone grafts showed 
a clear positive tendency in longer survival compared to the cups without a 
reconstruction. This could be the result of lower activity levels of the patients which 
needed a reconstruction. However, the wear of the cup, which is related to activity, as 
well as the Harris Hip score was the same for the cups with or without an acetabular 
reconstruction. The philosophy is that the reconstruction using bone impaction grafting 
creates a better and stronger trabecular interface between the bone, graft, cement and 
cup.
The long-term results of both the cup and stem in patients under 40 years in our study 
are promising (Chapter 5). Analysis of a group of 130 patients under 40 years (175 
hips) shows that was 83% (95%CI 76-90%) of all total hip arthroplasties survived at 10- 
year with endpoint revision for all reasons. Survival with endpoint revision for aseptic 
loosening was even 92% (95%CI 86-98%). After a mean follow-up of 8.1 years (range 
2.0-18.5 years), 24 of the 175 hips were revised. Aseptic loosening was the most 
frequent indication for revision (11 hips). There were also revisions because of septic 
loosening (8), recurrent dislocations (4), and traumatic loosening (1). Additionally, 8 
peroperative complications were seen. Postoperative there were 35 complications of 
which 7 needed a surgical intervention.
Replacement of the hip joint in patients under 40 years with a cemented total hip 
arthroplasty gives acceptable long term results. If we compare these results to the 
results in published studies, the results of uncemented total hip prosthesis are inferior to 
the published results of cemented prostheses in patients under 40 years of age.
In Chapter 6 all cemented total hip prostheses in all patients aged between 40 and 50 
years at the time of the operation, were examined. 140 consecutive patients with in total 
168 total hip prostheses were included. Acetabular reconstruction using bone impaction 
grafting was necessary in 70 hips (42%). The average follow-up was 10 (range 2-19) 
years. During the follow-up 29 hips (17%) were revised.
The clinical results using questionnaires showed statistically significant improvement 
after the surgery. Kaplan-Meier survival analysis showed a survival rate of 88% (95%CI
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82-94%) after 10 years with endpoint revision for any reason. Survival with endpoint 
revision for aseptic loosening was 94% (95%CI 90-99%) after 10 years.
This study shows that the chances of survival of cemented prostheses in patients aged 
between 40 and 50 years are high and comparable to the results achieved with cemented 
total hip arthroplasties in the elderly population. Reconstructions of acetabular bone 
defects with impacted morselized bone grafts in this population give promising results 
and are equal to the results of total hip prostheses without acetabular reconstructions, 
keeping in mind that the reconstructed cups are the more difficult hips.
Because of the promising results of the total hip arthroplasties reconstructed with 
impacted bone grafts in young patients (Chapters 4, 5 and 6), in Chapter 7 all total hip 
arthroplasties reconstructed with impacted bone grafts in all patients that were under the 
age of 50 at the time of surgery, and operated at our department since the development 
of this technology in 1979 were evaluated. Since 1979 177 hips in 150 patients have 
been reconstructed with impacted bone grafts. The average age was 38 years (range 16­
49 years) and the average follow-up was 10.3 (range 2-28.3) years. 34 hips (19%) had 
a type 1 segmental defect, 97 (55%) had a type 2 cavitary defect, 45 (25%) had a type 
3 combined defect, and 1 (0.6%) patient had a bony ankylosis according to the 
classification of the AAOS for bone defects.
Of the 177 hips 28 were revised. This leads to a survival rate of 91% after 10 years 
and 78% after 15 years with endpoint revision for all reasons. The survival rate with 
endpoint aseptic loosening was 96% for the cup and 97% for the stem after 10 years. 
Clinical outcome measured with clinical questionnaires increased significantly 
postoperative.
In conclusion, total hip arthroplasties reconstructed with impacted bone grafts show 
good results and meet the NICE-criteria (a survival of >90% after an average follow-up 
of 10 years with endpoint revision for any reason).
In Chapter 8, the concept of revisability is introduced using the results of 343 cemented 
total hip arthroplasties in 270 patients aged under 50 years. Not only were the results of 
the primary total hip prosthesis evaluated, but we evaluated also to the results of the 53 
revisions within the same population. The average age at the time of the primary 
operation was 38 (range 16-49) years. The average follow-up was 8.9 years (range 2.0­
19.3 years) for the primary hip prostheses and 4.2 (range 0.1-14.8) years for the 
revision total hip arthroplasties. Acetabular reconstruction with impacted bone grafts was 
primarily performed in 155 hips (45%). The most common diagnoses in this age group 
were: congenital hip dysplasia, rheumatoid arthritis, and corticosteroids induced femoral 
head necrosis.
53 of the 343 primary total hip prostheses were revised. In 2 cases with septic 
loosening, it was decided that no new hip prosthesis should be implanted but a 
permanent Girdlestone situation was created. A re-revision was necessary in 3 of the 51 
revised hips (6%) because of aseptic loosening (n=1) and septic loosening (n=2).
In the group of primary total hip prostheses the survival rate was 86% with endpoint 
revision for any reason after 10 years. The survival with endpoint aseptic loosening was 
100% and 93% after 10 years for the stem and cup respectively. Survival of the 
revisions was 91% after 5 years with endpoint re-revision because of any reason and 
100% with endpoint re-revision for aseptic loosening after 5 years. The outcome of 
clinical questionnaires improved significantly postoperative, both in the primary and 
revision total hip arthroplasty patients.
Cemented implants in young patients provide satisfactory results in both primary and 
revision arthroplasties with a good survival rate and good clinical outcome. The use of 
impacted bone grafts for the reconstruction of bone defects enhances the revisa bility of a 
THA.
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Chapter 9 describes the results of cemented revision hip arthroplasties in patients under 
the age of 60. Not only the results of a primary hip prosthesis should be good, but also 
the results of the following revision. All patients who have undergone a revision between
1992 and 2005 and under the age of 60 were evaluated. A total of 146 revisions in 129 
patients were included. There were 124 cup and 106 steel revisions. All bone defects 
were reconstructed using impacted morselized bone grafts. The average age was 47 
years and the average follow-up was 7.6 (range 2.0 16.7) years.
During the follow-up in 19% (28 hips) a re-revision was necessary. Reasons for re­
revision were: aseptic loosening (13), septic loosening (10), recurrent dislocations (2), 
traumatic loosening (2), and abductor contractracture (1). All bone defects were 
reconstructed with impacted bone grafts. Repeat revision of 7 of the 146 hips (5%) was 
not possible due to recurrent and permanent infection and ended in a permanent 
Girdlestone situation. The 10-year survival rate was 78% with endpoint re-revision for 
any reason and 87% with endpoint re-revision for aseptic loosening. No significant 
differences in survival were seen between the different indications for revision.
The survival of cemented revisions in patients under 60 shows fairly good results. 
Compared to the published literature, the results are at least similar or even better. 
Reconstruction of bone defects with impacted bone grafts, both acetabular and femoral, 
leads to acceptable results and improves the revisability of the revision because of 
restoration of the bone defects in a biological manner and at the next rerevision bone 
stock is generally preserved.
Conclusion
This thesis describes the results of cemented total hip arthroplasties in young patients. In 
the different chapters the results of cemented total hip prostheses in patients younger 
than 50 years in primary hip prostheses or 60 years at the time of the surgery in revision 
hip arthroplasty, are presented.
The results of the studied populations are similar to the results of cemented total hip 
arthroplasties in the literature. The results of cemented total hip arthroplasties are better 
than the published results of uncemented total hip prostheses in young patients. Based 
on this information, it could be stated that in young patients a cemented total hip 
prostheses is still preferred over an uncemented implant. This is definitely in contrast to 
what most leading expert surgeons and the orthopaedic industry claims. The 
Scandinavian Hip Arthroplasty Registers show that the use of uncemented components 
increases and the use of cemented components decreases in young patients and this in 
contrast to the shown long term results. In some countries even cemented implants were 
and are never used in this challenging population. In this thesis, it is stated that the 
results of the 'old-fashioned' well cemented hip arthroplasty are favorable and attractive. 
In addition, the outcome of revisions of these cemented hips also leads to acceptable 
results.
Multiple studies show that the acetabular cups reconstructed with impacted bone 
grafts have a positive tendency in better survival rates than the cups without an 
acetabular reconstruction. This difference cannot be explained by differences in activity 
levels, but it is probably related to the intrinsic characteristics of this reconstruction 
technique. Further research into the characteristics of the created interface between 
bone, grafts, cement, and cup is necessary. Pitfalls of this technique are that it is a 
difficult reconstruction method, it is relatively more time consuming, and the 
postoperative mobilisation is often delayed.
The conclusion of this study is that cemented implants definitely have good results in 
young patients, in both the past and present with the implants used nowadays. One 
could consider if not every total hip arthroplasty in younger patients should be 
reconstructed with impacted bone grafting to create this improved trabecular interface 
between host bone, impacted graft, cement and cup. This technique provides a better 
survival of the acetabular cup, which is normally the weakest link of a total hip 
arthroplasty.
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With this thesis the challenge has not yet been completed. It only describes a small 
proportion of all the factors related to total hip arthroplasty, different techniques, and 
survival. A few suggestions for further research are:
• The real long-term survival (>20yrs) of THA in young patients.
• The level of activity in young total hip arthroplasty patients.
• The long-term survival of the acetabular cup with newer bearing materials and the 
consequences of the use of these materials in wear rates.
• The cytological, histological and biomechanical aspects of the graft, host bone, 
cement, and cup interface in bone impaction grafting.
• The long-term survival of the new generation uncemented implants in young patients.
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Samenvatting
In Nederland worden jaarlijks bijna 21.000 totale heupprothesen geplaatst. De totale 
heupprothese is één van de meest succesvolle medische interventies van de afgelopen 
decennia. Al meer dan 50 jaar worden totale heupprothesen bij patiënten geïmplanteerd, 
waarbij de laatste 3 decennia deze operatie ook steeds meer bij jonge patiënten (<50 
jaar) wordt uitgevoerd. De resultaten van een totale heupprothese bij oudere patiënten 
zijn doorgaands zeer goed, maar de lange termijn resultaten bij de jongere patiënten 
populatie zijn zeer wisselend. Hiervoor zijn verschillende oorzaken aan te wijzen. 
Allereerst neemt men aan dat jonge patiënten actiever zijn. Een hoger activiteitsniveau is 
gecorreleerd aan een hoger revisie percentage. Dit zou verklaard kunnen worden door 
meer slijtage van het polyethyleen waarvan de cup of insert doorgaans gemaakt is (PE 
wear). Jonge patiënten belasten hun prothese zwaarder. Ze nemen deel aan zwaardere 
en inspannender activiteiten.
Ook hebben jonge patiënten vaak een onderliggende diagnose welke gepaard gaat 
met forse destructie van het acetabulum, bijvoorbeeld congenitale heupdysplasie of 
reumatoïde artritis. In tegenstelling tot de oudere patiëntengroep zijn grote acetabulaire 
defecten eerder regelmaat dan uitzondering. Deze defecten moeten eerst 
gereconstrueerd worden voordat er een acetabulaire cup geplaatst kan worden. In het 
UMC St Radboud worden deze defecten altijd gereconstrueerd met metaal gazen of 
netjes, geïmpacteerde botsnippers en een gecementeerde polyethyleen cup. Deze 
techniek wordt al vanaf 1979 gebruikt en is sindsdien verder ontwikkeld. De resultaten 
van deze techniek zijn zeer goed, zowel bij de oudere als bij de jongere patiënt.
Doel van dit proefschrift is het evalueren van de resultaten van gecementeerde 
primaire totale heupprothesen bij patiënten onder de 50 jaar en van revisie totale 
heupprothesen bij patiënten onder de 60 jaar. Tevens wordt het gebruik geëvalueerd van 
acetabulaire reconstructies met geïmpacteerde botsnippers in deze patiënten populaties.
In Hoofdstuk 2 wordt de theoretische basis voor dit proefschrift gelegd. Met behulp van 
een literatuur review is gekeken wat de gepubliceerde resultaten waren van lange 
termijn studies. Als selectie criteria is gekozen om alleen studies met een gemiddelde 
follow-up van 10 jaar of meer mee te nemen. Met behulp van de onderzoeksvraag 
kregen we 2999 hits, na selectie bleven er 109 artikelen over die over totale 
heupprothesen bij patiënten onder de 50 jaar gingen. Slechts 37 van de 109 (34%) 
studies hadden een gemiddelde follow-up van 10 jaar of meer. De resultaten van deze 
studies werden naast de NICE-criteria gehouden. De NICE werkgroep stelt dat een goede 
prothese een overleving van meer dan 90% zou moeten hebben na gemiddeld 10 jaar 
met eindpunt revisie voor alle redenen. Van de 37 studies voldeden er maar 15 aan de 
NICE-criteria, hiervan waren er 13 over gecementeerde prothesen, 1 over 
ongecementeerde prothesen en in 1 studie werden meerdere technieken gebruikt.
Bij een vergelijking van de resultaten van alle studies met een gemiddelde follow-up 
van minimaal 10 jaar, bleek dat de gecementeerde prothesen een statistisch significant 
betere overleving hadden dan ongecementeerde prothesen bij patiënten onder de 50 
jaar.
De Exeter™ (Stryker-Howmedica, Newburry, Groot-Brittannië) prothese is een implantaat 
dat wereldwijd steeds vaker wordt gebruikt. Deze prothese werd in 1991 geïntroduceerd 
in onze kliniek en is vanaf 1998 de standaard prothese die gebruikt wordt bij totale 
heupvervanging in het UMC St Radboud. Analyse van de resultaten van de Exeter steel 
bij patiënten onder de 40 jaar werd besproken in H oofdstuk  3.
In deze studie werden 104 Exeter stelen in 78 patiënten onderzocht. De gemiddelde 
leeftijd in deze groep was 31 jaar (spreiding 16-39 jaar). Na een gemiddelde follow-up 
van 6.2 jaar (spreiding 2-13 jaar) waren 3 femorale stelen (3%) gereviseerd. Allen 
waren gereviseerd wegens septische loslating. Na 7 jaar was de overleving van alle 
prothesen met als eindpunt revisie voor welke reden dan ook 96% (95%B.I. 87-99%). Er
Chapter 11: Samenvatting en Algemene Discussie 141
waren geen aseptische steel loslatingen, hierdoor was de overleving met eindpunt 
aseptische loslating van de steel 100% na 7 jaar.
De gecementeerde Exeter steel laat zeer goede middellange termijn resultaten zien bij 
jonge patiënten onder de 40 jaar.
Hoofdstuk 4 beschrijft de resultaten van conventionele gecementeerde polyethyleen 
cups. In de literatuur blijkt dat de cup een hogere revisie percentage heeft dan de steel. 
Dit maakt de cup tot de zwakste schakel van een totale heupprothese. Er werden 175 
cups in 130 patiënten onder de 40 jaar geëvalueerd. De gemiddelde leeftijd was 31 jaar 
(spreiding 16-39) en de gemiddelde follow-up was 8.1 jaar (spreiding 2.0-18.5 jaar). In 
totaal was er in 84 heupen (48%) sprake van een dusdanig acetabulair defect dat 
reconstructie met geïmpacteerde botsnippers noodzakelijk was.
In 21 gevallen (12%) vond er een revisie van de cup plaats. Er werden 8 cups 
gereviseerd wegens infectie, 2 wegens recidiverende luxaties, 1 wegens een 
traumatische loslating en 10 wegens aseptische loslating. Van de 10 gereviseerde cups 
wegens aseptische loslating waren er 4 gereconstrueerd met geïmpacteerde botsnippers. 
Deze cups werden na gemiddeld 11.7 jaar gereviseerd. De 6 gereviseerde cups zonder 
reconstructie waren na gemiddeld 4.0 jaar gereviseerd. Dit verschil is significant 
(p=0.032). Na 10 jaar was de overleving van alle cups 85% (95%B.I. 78-92%) met 
eindpunt revisie voor welke reden dan ook. Kijkend naar de aseptische loslatingen was 
90% (95%B.I 81-99%) van de cups zonder reconstructie revisie vrij na 10 jaar. Van de 
cups met reconstructie met geïmpacteerde botsnippers was 95% (95%B.I 89-100%) 
revisie vrij na 10 jaar. Dit verschil was echter niet significant (p=0.73).
Gecementeerde polyethyleen cups in patiënten onder de 40 jaar laten een goede 
overleving zien op de lange termijn. De cups met een reconstructie met geïmpacteerde 
botsnippers hadden een positieve trend in betere overleving ten opzichte van de cups 
zonder reconstructie. Mogelijk dat dit komt door een lager activiteitsniveau van de 
patiënten met een reconstructie, echter de slijtage van de cup welke afhankelijk is van 
activiteit was gelijk voor de cups met en zonder acetabulaire reconstructie. Waarschijnlijk 
zorgt de reconstructie met geïmpacteerde botsnippers voor een betere interface tussen 
bot, graft, cement en cup.
De lange termijn resultaten van zowel de cup als steel in patiënten onder de 40 jaar zijn 
veelbelovend (H oofdstuk  5). Na analyse van een groep van 130 patiënten onder de 40 
jaar (175 heupen) was de 10-jaars overleving van de totale heupprothesen 83%
(95%B.I. 76-90%) met eindpunt revisie voor alle redenen. Aseptische overleving was 
zelfs 92% (95%B.I. 86-98%).
Na een gemiddelde follow-up van 8.1 jaar (uitersten 2.0-18.5 jaar) werden 24 heupen 
gereviseerd. Aseptische loslating was de meest voorkomende indicatie voor revisie (11 
heupen). Er werden tevens heupen gereviseerd vanwege septische loslating (8), 
recidiverende luxaties (4) en traumatische loslating (1). Verder werden er 8 
peroperatieve complicaties gezien. Postoperatief waren er 35 complicaties waar er bij 7 
een chirurgische interventie noodzakelijk was.
Vervanging van het heupgewricht bij patiënten onder de 40 jaar door een 
gecementeerde totale heupprothese laat goede langetermijn resultaten zien. Als we deze 
resultaten vergelijken met de resultaten gepubliceerd in de literatuur blijkt dat de 
resultaten van ongecementeerde totale heupprothese niet zo goed zijn als de 
gepubliceerde resultaten van gecementeerde prothesen in patiënten onder de 40 jaar.
Om de studie populatie uit te breiden werden in Hoofdstuk 6 alle gecementeerde totale 
heupprothesen bij patiënten die ten tijde van de operatie tussen de 40 en 50 jaar waren 
onderzocht. Er werden 140 opeenvolgende patiënten geïncludeerd met in totaal 168 
totale heupprothesen. Acetabulaire reconstructie werden weer uitgevoerd met behulp van 
geïmpacteerde botsnippers en was in 70 heupen noodzakelijk. De gemiddelde follow-up
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was 10 (spreiding 2-19) jaar. Tijdens de follow-up werden 29 heupen (17%) gereviseerd. 
Alle patiënten werden zowel klinisch als radiologisch vervolgd.
De uitkomsten van klinische vragenlijsten verbeterden statistisch significant na de 
operatie. Kaplan-Meier overleving analyse liet een overleving zien van 88% (95%B.I. 82­
94%) na 10 jaar met eindpunt revisie voor alle redenen. Overleving met eindpunt revisie 
wegens aseptische loslating was 94% (95%B.I. 90-99%) na 10 jaar.
Uit dit onderzoek blijkt dat de overleving van gecementeerde prothesen bij patiënten 
tussen de 40 en 50 jaar goed zijn en zelfs vergelijkbaar zijn met de resultaten behaald 
met gecementeerde totale heupprothesen bij de normale, oudere populatie. 
Reconstructies van acetabulaire defecten met geïmpacteerde botsnippers in deze 
populatie laten veelbelovende resultaten zien en zijn gelijk aan de uitkomsten van totale 
heupprothesen zonder reconstructies, terwijl dit doorgaands toch de moeilijkere heupen 
zijn.
Aangezien de resultaten in de voorgaande studies van de totale heupprothesen met een 
acetabulaire reconstructie met geïmpacteerde botsnippers veelbelovend waren, hebben 
we in Hoofdstuk 7 alle heupen onder de 50 jaar nagekeken die sinds de ontwikkeling 
van deze techniek zijn geïmplanteerd. Hiervoor werden alle heupprothesen bij patiënten 
onder de 50 jaar zijn geïmplanteerd sinds 1979 geëvalueerd. Sinds 1979 zijn 177 heupen 
in 150 patiënten gereconstrueerd met geïmpacteerde botsnippers. De gemiddelde leeftijd 
was 38 jaar (16-49) en de gemiddelde follow-up bedroeg 10.3 (spreiding 2-28.3) jaar.
34 heupen (19%) hadden een type 1 segmentaal defect, 97 (55%) een type 2 cavitair 
defect, 45 (25%) een type 3 gecombineerd defect en 1 (0.6%) patiënt had een benige 
ankylosis volgens de classificatie van de AAOS voor botdefecten.
Van de 177 heupen werden 28 heupen gereviseerd. Dit gaf een overleving van 91% 
na 10 jaar en 78% na 15 jaar met eindpunt revisie voor alle redenen. Overleving met 
eindpunt aseptische loslating was 96% voor de cup en 97% voor de steel na 10 jaar. 
Klinische uitkomst gemeten met vragenlijsten nam postoperatief ook significant toe.
Concluderend laten totale heupprothesen gereconstrueerd met geïmpacteerde 
botsnippers goede resultaten zien die zelf de NICE-criteria halen (overleving van >90% 
na gemiddeld 10 jaar).
In Hoofdstuk 8 werd met behulp van de resultaten van 343 gecementeerde totale 
heupprothesen bij 270 patiënten onder de 50 jaar het begrip reviseerbaarheid 
gedefinieerd. Daarvoor werd niet alleen gekeken naar de resultaten van de primaire 
totale heupprothese, maar ook naar de resultaten van de 53 uitgevoerde revisies binnen 
dezelfde populatie. De gemiddelde leeftijd ten tijde van de operatie was 38 (spreiding 
16-49 jaar). De follow-up bedroeg gemiddeld 8.9 jaar (spreiding 2.0-19.3 jaar) voor de 
primaire heupprothesen en 4.2 (spreiding 0.1-14.8) jaar voor de revisie heupprothesen. 
Acetabulaire reconstructie met geïmpacteerde botsnippers was primair nodig in 155 
heupen (45%). De meest voorkomende diagnosen in deze leeftijdsgroep waren: 
congenitale heupdysplasie, reumatoïde artritis en corticosteroïden geïnduceerde 
kopnecrose. 53 van de 343 primaire totale heupprothesen werden gereviseerd. In 2 
gevallen werd besloten om geen nieuwe heupprothese te plaatsen en een permanente 
Girdlestone situatie te creëren. Een re-revisie was noodzakelijk in 3 van de 51 revisies 
(6%) wegens aseptisch loslating (n = 1) en septische loslating (n=2).
Kijkend naar de primaire totale heupprothesen was met eindpunt revisie voor alle 
redenen na 10 jaar 86% revisie vrij. De overleving met eindpunt aseptische loslating was 
100% en 93% na 10 jaar voor de steel en cup. Overleving van de revisies was 91% na 5 
jaar met eindpunt re-revisie wegens alle redenen en 100% met eindpunt revisie wegens 
aseptische loslating na 5 jaar.
Zowel na de primaire als na de revisie heupprothese was een significante toename te 
zien van de uitkomsten van klinische vragenlijsten.
Gecementeerde implantaten in jonge patiënten laten bevredigende resultaten zien 
zowel in primaire als in revisie prothesen met goede survival en klinische uitkomsten. Om
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de reviseerbaarheid te definiëren is geopperd om een criterium te stellen met een 
overleving van >90% voor de primaire en >85% voor de revisie prothese, samen met 
een klinische waardering van minimaal 75% na primaire en revisie totale heupprothese.
Hoofdstuk 9 gaat over de resultaten van gecementeerde revisie heupprothesen bij 
patiënten onder de 60 jaar. Niet alleen de resultaten van een primaire heupprothese 
moet goed zijn, maar ook de resultaten van de daaropvolgende revisie of re-revisie. Alle 
patiënten die een revisie ondergingen tussen 1992 en 2005 en die jonger waren dan 60 
jaar werden geëvalueerd. In totaal werden 146 revisies bij 129 patiënten verricht. Hierbij 
werden 124 cup en 106 steel revisies uitgevoerd. Alle botdefecten werden 
gereconstrueerd met behulp van geïmpacteerde botsnippers. De gemiddelde leeftijd bij 
revisie was 47 jaar en de follow-up bedroeg gemiddeld 7.6 (spreiding 2.0-16.7) jaar.
Tijdens de follow-up was in 19% (28 heupen) een re-revisie noodzakelijk. Redenen 
voor re-revisie waren: aseptische loslating (13), septische loslating (10), recidiverende 
luxaties (2), traumatische loslating (2) en abductor contractuur (1). Weer werden 
eventuele botdefecten met geïmpacteerde botsnippers gereconstrueerd. 7 van de 146 
heupen (5%) eindigden in een permanente Girdlestone.
De 10-jaars overleving was 78% met eindpunt revisie voor elke reden en 87% met 
eindpunt revisie voor aseptische loslating. Geen statistische significante verschillen in 
overleving waren zichtbaar tussen de verschillende oorzaken voor revisie.
De overleving van gecementeerde revisies bij patiënten onder de 60 jaar is redelijk 
goed. In vergelijking met de literatuur zijn de behaalde resultaten vergelijkbaar of vaak 
zelfs beter. Reconstructie van botdefecten, zowel acetabulair als femoraal, laten goede 
resultaten zien en verbeteren de reviseerbaarheid van de revisie omdat bot defecten 
biologisch worden aangevuld.
Conclusie
Dit proefschrift beschrijft de resultaten van gecementeerd prothesen bij jonge patiënten. 
In de verschillende hoofdstukken worden de resultaten onderzocht van gecementeerde 
totale heupprothesen die geplaatst werden bij patiënten die ten tijde van de operatie 
jonger waren dan 50 jaar bij primaire heupprothesen of 60 jaar bij revisies.
De resultaten van de onderzochte populaties zijn vergelijkbaar met de resultaten van 
gecementeerde totale heupprothesen in de literatuur. De resultaten van gecementeerde 
totale heupprothesen zijn beter dan de gepubliceerde resultaten van ongecementeerde 
totale heupprothesen bij jonge patiënten. Op basis van deze gegevens kan men stellen 
dat bij jonge patiënten de voorkeur uit gaat naar gecementeerde totale heupprothesen. 
Dit in tegenstelling tot wat vooraanstaande chirurgen of de orthopedische industrie 
beweren. Uit de Scandinavische implantaten registers blijkt dat het gebruik van 
ongecementeerde componenten toeneemt en het gebruik van gecementeerde 
componenten daalt bij jonge patiënten. In sommige landen worden überhaupt geen 
gecementeerde implantaten gebruikt bij deze uitdagende populatie. Uit dit proefschrift 
blijkt dat de resultaten van de 'ouderwetse' gecementeerde prothesen nog steeds 
aantrekkelijk zijn en dat ze zeer geschikt zijn om te gebruiken bij jonge patiënten omdat 
ze ook nog eens goed reviseerbaar zijn. Tevens zijn de resultaten van de revisie THA 
zeker acceptabel en concurrerend met andere methoden.
Tevens bleek uit meerdere studies dat de acetabulaire cups die een reconstructie met 
geïmpacteerde botsnippers ondergingen een trend in betere overleving hadden dan de 
cups zonder acetabulaire reconstructie. Dit verschil wordt niet verklaard door een verschil 
in activiteitniveau maar is waarschijnlijk gerelateerd aan de intrinsieke kenmerken van 
deze reconstructie techniek. Verder onderzoek naar de karakteristieken van de gevormde 
interface tussen bot, graft, cement en cup is noodzakelijk. Nadelen van deze techniek 
zijn dat de reconstructie methode moeilijk is, het is meer tijdsconsumerend en de 
postoperatieve mobilisatie is langzamer.
De conclusie van dit onderzoek is dat gecementeerde totale heupprothesen bij jonge 
patiënten zowel vroeger als tegenwoordig met de nieuwere implantaten goede resultaten
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hebben. Tevens zou eigenlijk iedere totale heupprothese bij jongere patiënten geplaatst 
zou moeten worden met geïmpacteerde botsnippers. Deze techniek geeft een betere 
overleving van de acetabulaire cup, welke doorgaans de zwakste schakel is van een 
totale heupprothese.
Met dit proefschrift is de uitdaging nog niet voltooid. Het beschrijft enkel een klein 
gedeelte van alle aspecten van totale heupprothesen, verschillende technieken en 
overleving. Enkele suggesties voor verder onderzoek zijn:
• Resultaten van totale heupprothesen op de zeer lange termijn (>20jr)
• Activiteiten niveau van jonge patiënten met een totale heupprothese.
• Lange termijn resultaten van cups met nieuwere articulatie materialen (zoals 
keramiek, crosslinked PE) en de gevolgen van deze materialen of slijtage cijfers.
• Cytologische, histologische en biomechanische eigenschappen van de bot, graft, 
cement en cup interface in reconstructies met geïmpacteerde botsnippers.
• Lange termijn overleving van de nieuwere generatie ongecementeerde implantaten in 
jonge patiënten.
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'Even' het s-je van je naam afhalen, zo noemde ik mijn promotie onderzoek toen ik net 
begon. Nu, ruim 2 jaar en heel wat moeite verder, moet ik het begrip 'even' toch 
aanpassen. Een promotie is een hele onderneming en ik had het zeker niet kunnen 
volbrengen zonder de hulp en steun van een aantal mensen. Ondanks dat jouw naam op 
de voorkant van je boekje mag prijken doe je promoveren zeker niet alleen. Vele mensen 
hebben mij gesteund en geholpen om mijn promotie met succes af te ronden en mij voor 
te bereiden op de opleiding. Graag zou ik al deze mensen willen bedanken.
Wim, wat ben ik blij dat ik bij jou mijn onderzoek mocht doen. Tijdens mijn 
onderzoekstage van mijn geneeskunde opleiding vroeg je of ik wilde blijven om fulltime 
onderzoek te doen. Dit resulteerde in een zeer prettige en fijne samenwerking. We 
hebben heel wat uurtjes samen doorgebracht om alle studies door te nemen, 
röntgenfoto's te bekijken en alle stukken die ik had geschreven door te nemen. Tevens 
heb jij me helemaal wegwijs gemaakt in de wereld die heupprothesiologie heet. Volgens 
mij hebben al mijn manuscripten jou heel wat tijd en flessen wijn gekost. Je zult altijd 
wel een voorbeeld voor me blijven als een goede klinische arts en gepassioneerd 
onderzoeker.
Jean, met jouw ervaring en humor was het promoveren een stuk leuker. Je hebt altijd 
wel een mooie anekdote paraat en er was nooit een saai moment met jou in de buurt. 
Indien we iets te overleggen hadden had je altijd wel een vrij moment voor me en ik kon 
altijd bij je binnenlopen.
Professor Veth, het zal altijd wel professor voor me blijven. Bedankt voor alle 
overlegmomenten in de voorbereiding van mijn promotie en dat u mijn promotor wilt 
zijn. De overlegmomenten heb ik altijd ervaren als een moment van reflectie en 
voorbereiding. Ook werden alle adviezen uitgesproken om mijn carrière en promotie zo 
goed mogelijk te laten verlopen.
De manuscriptcommissie: hartelijk dank voor het beoordelen van mijn manuscript.
De jaren in de barak zouden zonder Joost, Martin en Jaap een stuk minder leuk zijn 
geweest. Met jullie hing er altijd wel een ontspannen academische sfeer in de bedompte 
barak lucht. We hebben heel wat afgelachen, gediscussieerd, ongein uitgehaald en 
gedart. Ik zal nooit de middag break dart wedstrijden vergeten en de (soms) hevige 
discussies over vele verschillende onderwerpen. Indien we onderzoekstechnisch met 
problemen of obstakels zaten konden we er samen wel vaak uitkomen. Ik kijk uit naar 
het moment dat we onze wall of fame vol krijgen.
Maarten, bedankt voor alle flexibiliteit en mogelijkheden voor en tijdens mijn klinische 
periode. Na deze periode heb ik ook je fijne samenwerking mogen ervaren tijdens enkele 
projecten.
Alle dames en heren van het assistentensecretariaat, het stafsecretariaat en de 
polikliniek orthopedie en heelkunde. Iedere keer wanneer ik met mijn verzoekjes 
aankwam werd alles tot in de puntjes geregeld. Dit kon variëren van het oproepen van 
patiënten tot het regelen van vergoedingen en aanvragen.
Al het personeel van de verpleegafdeling, zonder jullie zou ik zeker niet zo'n fijne tijd 
hebben gehad tijdens mijn klinische periode.
Tevens wil ik alle mensen op het orthopedisch en centraal OK-complex willen bedanken 
voor de fijne tijd als ik weer eens mocht genieten tijdens de operaties.
De medewerkers van het status- en röntgenarchief, bedankt voor alle steun en hulp 
bij het opzoeken van de patiënten statussen en oude röntgenfoto's van alle (ruim 500) 
patiënten.
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Jan, als ik statistische ondersteuning nodig had kon ik altijd wel bij je terecht. Jij hebt me 
zeker meer wegwijs gemaakt in de wereld die statistiek heet.
Nienke, Moniek, Sofie, Paul, Gerdien, Katja, Linda, Dirk, Sander, Joost; ik vond het super 
om jullie te mogen begeleiden in het onderzoek tijdens jullie studentenperiode en 
onderzoekstages. Met enkele van jullie heb ik zelfs wat artikelen kunnen schrijven en 
opsturen. Veel succes in jullie toekomstige carrière.
Bram, Kim en Els; dank je voor alle etentjes en ontspanning. Het is fijn om jullie als 
vrienden te hebben. Ondanks het feit dat ieder nu meer zijn eigen weg aan het vinden is 
hoop ik dat de etentjes zullen blijven.
Beste Schoonouders, Marina, Stefanie en Antal & Carolien; dankzij jullie kon ik vaak nog 
even doorwerken terwijl jullie op mijn kostbare kroost pasten. Ook jullie interesse in mijn 
onderzoek stel ik zeer op prijs.
Ben, als mijn broertje kon ik altijd je hulp vragen als ik die nodig had. Samen met Lianne 
heb je ook diverse malen mijn kinderen kunnen bezighouden zodat ik kon werken of 
samen met Christa wat wel verdiende ontspanning kon genieten.
Pa en ma, nou dit is hij dan: mijn proefschrift. Dankzij jullie heb ik de kans gekregen om 
te worden wie ik ben. Jullie hebben me altijd vrij gelaten in alle keuzes van sport tot 
opleiding. Mijn dank is groot.
Christa, je staat hier als een van de laatste maar je verdient eigenlijk een hele speciale 
plaats in dit boekje. Zonder jou zou ikzelf niet compleet zijn. Je hebt me altijd 
ondersteund en je interesse getoond in alles wat ik deed. Dank je dat je me de vrijheid 
en kansen geeft om mijn dromen te verwezenlijken. Het heeft heel wat opofferingen van 
je gekost om mijn promotie en carrière op te bouwen. Tevens heb je me 2 
kostbaarheden gegeven waar ik niet meer zonder kan: onze kinderen Nathan en Evelien.
Nathan en Evelien, ik zou jullie al kunnen bedanken voor alle slapeloze nachten die 
jullie mij en je moeder hebben bezorgd, maar deze vervallen in het niets als ik kijk naar 
alle vreugde, plezier en liefde die jullie me geven. Ik ben er trots op dat ik jullie vader 
mag zijn.
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